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Currently there is considerable interest from both academe and pharmaceutical industry in 
exploring foaming processes and their products in drug delivery applications.  However, 
there is still little knowledge of the impact of the morphology of the foamed structures on 
the performance of drug products in spite of some publications in this area.  Therefore, the 
main objective of this dissertation is to gain a fundamental understanding of the correlation 
between foam morphology and performance of amorphous drug delivery systems, which 
are comprised of an Active Pharmaceutical Ingredient (API) and Polymer excipient. 
The Hot Melt Extrusion (HME) process is used to compound the following API / 
polymer binary systems:  Indomethacin (INM) with Soluplus® (PVCap-PVAc-PEG); 
Carbamazepine (CBZ) with PVCap-PVAc-PEG; and INM with Eudragit® EPO.  
Comprehensive characterization of these binary systems carried out by combining 
Differential Scanning Calorimetry, Fourier Transform Infrared spectroscopy, X-Ray 
Diffraction, and Scanning Electron Microscopy, shows that in all HME-prepared and 
foamed samples the APIs are amorphous and dissolved in the polymer excipients.   
The most important contributions of this dissertation can be grouped into three 
areas: (a) an understanding of the mechanisms by which foamed dosage forms can lead to 
faster API release, as well as the key morphological aspects of the cellular structures to 
achieve this, (b) an understanding of the correlation between the mechanism controlling 
the release of an API from an amorphous dosage and the enhancement in its release rate 
upon foaming, and (c) an understanding of the impact of the morphology of the cellular  
ii 
structures in the milling efficiency of HME products and the dissolution performance of 
the particles produced.   
In the first area, foamed amorphous solid solutions with three different 
morphologies are produced through the batch foaming process.  A strong correlation 
between foam morphology and the enhancement in API release rate is observed.  A 
significant increase in API release rate is achieved by fast disintegration.  Through a very 
broad distribution of wall thicknesses, internal stresses are generated due to different 
local swelling rates in the sample.  In this sense, such foam morphologies act as 
disintegrant-less disintegrants, speeding up API release and release rates.  
In the second area, the release controlling mechanisms of INM and CBZ from the 
amorphous systems are identified by using the Power Law model.  Three distinct 
mechanisms are observed: relaxation controlled, anomalous transport, and diffusion 
controlled.  In all cases, the release rates of the APIs are increased upon foaming.  
However, in cases where the API release is relaxation-controlled, the foamed structures 
show to have the strongest impact at the initial stages of its in vitro release.   
Finally, the Foam Hot Melt Extrusion process is used to produce foamed 
amorphous solid solutions with two different morphologies.  Their performance in terms 
of milling efficiency and in vitro dissolution behavior is compared to that of the un-
foamed extrudates of the same composition.  The milling efficiency is increased 
appreciably through foamed extrudates, and smaller particles with narrower particle size 
distributions are obtained compared to un-foamed extrudates.  Additionally, it is found 
that the enhancement of the release rate exhibited by milled foamed extrudates is the 
most significant for the particles produced by milling the lower density foam extrudates. 
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CHAPTER 1  
INTRODUCTION 
 
Pharmaceutical Hot Melt Extrusion (HME) has and is being incorporated into the units of 
operation used to manufacture of drug delivery systems.  This has been driven by the 
Process Analytical Technology (PAT) initiative of the Food and Drug Administration 
(FDA).  The PAT initiative promotes the used of continuous manufacturing process with 
in-line quality control (FDA 2004), which can be easily accomplished through the 
extrusion process.  HME is a continuous, solvent-free manufacturing process that allows 
to uniformly distribute an Active Pharmaceutical Ingredient (API) in a polymeric 
excipient or carrier; additionally, other intergranular excipients can be incorporated in a 
single process.  The API may exist in its native crystalline state or it may be dissolved in 
an amorphous polymer excipient in order to produce single phase amorphous systems.  
The latter case is of great value for solubilization of APIs with poor aqueous solubility.  
Since amorphous systems make it possible to increase the release and apparent solubility 
of an API, then, potentially its bioavailability can be enhanced. 
In spite of extensive research conducted in the HME area since the 1980’s, there 
still exist challenges associated to this process, specifically in view of the conservative 
nature of the pharmaceutical industry.  First, many APIs are susceptible to thermal 
degradation during processing.  Similarly, the majority of the polymer excipients used in 
the manufacture of orally delivered dosage forms are not well suited (or were not 




excipients used have high melt viscosities and very narrow processing windows which 
makes them very difficult to be processed without plasticizers. 
Other challenges associated with the HME process are related to the nature of the 
extrudates produced after compounding.  On the one hand, extrudates tend to be very 
tough, and, thus, difficult to mill into suitable particle sizes with narrow distributions to 
be used for tableting, to fill into capsules or to be used in liquid suspension.  
Additionally, extrudates tend to be non-porous and, as result, their dissolution rates are 
hindered by slow fluid absorption by the HME products.   
In order to overcome the aforementioned challenges associated with HME, 
foaming processes widely used in the polymer industry, such as foam extrusion and foam 
injection molding, have been explored in the last decade.  Physical blowing agents have 
been used as “fugitive” plasticizers, foamed extrudates have shown to facilitate milling 
operation, and cellular structures have been evaluated as a means to enhance API release 
rate.  Detailed literature review of these and other uses of foaming processes and foamed 
products in pharmaceutics are presented in section 2.3 of Chapter 2. 
Currently there is a lot of interest from both academe and pharmaceutical industry 
in exploring foaming processes and their products in drug delivery applications.  However, 
there is still little knowledge of the impact of the morphology of the foamed structures on 
the performance of drug products in spite of some publications in this area.  Therefore, the 
main objective of this dissertation is to gain a fundamental understanding of the 
correlation between foam morphology and performance of amorphous drug delivery 
systems using foam extrusion and batch foaming processes.  Additionally, the effect of 




In the first part of this dissertation the HME process is used to compound the 
binary system comprising of Indomethacin (INM) as model API and Soluplus® (PVCap-
PVAc-PEG).  Since this is the binary systems used for the majority of the foaming 
studies, its general properties (i.e. solubility of INM is the excipient, in vitro dissolution 
and CO2 solubility in the binary system) are studied in detail. 
Since batch foaming is carried with supercritical carbon dioxide (ScCO2) as the 
blowing agent, its effect on crystallization of INM from its amorphous state is 
investigated.  Amorphous samples of INM are subjected to different batch foaming 
conditions, and their morphological changes are evaluated through Fourier Transform 
Infrared Spectroscopy (FT-IR).   
The Foam Hot Melt Extrusion process is used to produce foamed extrudates of 
the INM / PVCap-PVAc-PEG binary system.  The objective of the foam extrusion study 
been to understand the effect of the morphology of the cellular structure on the milling 
efficiency of extrudates and the in vitro dissolution performance of the particles 
produced.  In this study by varying the foam extrusion conditions two foam morphologies 
were produced and their performance is compared to that of the un-foamed extrudate of 
the same composition. 
The batch foaming process is used perform two different studies.  The main 
objective of first batch foaming study is to understand the correlation between the 
mechanisms controlling the release of an API from an amorphous dosage form and the 
enhancement in its release rate upon foaming.  The Power law model is used to identify 
the API release mechanism from four amorphous systems:  30:70 INM / PVCap-PVAc-




two aqueous buffer solutions with pHs 1.2 and 7.4.  In addition, the effect of the batch 
foaming process with ScCO2 as blowing agent in the physical state of the APIs is studied 
combining Scanning Electron Microscopy (SEM), FT-IR, and X-ray diffraction (XRD).   
The main objective of the second study performed through batch foaming, is to 
gain an understanding of the mechanisms by which foamed dosage forms can lead to 
faster API release as well as the key morphological aspects of the cellular structure 
needed to achieve this.  A secondary goal if this study is to evaluate the impact of the 
cellular structure in the long term physical stability of an amorphous solid solution.  The 
30:70 INM / PVCap-PVAc-PEG binary system is used for this section of the dissertation.  
Foamed samples with three distinct morphologies are produced by varying the batch 
foaming conditions, and compared to the performance of compression molded (non-





CHAPTER 2  
LITERATURE REVIEW 
2.1 Pharmaceutical Hot Melt Extrusion / Hot Melt Mixing  
Pharmaceutical Hot Melt Extrusion (HME) has been an area of great interest in academe 
and pharmaceutical industry since the 1980’s (Crowley et al. 2007), with many and 
extensive investigations, as well as numerous patents and research papers published since 
then.  Briefly, HME is a polymer melt compounding process, adapted from the polymer 
processing industry, where one or more active pharmaceutical ingredients (APIs) are fed 
in an extruder with at least one polymeric excipient.  The processed stream undergoes 
melting of the polymer excipient, mixing and / or dissolution of the API, and is then 
shaped into a continuous extrudate by pumping it through a die followed by cooling.  The 
typical applications of pharmaceutical HME include: sustained release delivery systems, 
drug solubilization, target release and prevention of substance abuse.  Some of these 
applications can be seen in the list of drug products shown in Table 2.1, where a 
summary of their commercial status and the purpose of the HME process are listed.   
As can be seen in Table 2.1, a significant number of the drug delivery systems 
currently manufactured by HME in the market are implants.  In order words, these 
products are drug delivery systems or medical devices that provide sustained API release, 
where the HME process is used to produce an homogenous blend of the API – in either 
its crystalline or amorphous form – with a polymer excipient or carrier and to provide the 
desired shape of the device (Ghebre-Sellassie and Martin 2007).  It should be pointed out 




Controlled release oral dosages have been also be manufactured by this process 
(Follonier et al. 1995; Repka et al. 2007).  The release of the API is delayed or modulated 
by the carrier, which can be either insoluble or slow dissolving in body fluids (Follonier 
et al. 1995).   
Given that one of the prerequisites for absorption of an orally administered API is 
that it must dissolve along the gastrointestinal tract (GI) (Amidon et al. 1995; Dahan and 
Miller 2012), solubilization of APIs with poor aqueous solubility through HME is 
another area where significant research efforts and interest lay.  A significant portion of 
the new discovered APIs have poor aqueous solubility (Crowley et al. 2007; Dahan and 
Miller 2012); it has been estimated that more than 30 % of the APIs in the market have 
poor solubility in an aqueous medium.  Furthermore and more significantly, 70 % out of 
all new molecule entities are expected to show poor aqueous solubility (Benet et al. 
2006).   
Through HME and Hot Melt Mixing (HMM), a batch melt compounding process 
that can be used to perform feasibility assessment for HME, it is possible to dissolve an 
API in a molten polymer excipient, and, thus increase its release rate and apparent 
solubility (Breitenbach 2002; Crowley et al. 2007; Ghebre-Sellassie and Martin 2007; 
Repka et al. 2007; Liu 2010).  It is important though to bear in mind that this does not 
necessarily result in enhanced bioavailability, since permeability of the API through the 
GI track also plays a significant role in its absorption (Amidon et al. 1995; Dahan and 
Miller 2012).  However, rendering a poorly soluble API soluble is the starting point for 
rendering poorly soluble APIs bioavailable.  The dissolution mechanisms of the API in 




















 Implant Anti-Viral (HIV) UD
a
 Shape 
Lacrisert® None HPMC Implant Dry eye syndrome M Shape 
NuvaRing Etonogestrel + Ethinyl Estradiol EVA
a
 Implant Contraceptive M Shape 
Zoladex Goserelin acetate PLGA Implant Prostate cancer M Shape 
Implanon Etonogestrel EVA Implant Contraceptive M Shape 
Ozurdex® Dexamethasone PLGA Implant Macular Edema M Shape 
Kaletra® Lopinavir + Ritonavir PVP-VA Tablet Anti-Viral (HIV) M Amorphous solution 
Norvir® Ritonavir PVP-VA Tablet Anti-Viral (HIV) M Amorphous solution 
Eucreas® 
Vildagliptin + Metformin 
hydrochloric 
HPMC Tablet Diabetes M Melt granulation 
Zithromax® Azithromycin HPMC Tablet Antibiotic M Taste Masking 
Gris-PEG® Griseofulvin PEG Tablet anti-fungal M Crystalline dispersion  
Rezulin® Troglitazone PVP Tablet Diabetes W Amorphous solution 
Palladone
TM
 Hydrophone EC + ERS Tablet Pain W Controlled release 
Posaconazole Posaconazole - - Anti-fungal UD Amorphous solution 
Anacetrapib Anacetrapib - - Cardiovascular disease UD Amorphous solution 
*EVA: Ethyl Vinyl Acetate, HPMC: Hydroxypropyl methylcellulose, PLGA: Poly(lactic-co-glycolic acid), PVP-VA: Polyvinyl pyrrolidone co-vinyl acetate, 
PEG: Polyethylene glycol, PVP: Polyvinyl pyrrolidone, EC: Ethyl cellulose, ERS: Eudragit® RS. 
Source: 
a
 (Loxley 2010) 
b
 (DiNunzio 2011).  
c




Besides sustained release and API solubilization, HME allows to target the release 
of an API to a specific section of the GI tract.  This is accomplished by embedding the 
API (either in its crystalline or amorphous form) in a polymer excipient that only 
dissolves in a specific pH range (Doelker 1993; Follonier et al. 1995; Andrews et al. 
2008) or through specific API / excipient interactions (Sriwongjanya and Bodmeier 1998; 
Lele and Hoffman 2000).  This is also of great interest for taste-masking applications. 
Finally, HME allows the manufacturing of dosage forms that aid the prevention of 
substance abuse (Oshlack et al. 2001; Arkenau-Maric and Bartholomaus 2008).  Many 
APIs have habit-forming side effects that may lead to addiction and substance abuse.  For 
example, in order to obtain a fast-acting and high dosage of such types of APIs, abusers 
crush the dosage forms into fine powders, which then can be consumed nasally or can be 
dissolved to be administered intravenously (Arkenau-Maric and Bartholomaus 2008).  
Therefore, HME is used to manufacture very tough dosage forms – with breakage 
strengths exceeding 500N (Arkenau-Maric and Bartholomaus 2008) –  which makes it 
very difficult to break and grind them.   
2.1.1 Description of the HME Process and Mechanisms 
The pharmaceutical HME process is carried out at temperatures 50 to 100 C above the 
glass transition temperature (Tg) of the polymer (or above its melting point in the case of 
semi-crystalline polymer excipients) and generally below the melting point of the API, 
though it can also be carried out above the melting point of the API if thermal 
degradation is not an issue.   
From a general perspective, the HME process can be described by the following 




the system is miscible), devolatilization and pumping (Tadmor and Gogos 2006; Gogos 
2012).   
In more detail, the API and the polymer are fed as solids particulates, either 
independently or as a dry blend.  These solids are then conveyed by the screws, thereafter 
the materials are heated and the polymer melts primarily by heat generated volume-wise 
through frictional and plastic energy dissipation created by the action of kneading blocks 
deforming fully-filled stream regions (Tadmor and Gogos 2006).  Once the polymer is 
melted, and if the system is miscible, the API can be progressively dissolved in the 
polymer, by distributive laminar mixing flows. 
Figure 2.1 shows the dissolution mechanism of API in a molten polymer of a 
miscible system when compounding is carried out below the melting point of the active 
ingredient.  This schematic representation shows first the dry blend of the API and the 
excipient, representing the feed, and once the polymer is melted the crystalline particles 
are suspended in the melt.  Then, dissolution of the API in the polymer commences by 
the formation of a boundary layer along the surface of the crystalline particles, followed 
by distributive and dispersing mixing, until the API is completely dissolved in the 
polymer.  
After melting and mixing, devolatilization or venting is necessary to remove 
trapped air and steam in the melt (Todd 1998).  Lastly, pressure is generated by the 
rotating screws in order to pump the melt stream through the die.  Finally, this API / 
Polymer single phase mixture is cooled to room temperature and solidifies.  As a result 
the dissolved API is immobilized by the matrix in an amorphous state.  Two factors 




glassy polymer matrix aided by choosing an API / Polymer system with a Tg considerably 
above the storage temperature, and the other and most important, is the existence of 
specific and strong interactions between the API and the polymer, such as hydrogen 
bonding and ionic bonding (Breitenbach 2002; Bhugra and Pikal 2008).  
 
Figure 2.1  Schematic representation of the dissolution mechanism of an API during the 
HME process carried out at a temperature above the melting point of the API.  Source: 
(Liu et al. 2010) 
 
2.2 Foams, Foaming Processes, and Mechanisms 
The terms “foams” and “cellular structures” refer to solid porous structures, which can be 
visualized as, and often is a honeycomb structure, in the case of closed cells foams shown 
in Figure 2.2 (a), or as a rigid sponge, for the case of open cell foams, Figure 2.2 (b).  
Foams are widely used in both food and plastic industries, and for the last decade the 
applications of foamed products and foaming processes have grown dramatically, as the 




have grown. They have been also recently explored by the pharmaceutical industry to 
investigate novel drug delivery methods.   
Some examples of foams in the food industry include: bread, cakes and puffed 
cereals and snacks.  Some of the typical applications of foamed products in the plastic 
industry include: insulation (thermal, acoustic and electrical), floating devices, shock 
mitigation, packaging and cushioning among others.  The end use, as well as the 
performance and properties of polymeric foams strongly depend on their physical 
characteristics.  For example open cell foams, where all the cells are interconnected, are 
used for applications that require high permeability to gasses and higher capacity to 
absorb fluids and moisture (Shutov 1991; Mills 2007).  On the other hand, closed-cell 
foams – where each cell is isolated from the rest – are preferred for thermal, noise and 





Figure 2.2  Schematic representation of: (a) a closed cell foam, and (b) an open cell 
foam. Source: (Mills 2007). 
2.2.1 Foaming Processes and Mechanism 
Cellular structures can be commercially created through continuous processes, such as 
foam extrusion, or through batch or semi-continuous processes, such as injection 
molding.  From a general perspective, the foaming process involves the following 




nucleation, (3) bubble growth, and (4) stabilization of the cellular structure (Zhang and 
Xanthos 2004), these are depicted schematically in Figure 2.3. 
 
 
Figure 2.3  Schematic representation of the foaming elementary steps. 
 
Independently of the method used for producing the foam structure, first the 
polymer is saturated with a gas, and then a thermodynamic instability is induced by a 
rapid increase in temperature or drop in pressure.  As a result, the system becomes 
oversaturated and cell nucleation and growth takes place.  From a physical perspective, as 
depicted in Figure 2.3, the first isolated spherical bubbles are formed by nucleation, 
which then start to grow.  Once these gas bubbles start to touch each other, their spherical 
shapes start becoming hexagonal and the facets become planar, and, depending on the 
strength of the material, the walls could either remain intact (i.e. forming a closed-cell 
structure) or may break generating an open cell structure (Saunders 1991; Mills 2007). 
Cell nucleation can be homogeneous, heterogeneous or of a mixed mode (Colton 
and Suh 1987; Ramesh 2004).  Homogenous nucleation occurs when the dissolved gas 
coalesces forming a second phase.  During the formation of this second phase the free 
energy of the system changes according to expression 2.1 below, where the first term on 
the right side of the equation corresponds to a reduction in free energy as the gas 




equation corresponds to an increase on free energy due to the formation of a new surface 
and it is associated  interfacial energy (Colton and Suh 1987).  
 
                   (2.1) 
 
Where Ghom is the change of free energy during homogenous nucleation, Vb is 
the nucleus volume, P = Psat- Ps is the difference between saturation pressure (Psat) and 
atmospheric pressure (Ps), Abp is the surface area of the nucleus, and bp is the surface 
energy of the polymer-bubble interface (Colton and Suh 1987; Kumar and Suh 1990; 
Goel and Beckman 1994a; Ramesh 2004).   
As can be seen in Figure 2.4 (a), at the beginning of the nucleation process the 
interfacial energy plays a dominant role, but once a critical nucleus size is reached (r*) 
the energy barrier for nucleation is overcome and the bubble growth process is favored.  
By assuming a spherical nucleus with radius r – since this is the geometry that will give 
the minimum excess in energy (Colton and Suh 1987; Ramesh 2004) – then, from the 
expression 2.1 the critical radius (r*) and the nucleation activation energy (     
 ) can be 
obtained as defined by the following expressions:  
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Another important parameter that defines the cellular structure is the nucleation 
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Where Jhom is the homogenous nucleation rate, fo is frequency of formation of 
stable nuclei, Co is the gas concentration,   is the Boltzmann constant and T the absolute 
temperature (Colton and Suh 1987). 
  
(a) (b) 
Figure 2.4  Change in free energy as a function of radius (r) of the nucleus.  (a) Change 
in interfacial energy, volume free energy, and net free energy associated with 
homogeneous nucleation process as a function of the radius of the nucleus. (b) 
Comparison between homogenous and heterogeneous free energies of nucleation as a 
function of the radius of the nucleus. Source: (Colton and Suh 1987). 
 
By understanding the homogenous nucleation theory it is easy then to identify the 
variables that affect the cellular morphology in a given process.  From expressions 2.2 
through 2.4 it is evident that by increasing the saturation pressure and/or reducing the 
surface energy, both the r* and the activation energy are reduced, and hence the 
nucleation rate can be significantly increased.  From expression 2.4 it is also clear that 




concentration and temperature, where an increase in either one results in faster nucleation 
rate.   
Finally, through heterogeneous nucleation, it is also possible to accelerate 
nucleation, as shown schematically in Figure 2.4 (b).  Nucleation agents are used to 
reduce the nucleation activation energy by providing lower surface energy sites, or by 
lowering the polymer surface tension (Saunders 1991; Ramesh 2004).  Based on the 
above, crystalline API particles suspended in the melt, whether insoluble or only partially 
soluble in the polymer, may act as nucleating agents during foaming operations.   
In general, by increasing the nucleation rate it is possible to produce foams with 
smaller cells and lower densities. 
Once critical size nuclei are formed, gas dissolved in the polymer diffuses into in 
the gas bubbles, and as a result, the pressure inside the bubbles increases subjecting the 
polymer to bi-axial tension and deformation.  The rate of cell growth will depend on the 
gas diffusion rate, heat transfer affecting melt temperature, and polymer strength (i.e. 
melt strength and polymer-gas rheological and viscoelastic properties) (Holl et al. 1999; 
Tadmor and Gogos 2006). 
2.2.1.1 Types of Foaming Agents.  The sources of the gases that provide expansion 
during foaming of the material are called “Foaming or Blowing Agents”.  These are 
divided into two categories: chemical blowing agents (CBAs) and physical blowing 
agents (PBAs).  CBAs are compounds added to a given formulation that, upon heating 
and at CBA-specific temperature ranges decompose releasing a gas, such as nitrogen, 
water, and carbon dioxide (CO2) (Throne 2004; Ahuja et al. 2007).  An example of a 




food industry is sodium bicarbonate.  In general, CBAs result in high density foams (Han 
et al. 1976; Throne 2004).   
In contrast to chemical foaming agents, PBAs do not undergo any chemical 
reaction to produce a blowing gas.  PBAs can be grouped into two categories: permanent 
gases and volatile organic compounds (Throne 2004).  Table 2.2 shows a summary of the 
properties of PBAs that are used in the polymer industry and have direct applications in 
the manufacture of pharmaceutical products.  It should be noted that both water vapor 
and CO2 are commonly used in the food industry to manufacture puffed snacks and 
cereals through the foam “extrusion cooking” process (Moraru and Kokini 2003; Cho and 
Rizvi 2010).  
 
Table 2.2  Properties of Commonly Used Physical Blowing Agents 
PBA 










Nitrogen 1.146 - -147 3.40 
Carbon dioxide 1.811 -78.5 31 7.39 
Water vapor 1.000 100 374.1 22.1 
Source: (Throne 2004) 
2.2.1.2 Batch Foaming.  During the batch foaming process with PBAs the polymeric 
sample is saturated with a gas at high pressure, then a thermodynamic instability is 
introduced to the process to initiate cell nucleation  In general two approaches are used: 
(1) a low temperature gas saturation method, and (2) a high temperature gas saturation 
method or sometimes called the pressure quenching method.     
When the low temperature approach is used, the sample is saturated with gas at a 




temperature bath to raise its temperature above the Tg of the polymer-gas system.  As a 
result the system becomes oversaturated with gas and, due to the increased molecular 
mobility, the nucleation process is triggered (Colton and Suh 1987; Kumar and Suh 1990; 
Ramesh et al. 1991; Goel and Beckman 1994a).  Afterwards, the cellular structure is 
stabilized by quench-cooling the foamed sample (Goel and Beckman 1994b).   
On the other hand, through the pressure quenching method the polymeric sample 
is saturated with gas at a temperature above its Tg and at a high pressure.  The driving 
force for nucleation in this case is a sudden depressurization of the system which makes 
the system oversaturated with gas.  Therefore, very fast and extensive nucleation can be 
promoted and, thus, foams with very small cells can be produced (Goel and Beckman 
1994a; Arora et al. 1998; Sun et al. 2002).  It should be mentioned that the 
depressurization step takes place at a constant temperature, even though the temperature 
of gases tends to decrease, due to expansion following the Joule-Thomson effect (Burnett 
1923).  The overall temperature change can be considered negligible.  Goal and Beckman 
(Goel and Beckman 1994b) reported only 2 to 3 C drop in temperature during the 
pressure quenching batch foaming process with supercritical carbon dioxide (ScCO2).  
Figure 2.5 shows a summary of the variables that affect the properties of foams 
produced by batch foaming.  As in any other process, these are grouped in terms of 
process, material and design variables.  However, these groups of variables are not 
independent of each other, in the sense that even the independent process variables are 





Figure 2.5  Summary of the variables that affect the properties of foams produced by the 
batch foaming process.   
 
2.2.1.3 Foam Extrusion.  In contrast to the batch foaming process, where the sample is 
exposed to the PBA at a temperature close to its Tg, during foam extrusion the gas is 
dissolved in the molten polymer inside an extruder.  Figure 2.6 shows schematically the 
elementary steps during the foam extrusion process in the presence of an API, which is 
miscible with the excipient.  Prior to gas injection, the foam extrusion process is 
equivalent to the conventional HME process described above.  However, a melt seal must 
be created upstream, that is before the gas injection in order to prevent gas back flow and, 
thus, gas loss thought the hopper.  Such melt seal is achieved by having a fully-filled 
screw section, which is generated in a co-rotating twin screw extruder through reversing 
self-wiping screw elements.  Subsequently, downstream of the gas injection site, the gas 
must be dissolved in the melt and this “solution” has to be cooled in order to increase the 




cellular structure without collapsing.  Finally, foaming occurs along the die as the 
pressure is rapidly dropped to atmospheric conditions. (Lee 2000; Zhang and Xanthos 
2004) 
 
Figure 2.6  Schematic representation of the foam extrusion process.  Extruder sketch 
modified from: (Lee and Scholz 2009) 
 
Figure 2.7 shows schematically a summary of the process, design and material 
variables that affect the morphology of the cellular structure.  It is important to have in 
mind that all these variables are not fully independent, as mentioned above.  As an 
example, the amount of PBA dissolved is dependent not only on the material variables, 
such as the miscibility and viscosity of the melt, but it also depends on processing 
variables such as pressure, temperature, and screw speed, and design variables such as 
screw configuration (Zhang and Xanthos 2004). Among the design variables, die 
geometry is one of the most important design variables, since it defines the 
depressurization rate and it has a very strong influence on the magnitude of the pressure 





Figure 2.7  Summary of the variables that affect the properties of foams produced by the 
foam extrusion process.   
2.3 Use of Foaming Technology in the Manufacture of Drug Products  
Even though for the last decade research work has been conducted and published related 
to foams and foaming processes in drug delivery products, results are very scarce and 
further studies must be conducted in order to gain fundamental understanding of the 
impact of foaming on the performance of HME products.  
The application of polymeric foams in drug delivery can be grouped in four 
categories: (1) the use of PBAs as “fugitive” plasticizers (Verreck et al. 2005; Verreck et 
al. 2006a; Verreck et al. 2006b; Lyons et al. 2007; Verreck et al. 2007; Nikitine et al. 
2010; Nagy et al. 2012), (2) floating oral dosages (Nakamichi et al. 2001; Streubel et al. 
2003; Fukuda et al. 2006), (3) foams as intermediate products (Hsu et al. 1996; Hsu et al. 
1997; Verreck et al. 2005; Verreck et al. 2006b; Verreck et al. 2007; Nagy et al. 2012), 
Process variables:
•Independent variables: screw 
speed, temperature profile, 
feeding rate.
•Dependent variables: die 




•Screw design: screw 






•Type of blowing agent: gas yield 
or concentration, solubility, 
diffusivity and permeability.
•Polymer – API system
Foam properties:






and (4) foams to increase release rate of amorphous systems (Breitenbach and Baumgartl 
2000; Clarke 2005; Lyons et al. 2007; Andrews et al. 2010; McKelvey et al. 2010).   
2.3.1 Physical Blowing Agents as “Fugitive” Plasticizers 
Many APIs are susceptible to thermal degradation under HME processing conditions.  
Thus, they may become inactive or lose their functionality (Verreck et al. 2007).  
Similarly, many polymeric excipients in the market have very narrow processing 
windows and high viscosity which makes them very difficult to be processed without 
plasticizers.   
However, adding permanent plasticizers may be unfavorable to the formulation 
for several reasons: (1) they add “dead weight” to the dosage, which could become 
unacceptably high (Verreck et al. 2006b). (2) Plasticizer volatilization during storage may 
result in unexpected changes in product performance during the shelf life of the dosage 
(Crowley et al. 2007). (3) Finally, plasticizers permanently increase the overall mobility 
of the system; thus, it may be detrimental to the stability of the system, reducing the shelf 
life of the product.  Therefore the use of “fugitive” plasticizer during HME process is of 
great interest for the pharmaceutical industry, because the processing temperature can be 
decreased without affecting the long term stability of the product.  Since it is well known 
that, once a PBA is dissolved in a polymer can act as a plasticizer, these are great 
candidates as “fugitive” plasticizers.  For example Elkovitch and Tomasko (Elkovitch 
and Tomasko 2000) observed a maximum decrease in viscosity for poly(methyl 
methacrylate) and polystyrene of 80 and 70 %, respectively in the presence of CO2.  
Verreck et al. (Verreck et al. 2005; Verreck et al. 2006b; Verreck et al. 2007) 




extruder by determining the minimal temperature at which the maximum torque of the 
extruder was reached with and without injecting CO2.  In studies performed with pure 
polymer excipients (placebos) a decrease in minimum temperature for PVP-VA, 
Eudragit® E100 (EPO) and EC of 30, 15 and 65 C, respectively (Verreck et al. 2006b) 
was observed.  The same study was performed using two binary systems: Itraconazole / 
EC (Verreck et al. 2007) and Itraconazole / PVP-VA (Verreck et al. 2005).  In the former 
case the minimum processing temperature was decreased by 30 and 65C and in the 
latter case by 5 and 10 C, depending on API loading.  
Verreck et al. (Verreck et al. 2006a) used CO2 as a fugitive plasticizer during 
compounding of p-Amino salicylic acid – which is highly sensitive to thermal 
degradation – with EC in an 18 mm twin screw extruder.  The authors observed that 
through a conventional HME process, 17 % of the API decomposed during 
compounding, but by using CO2 as fugitive plasticizer the processing temperatures were 
reduced and the amount of decomposed API was reduced to 5 %. 
Other evidence of the plasticizing effect of CO2 in pharmaceutical materials can 
be found in the literature.  Nikitine et al. (Nikitine et al. 2010) observed a 27 – 43 % 
reduction in torque by injecting CO2 when extruding EPO in a 30 mm single screw 
extruder.  Nagy et al. (Nagy et al. 2012) also observed a decrease in torque of 7 to 20 % 
by using CO2 as PBA during compounding of the binary system of Carvedilol and EPO 
in a 30 mm single screw extruder.  Lyons et al. (Lyons et al. 2007) also observed a 





2.3.2 Floating Oral Dosage Forms 
Gastroretentive drug delivery systems, with up to 6 h of sustained release, are required 
for some orally administered APIs.  Some drugs must be absorbed in the stomach or 
upper section of the intestine due to either therapeutic reasons or to instabilities of the 
API at higher pH values (Nakamichi et al. 2001; Streubel et al. 2003; Fukuda et al. 2006).  
Floating dosages, using polymeric foams have been studied for this application.   
Fukuda et al. (Fukuda et al. 2006) produced floating oral dosages by foam 
extrusion in a single screw extruder, using 5 - 10 wt% of sodium bicarbonate as CBA.  
The polymeric matrix used for the study was Eudragit® RS, an ionic acrylic based co-
polymer which is highly hygroscopic but does not dissolve in aqueous solution or body 
fluid, but only swells.  Two model APIs were used in order to evaluate two different oral 
dosage systems: (1) a miscible system using chlorpheniramine maleate (CMP), and (2) an 
immiscible system using acetohydroxamic acid (AHA).  The foamed extrudates produced 
had average cell size of ~200 m and densities in the range 0.8 - 0.6 g/cm
3
.  These 
foamed dosages maintained their buoyancy for 24 h in an acid aqueous solution.  API 
release profiles obtained for all samples (foamed and un-foamed) showed sustained API 
release in a 24 h period.  Nonetheless, the miscible system showed an increase in release 
rate upon foaming (approximately 80 % of CMP was released from the foamed sample in 
24 h whereas only approximately 40 % from the un-foamed sample).  In contrast, no 
appreciable variation was observed for the immiscible system.  The influences of cell size 
and foam density on API’s release profiles were not explored.   
Nakamichi et al. (Nakamichi et al. 2001) used foam extrusion with water as PBA 




(HPMCAS), an enteric polymer (i.e. soluble only in aqueous solution with pH 5 or 
higher), containing nicardipine hydrochloride (NH) as the model drug.  Compounding 
and foaming was conducted in a co-rotating twin screw extruder.  In addition, Calcium 
phosphate dehydrate (CP) was added to the formulation as nucleating agent.  Closed-cell 
foams were produced with cell size in the range 1-350 m and porosities ranging from 5 
% up to 72 %.  The porosity as well as the average cell size increased as the CP 
concentration increased.  Buoyancy and dissolution tests were conducted in aqueous 
solution with pH 1.2.  An increase in initial buoyancy was observed as the porosity 
increased; however, for high CP loading the dosage form disintegrates due to CP’s 
dissolution and its buoyancy was lost.  Cell size showed negligible effect over the release 
profile of the API.  
Streubel et al. (Streubel et al. 2003) developed a floating oral dosage by 
incorporating into the formulation foamed Polypropylene (PP) powder.  Tablets were 
produced by direct compression of HPMC, the API, foamed PP particles and other 
excipients.  The tablets showed good floating behavior for 8 hours, but it was lost 
afterwards due to dissolution of the HPMC phase. 
2.3.3 Foams as Intermediate Products 
While for gastroretentive applications the foamed samples is the final product, in 
some other cases the foamed material is just an intermediate product during the 
manufacture of the final dosage form.  Two approaches can be found in the literature for 
foamed intermediate products:  milling of HME products and API infusion.  Since the 
former is of greater interest to the pharmaceutical industry, milling of foamed extrudates 




After HME compounding, the extrudates are often milled.  The final dosage form 
is produced by pressing the ground material into tablets, filling capsules with it or using 
the particles in suspension for liquid formulations.  However, extrudates tend to be very 
difficult to mill into suitable particle sizes with narrow distribution (Verreck et al. 2005; 
Verreck et al. 2006b; McKelvey et al. 2010; Brown et al. 2011).   
Verreck et al. (Verreck et al. 2005; Verreck et al. 2006b; Verreck et al. 2007) used 
foamed extrudates to improve the milling efficiency of HME products.  The studies were 
carried out using a pure polymer excipient (i.e. placebos) (Verreck et al. 2006b), and two 
polymer-API pairs (Verreck et al. 2005; Verreck et al. 2007).  Compounding and foaming 
was carried out in an 18 mm co-rotating TSE, employing CO2 as PBA.  The milling 
efficiency was determined by grinding 25 g of each extrudate for 30 s with a Bamix 
blender; the resulting particle size distributions were determined through a vibrating sieve 
method.  In all cases, the particles produced by grinding foamed extrudates had smaller 
measured average particles size, higher porosity and bigger specific surface area than the 
particles produced from un-foamed extrudates, thus, improving the milling efficiency of 
drug products.  
In the cases of the polymers alone (Verreck et al. 2006b) and the Itraconazole / 
EC binary system (Verreck et al. 2007), API release rates of milled foams were faster 
than that of the ground un-foamed extrudates.  Faster API release rates were a 
consequence of smaller particle size with higher surface area and porosity. 
Surprisingly, for the system Itraconazole / PVP-VA Verreck et al. (Verreck et al. 
2005) observed that API release from particles obtained by milling the foamed extrudates 




Since water absorption was very fast for the milled foams, particle agglomeration took 
place slowing the API release rate.   
On the other hand, Nagy et al. (Nagy et al. 2012) observed only a slight faster API 
release for ground foams compared to the particles produced by milling un-foamed 
extrudates.  The small enhancement in the in vitro performance was attributed to higher 
surface area in the case of the milled foams.   
In summary, it has been shown in the literature that the milling process of foamed 
extrudates is more efficient than that of un-foamed extrudates, and as expected, it yields 
smaller particles with higher surface area and porosity.  However, a direct relationship 
between particle size distribution and cell size distribution has not been established.  
Neither a target nor optimal cell size and density have been defined.  
Another application of polymeric foams as intermediate product was explored by 
Hsu et al. (Hsu et al. 1996; Hsu et al. 1997).  Lyophilization (i.e. freeze-drying 
technology) was used to produce low density open cell foams of PLGA.  Then the API 
(Isoniazid, INH) was incorporated by immersing the foam in an INH aqueous solution.  
Following drying, the drug impregnated foam was compression molded into the dosage 
form.  
2.3.4 Foams to Increase API Release Rate 
One of the challenges of the HME process, which is inherent to the process, is 
that the extrudates have very low porosity.  This may slow down penetration of body 
fluids into the sample and, thus, hinder API release (Andrews et al. 2010).  Thus, foaming 




Andrews et al. (Andrews et al. 2010) observed that the release rate of Celecoxib 
(CX) from PVP, a water soluble polymer, was significantly increased upon foaming; the 
time for 100% release was reduced in half .  Compounding was carried out in the conical 
twin screw extruder MiniLab.  Foams were produced through a batch foaming process of 
the extrudates employing ScCO2 as PBA.  The authors did not provide information 
regarding average cell size or foam densities.  
Verreck et al. (Verreck et al. 2007) also observed an increase in release rate for 
the Itraconazole / EC system upon foaming.  By the end of the dissolution test the amount 
of API released from the foamed samples was approximately 11-fold higher than that 
from un-foamed samples. 
Lyons et al. (Lyons et al. 2007) also observed an increase in API release rate by 
using foamed samples.  HME and foam extrusion of a ternary system comprising 
Carvedilol, Polyethylene oxide (PEO) and EPO was carried out in a 16 mm co-rotating 
twin screw extruder, with CO2 as the PBA. However, the morphologies of the cellular 
structures produced were not shown or analyzed.   
Since API’s release rate can be increased by foaming, then this process could be 
used in the manufacture of orally disintegrating dosages (ODT).  These types of dosages 
must disintegrate within 30 s in the buccal cavity (FDA 2008) and are of great interest in 
pediatrics or for adults when swallowing is difficult (Clarke 2005; Banbury and 
MacGregor 2011).  Commercially used ODT manufacturing techniques based on freeze-
drying technology include: Zydis®, Lyoc®, Quicksolv
TM
 and Pharmafreeze (McLaughlin 
et al. 2009; Badgujar and Mundada 2011; Banbury and MacGregor 2011).  Freeze-drying 




times; in the case of dosages manufactured by Zydis® technology this has been reported 
to be between 0 and 2 s (McLaughlin et al. 2009).  However, this technology has some 
limitations in terms of drug loading and friability of the dosage form (McKelvey et al. 
2010; Badgujar and Mundada 2011).  
McKelvey et al. (McKelvey et al. 2010), explored the used of foam injection 
molding to produce fast dissolving dosage forms for pediatric applications.  The in vitro 
dissolution performance of the foamed dosage forms was compared to conventionally 
compressed tablet.  The authors found that through foam injection molding it was 
possible to attain the same dissolution performance as compressed tablets, but with a 40 
% smaller dosage.  However, the release times were not in the 30 s requirement for ODT 
applications.  
Clarke also proposed the use of foam injection molding to produce these “flash-
dissolving” dosage forms (Clarke 2005).  Similarly, the patent by Breitenbach and 
Baumgartl (Breitenbach and Baumgartl 2000) proposes the use of foam extrusion process 
to produce “flash-dissolving” foamed dosages.  As an example the authors reported that 
API release was 30-fold faster upon foaming.  The model API used was Ibuprofen and 
the carrier in a mixture of PVP and PVAc (Polyvinyl acetate); ScCO2 was used as the 
PBA.   
2.4 Brief Overview on the Applications of Supercritical Fluids in the Pharmaceutics 
Since many of the foaming processes described here use ScCO2 as the PBA it is of 
interest to briefly review the applications of supercritical fluids in pharmaceutical 
applications.  Some of its applications include: gas anti-solvent crystallization (GAS or 




The use of ScCO2 for the GAS process is shown schematically in Figure 2.8.  
Through this technology the API is first dissolved in a good solvent, then the supercritical 
fluid is injected enabling API crystallization and as a result it precipitates; then, the 
system is drained and the crystals are dried (Moribe et al. 2008; Brittain 2009).  Other 
anti-solvent approaches include: SEDS, solution-enhanced dispersion by supercritical 
fluids; and ASES, aerosol solvent extraction system (Moribe et al. 2008).  These anti-
solvent processes have been used to produce specific API polymorphs and particles 
composed of an API and a polymeric excipient (Sethia and Squillante 2004; Davies et al. 
2008; Moribe et al. 2008). 
 
Figure 2.8  Schematics describing gas anti-solvent crystallization (GAS) process. Source: 
(Brittain 2009) 
 
Other processes that use supercritical fluids are rapid expansion of supercritical 
fluid (RESS) and particles from gas-saturated solutions (PGSS).  In both cases the API is 
dissolved in the supercritical fluid followed by depressurization as the fluid is sprayed 
through a nozzle producing drug particles. These techniques are used as a means to 
reduce API particle size, manufacture of nanoparticles and induce API polymorphic 
changes (Davies et al. 2008; Moribe et al. 2008). 
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CHAPTER 3  
EXPERIMENTAL 
3.1 Materials 
3.1.1 Active Pharmaceutical Ingredients (APIs) 
Two model Active Pharmaceutical Ingredients (APIs), Indomethacin (INM) and 
Carbamazepine (CBZ) were evaluated.  Their chemical structures are presented in Figure 









O NH2  
Figure 3.1  Chemical structures of: (a) INM and (b) CBZ.  
INM, purchased from Spectrum Chemical and Laboratory Products (Gardena, 
CA), is an acidic nonsteroidal anti-inflammatory drug (NSAID), with pKa value of 4.5 
(Yazdanian et al. 2004).  The carboxylic group gives INM the capacity to form hydrogen 
bonds with itself and with other molecules.  Due to the ionizable character of carboxylic 
group its solubility in aqueous solution is pH-dependent, being extremely low (1 mg/L) at 






Table 3.1  Summary of Some of the Properties of INM and CBZ  
Property INM CBZ 
Melting temperature [°C] Polymorph dependent Polymorph dependent 


















(Forster et al. 2001), 
b
(Wishart et al. 2012), 
c
(Patterson et al. 2005), 
d
(Li et al. 2000) 
INM can exist in either of two crystalline polymorphic forms (namely -form and 
-form) or in the amorphous state.  -INM is the most stable form, while -form and 
amorphous INM are metastable; the latter being the less stable state.  However, 
crystallization of INM from its amorphous state into either γ or  forms is very slow and 
temperature dependent; furthermore, it may exist as a glass by itself for several days 
(Andronis and Zografi 2000).  Table 3.2 summarizes the properties of its two crystalline 
forms; the differences in density and melting behavior result from the differences in 
molecular packing within their unit cells.  In the case of -INM two molecules are packed 
in the unit cell by forming cyclic dimmers through hydrogen bonds between carboxylic 
groups.  On the other hand, three molecules are packed into each unit cell in - INM 
(Taylor and Zografi 1997; Andronis and Zografi 2000).  Since molecular interactions are 
weaker due to looser packing in the latter case; thus -INM has lower melting point and 






Table 3.2  Main Properties of the Two Crystalline Forms of INM  
Property - INM - INM 
Melting temperature [°C] 161* 155 
Melting Enthalpy [J/g] 116* 91 
Density [g/cm
3
] 1.37 1.43 
Crystal system triclinic monoclinic 
Source: (Andronis and Zografi 2000).  *Experimentally determined values in 
this dissertation  
Carbamazepine (CBZ), kindly donated by BASF, was also used as model API.  
This drug substance is used as anticonvulsant to treat epilepsy and trigeminal neuralgia 
(Matsuda et al. 1994; Rustichelli et al. 2000; Brittain 2009).  CBZ has been reported to 
have several polymorphs: triclinic, trigonal, and two monoclinic forms (Otsuka et al. 
1999; Rustichelli et al. 2000; Ugaonkar et al. 2007; Brittain 2009), their differences are 
summarized in Table 3.3.  Solid-solid transitions between polymorphs can occur upon 
heating (Lowes et al. 1987; Rustichelli et al. 2000; Brittain 2009).  Among all forms, 
monoclinic CBZ with four molecules per unit cell is the most stable form at room 
temperature (Brittain 2009); it also provides the highest bioavailability (Kipouros et al. 
2006). 
Table 3.3  Summary of CBZ Polymorphs and their Properties  
Property 
Crystal System 
Triclinic Trigonal p-Monoclinic c-Monoclinic 
Tm [C] 192 183 176 Not reported 
Molecules in unit cell 4 18 4 8 
Density [g/cm
3
] Not reported 1.235 1.35 1.31 





CBZ is considered a BSC Class II API (i.e. a low solubility, high permeability 
compound) (Sethia and Squillante 2004).  Its solubility in water is limited (170 mg/L at 
25C) and is reported to have a low absorption rate when administrated orally due to its 
slow dissolution rate (Moneghini et al. 2001; Ugaonkar et al. 2007). 
3.1.2 Polymer Excipients 
Two polymer excipients are used in this study Soluplus® (PVCap-PVAc-PEG) and 
Eudragit® EPO.  Their chemical structures are presented in Figure 3.2 (a) and (b), 


























Figure 3.2  Chemical structure of: (a) Soluplus® and (b) Eudragit® EPO. 
PVCap-PVAc-PEG, donated by BASF (Tarrytown, NY), is an amorphous 
polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer (molar 
ratio 57:30:13) (Kolter et al. 2010).  Polyethylene glycol (PEG) is the backbone while 
polyvinyl caprolactam (PVCap) and polyvinyl acetate (PVAc) are the branches.  Even 
though it is a graft copolymer it is reported to have a single glass transition temperature 
(Tg) at 73  2C.   
This polymer was specifically developed by BASF as polymeric excipient to be 
used in pharmaceutical HME.  It has pH independent solubility in aqueous solution, and a 





micelles at temperatures close to body temperature (37 C) results from the PVCap 
branches; the lower critical solution temperature of this polymer in water can be tailored 
by its molecular weight (Meeussen et al. 2000).  Since PVCap-PVAc-PEG is capable of 
acting as a surfactant (by forming micelles in aqueous solution) it can increase the 
apparent solubility of numerous APIs such as Carbamazepine, Griseofulvin, Cinnarizine, 
Clotrimazole, and Estradiol, among others (Hardung et al. 2010) and therefore prevent 
drug precipitation after release.  In addition, it has the potential to solubilize, during 
HME, multiple drugs with diverse functional groups due to its dual lipophilic and 
hydrophilic character.   




Tg [˚C] 732 44.6±0.9 
Tm [˚C] - - 
Melting enthalpy [kJ/mol] - - 
Onset degradation temperature in N2 [˚C] 300 276
b
 




















] 0.6 - 
Source: 
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EPO, donated by Evonik Degussa (Piscataway, NJ), is an amorphous cationic 





methyl methacrylate) with molar ratio 1:2:1.  This polymer has pH dependent solubility 
in aqueous media; while soluble in acid conditions, at pH above 5.0 it only swells and is 
permeable but does not dissolve (Rowe et al. 2009).  Therefore, this excipient is a great 
candidate for taste masking applications - since it will not dissolve in the buccal cavity - 
and for targeting API release to the stomach. 
3.1.3 Carbon Dioxide (CO2) 
Supercritical CO2 (ScCO2) with 99% purity was purchased from GTS-Welco (Allentown, 
PA).  The phase diagram of CO2 is shown in Figure 3.3.  Its critical point is 31C and 
7.37MPa (Throne 2004; Sauceau et al. 2011). 
 
Figure 3.3  Phase diagram of CO2. Source: (Leitner 2000).  
 
3.2 Sample Preparation 
3.2.1 Hot Melt Mixing (HMM) 
A particulate physical mixture (PM) of PVCap-PVAc-PEG and 30 wt% of INM was 





in a batch mixer Brabender FE-2000 (C.W. Brabender Instruments Inc., South 
Hackensack, NJ) with counter- rotating screws operating at 50 rpm, 130 °C for 9 min.  
The batch mixer was electrically heated and cooled by air.  
3.2.2 Hot Melt Extrusion (HME) 
Compounding through HME of the binary mixtures described in Table 3.5 was carried 
out in a 16mm co-rotating twin screw extruder, the Nano16, manufactured by Leistritz 
(Somerville, NJ).  The screws diameter was 16 mm and the length to diameter ratio (L/D) 
was 26.  The extruder’s barrel is divided into five segments as shown schematically in 
Figure 3.4.  The feeding zone is water cooled; the remaining zones are electrically heated 
and cooled with air.  Physical mixtures were fed as powders using a volumetric single 
screw feeder.  The temperature settings, feeding rates, screw speeds and die size used are 
summarized in Table 3.6. 
Table 3.5  Composition of the Binary Systems Evaluated 
System Polymer Excipient API Polymer : API ratio 
S10INM PVCap-PVAc-PEG INM 9:1 
S30INM PVCap-PVAc-PEG INM 7:3 
S50INM PVCap-PVAc-PEG INM 1:1 
S75INM PVCap-PVAc-PEG INM 25:75 
S15CBZ PVCap-PVAc-PEG CBZ 85:15 
EPO30INM EPO INM 7:3 
 
 
The screw elements of the Nano 16 have a tri-lobal design, with outer to inner 





consisted of only forward conveying elements with one mixing zone of 30 conveying 
kneading blocks located at 15 L/D.   
 
 
Figure 3.4  Schematics of the screw configuration used for HME. GFA = conveying 
fully-intermeshing element x-yy-zz (x = number of flights, yy = pitch, zz = element 
length in mm). KB =kneading block x-y-zz-vv (x = number of kneading segments, y = 
number of flights, zz = length in mm, vv = phase angle of the individual kneading 
segment).  See Appendix A for more details on the screw elements. 
 
Table 3.6  Summary of the HME Conditions Used 
System 





[mm] T1 T2 T3 Tdie 
S+INM* 120 130 130 138 200 4.7 1 
S15CBZ 120 130 130 125 100 4.5 2 
EPO30INM 110 130 140 138 200 3.3 2 







3.2.3 Compression Molding 
After HMM and HME the processed materials were milled in a laboratory coffee grinder 
and molded into disks by compression molding.  Four different dimensions were used 
through the study: 5 x 1 mm (HMM samples), 19 x 0.3 mm (release mechanism 
studies, HME samples), 16 x 1 mm (effect of foam morphology on release/dissolution 
rates, HME samples) and 25.4 x 1mm.  In all cases the following molding cycle was 
used: 1 min at molding temperature without load, 3 min at molding temperature under 
load and finally 2 min cooling under load.  The molding temperatures and loads used for 
each binary system are summarized in Table 3.7.  






Disk Dimensions [mm] 
S30INM (HMM) 100 44 5 x 1 
S30INM (HME) 120 44 16 x 1, 19 x 0.3 & 25.4 x 1 
EPO30INM 100 44 19 x 0.3 
S15CBZ 100 44 19 x 0.3 
PVCap-PVAc-PEG 100 44 16 x 1 
 
3.2.4 Batch Foaming 
Compression molded disks were foamed through a batch foaming process employing 
ScCO2 at 10.34 MPa as the physical blowing agent (PBA).  The experimental apparatus 
used is schematically shown in Figure 3.5.  The compression molded samples were 





air in the cavity was evacuated using a vacuum pump for 4 min.  Following the 
application of vacuum, the PBA was injected into the vessel’s cavity and the system was 
pressurized for pre-established dwelling times to allow for the dissolution of the PBA in 
the polymer/API disk.  Then, the pressure in the cavity was suddenly released, abruptly 
causing a thermodynamic instability which induces very rapid cell nucleation.  Foaming 
temperatures and dwelling times for each of the sample sizes used are summarized in 
Table 3.8.  It should be mentioned that the mold was not cooled during depressurization.  
Also due to the hygroscopic character of the polymer excipients, all the samples were 
dried under vacuum at 60 C for 12 h prior to foaming. 
 
Figure 3.5  Schematic representation of the batch foaming device.  
 








PVCap-PVAc-PEG 16 x 1 90 15 
S30INM 16 x 1 100 
15, 30 & 60  
(F15, F30 & F60) 
S30INM 19 x 0.3 100 15 
EPO30ONM 19 x 0.3 95 15 





3.2.5 Foam Extrusion 
Compounding and foaming was carried out in a single step through Extrusion Foaming in 
a co-rotating fully intermeshing twin screw extruder with screws  of 18 mm in diameter 
and 40 L/D manufactured by Leistritz (Somerville, NJ).  The barrel was equipped with a 
die plate having eight capillaries of 0.8 mm diameter for forming eight extrudate strands.  
Excipient and crystalline INM particulates were independently fed using two feeders.  
Their feeding rates were set so as to produce foamed extrudates containing 30 wt% of 
drug loading.  As shown in Figure 3.6, the extruder barrel was divided in eight zones.  
The first one (feeding zone) was continuously cooled with water, while the remaining 
seven zones were electrically heated and cooled with air to control their temperature.  
The adapter and die were electrically heated.  Carbon Dioxide (CO2) was employed as 
the physical blowing agent, and it was injected at 5.5 - 5.8 MPa at a barrel position 18 
diameters downstream from the feed, as shown in Figure 3.6.  The process conditions 
studied are presented in Table 3.9. 
 
Figure 3.6  Screw design used during foam extrusion experiments.  GFF = conveying 
freely cut element, GFA = conveying free-meshing element, GFM = conveying mixing 
element x-yy-zz (x = number of flights, yy = pitch, zz = element length in mm). KB 
=kneading block x-y-zz-vv (x = number of kneading segments, y = number of flights, zz 
= length in mm, vv = phase angle of the individual kneading segment).  See Appendix A 





The 18 mm extruder screws were bilobal, and as shown in Figure 3.6 the screw 
configuration had one reverse conveying element prior to the gas injection site in order to 
create a melt hold-up, leading to a fully melt-filled section, which acts as a melt seal to 
prevent the pressurized gas escaping through the hopper.  The extruder was also equipped 
with four mixing zones; the ones prior to the gas injection site were intended to complete 
the elementary processing steps of polymer melting, laminar mixing, and dissolution of 
API in the melt.  The mixing zones after CO2 injection were designed to promote 
dissolution of the gas in the melt and homogenization of the polymer-API-gas system.   




Temperature Profile [C] 
w/w % 





1 1 122 135 135 122 101 99 96 96 115 12 
2 1.5 122 140 140 130 115 90 90 90 118 4 
 
3.2.6 Milling of Extrudates 
Foamed and un-foamed extrudates of the binary mixtures S30INM were milled in a 










3.3.1 Thermogravimetric Analysis (TGA) 
The thermal stability of APIs and excipients was studied through TGA in a TA 
Instruments Q50 Thermogravimetric Analyzer (New Castle, DE).  Two different studies 
were performed: ramp heating tests and isothermal tests.  In the ramp heating studies,      
5 – 10 mg of material was placed in an open aluminum pan, and heated from room 
temperature up to 550 ˚C at a heating rate of 10 ˚C/min, and recording the sample weight 
loss continuously.  For the isothermal study, 5 - 10 mg of material in open aluminum 
pans was heated at 10 ˚C/min from room temperature to a desired-established 
temperature and held isothermally for 60 min, again recording sample weight loss 
continuously.  Both ramp and isothermal TGA studies were conducted in a dry air 
atmosphere by purging the chamber with air at a flow rate of 40 mL/min. 
3.3.2 Differential Scanning Calorimetry (DSC) 
DSC analyses were carried out in a TA Instruments Q100 (New Castle, DE) equipment.  
Between 5 and 10 mg of material was placed in closed/sealed aluminum pans.  Heating 
and cooling scans were performed at 10 C/min between 0 and 165 C.  Samples were 
held isothermally for 3 min at 0 C prior each heating scans in other to stabilize the 
temperature of the samples, and before the cooling scans a 3 min isothermal at 165 C 
was used to erase thermal history of the material.  Throughout the study, the equipment’s 
chamber was blanketed with nitrogen (N2) gas at a flow rate of 40 mL/min.  Due to the 
hygroscopic character of the PVCap-PVAc-PEG, all samples containing this excipient 





First heating thermograms were used to assess the state of the APIs prior to 
processing and after undergoing different processing steps.  Second heating thermograms 
were employed to evaluate the thermal properties of the materials after erasing their 
thermal history.   
3.3.3 Modulated Temperature Differential Scanning Calorimetry (MTDSC) 
MTDSC was carried out in a TA Instruments Q100 (New Castle, DE) equipment.  
Between 5 and 10mg of material was placed in closed aluminum pans.  Samples were 
heated from 0 to 180 C at 2 C/min with a 60 s temperature modulation period and  
1.25 C amplitude.  Throughout the study, the equipment’s chamber was blanketed with 
nitrogen (N2) gas at a flow rate of 40 mL/min. 
3.3.4 Polarized Optical Microscopy (POM) 
Polarized light optical microscopy was used to evaluate the presence of crystalline API 
after compounding.  Samples drawn from the batch mixer and extrudates were observed 
with a Carl Zeiss microscope (Thornwood, NY) equipped with a digital camera Zeiss 
AxioCam MRc5 (5 MB-pixel resolution). 
3.3.5 Fourier Transform Infrared (FT-IR) Spectroscopy 
FT-IR analyzes were carried out in a PerkinElmer Spectrum One Spectrometer 
(Waltham, MA).  Samples were analyzed in the 400 to 4000 cm
-1
 wavelength region 
using Potassium Bromide (KBr) disks.  The KBr disks were prepared by grinding 
together crystalline KBr and 1 wt% of sample into fine powders using a mortar and 





3.3.6 X-Ray Diffraction (XRD) 
XRD analyzes were carried out in a Philips PW3040 X-Ray diffractometer (PANanytical 
Inc., Westborough, MA), using Cu K radiation (λ=1.54 Å) generated from a copper 
source operating at a power level of 40 KV and 40 mA.  Samples were scanned over a 2θ 
range between 5 and 30.  Pure PVCap-PVAc-PEG and EPO were analyzed using disks 
prepared by compression molding; all other samples were analyzed while in powder 
form. 
3.3.7 Scanning Electron Microscopy (SEM) 
The morphology of cross-sections (or fracture surfaces) of foamed and un-foamed 
samples, as well as milled extrudates was examined with a LEO 1530 Field Emission 
Scanning Electron Microscope (Carl Zeiss SMT Inc., Peabody, MA).  The fracture cross 
section of the samples was coated with a thin layer of carbon by sputtering to improve the 
conductivity and thus allow for the SEM images.  The image processing software ImageJ 
was used to measure the cell sizes and wall thicknesses. 
3.3.8 Particle Size Distribution (PSD) 
Particle size distributions of milled samples were determined employing a laser 
diffraction particle size analyzer Beckman Coulter LS230 (Brea, CA).  Analyses were 
conducted in the dry state and in triplicate. 
3.3.9 In Vitro Dissolution Test 
Dissolution tests were carried out in a Distek 2100A USP apparatus (North Brunswick, 





water, pH 7.4 phosphate buffer solution, or pH 1.2 hydrochloric acid buffer solution.  At 
pre-established time intervals 5 mL samples were withdrawn from the dissolution 
medium, filtered through polyvinylidene fluoride (PVDF) filters with pores size of      
0.45 μm.  Samples were then analyzed using a 10 mm quartz cell and an Agilent 8454 
UV Spectrophotometer (Foster City, CA).  The concentration of API or polymer in the 
solution was determined through a UV absorbance calibration curve.  A summary of the 
in vitro dissolution test conditions used for the different samples is presented in         
Table 3.10.   
It should be mentioned that the filters were not used during the dissolution tests of 
pure PVCap-PVAc-PEG; the polymer was trapped in the filter and no signal was 
observed during the UV analysis. In addition “sinkers” were used in the case of samples 





















PVCap-PVAc-PEG (un-foamed and foamed 
disks) 
240* Paddle 50 Deionized water 201 
PM S30INM in capsules 24 Basket 100 pHs 1.2 and 7.4 268 
HMM S30INM (un-foamed and foamed disks) 24 Basket 100 pHs 1.2 and 7.4 268 
INM in capsules 24 Basket 100 pHs 1.2 and 7.4 268 
HME S30INM (un-foamed and foamed disks) 72 Paddle 50 pH 7.4 319 
HME S30INM (un-foamed and foamed disks) 35 Paddle 50 pH 7.4 319 
INM in capsules 25 Paddle 50 pH 7.4 319 
Milled HME S30INM in capsules 25 Paddle 50 pH 7.4 319 
Milled foamed extruded S30INM 25 Paddle 50 pH 7.4 319 
HME S15CBZ (un-foamed and foamed disks)  16 Paddle 50 Deionized water 284 
HME EPO30INM (un-foamed and foamed 
disks) 
33 Paddle 50 pHs 1.2 and 7.4 319 






3.3.10 Extrudate Content Uniformity 
Content uniformity of the extrudates was evaluated by determining the concentration of 
INM in five randomly collected samples of each particular extrudate.  Samples of          
16 - 30 mg were placed in a 100-mL volumetric flask containing 10 mL of methanol and 
shaken until the extrudate was completely dissolved.  Then the solution was diluted to the 
100 mL volume with a pH 7.4 phosphate buffer solution.  The API loading in the 
extrudates was calculated based in the concentration of INM in the solution.  The latter 
was determined by UV spectroscopy at 319 nm using an absorbance calibration curve as 
mentioned in section 3.3.9 above. 
3.3.11 Solubility of CO2 in S30INM 
Solubility measurements of CO2 in S30INM were performed using HME and 
compression molded samples of 25.4 x 1mm.  Two high pressure steel vessels with     
45 cm
3
 cavities, as shown in Figure 3.7, were used to saturate the samples with CO2 for 
24 h at different pressures and temperatures.  The vessels were heated in an oven; oven 
temperature and pressure in each vessel were measured and recorded continuously during 
gas saturation.  Samples were weighed and placed inside vessels preheated to the test 
temperature; air in the system was evacuated using a vacuum pump for 4 min.  Following 
the application of vacuum, CO2 was injected into the vessels’ cavities and the system was 
pressurized.  After 24 h of saturation, the vessels were depressurized and the samples 
extracted and weighed immediately.  It should be mentioned that samples did not foam at 
any of the temperatures and pressures used, otherwise excessive gas loss would have 






Figure 3.7  Drawing of the high pressure vessels used for the CO2 solubility 
measurements (Faridi and Todd 2007). 
 
3.3.12 Long Term Physical Stability of the S30INM Binary System 
The six month stability of the binary system S30INM was determined in open containers 
at 75 % RH and room temperature.  Un-foamed compression molded disks of              
16 x 1 mm and the corresponding foamed samples produced with dwelling times of 15, 





CHAPTER 4  
RESULTS AND DISCUSSION 
4.1 Solubility of INM in PVCap-PVAc-PEG  
One of the objectives of this research is to gain fundamental understanding of the effects 
of the foaming process and cellular structure on the performance of amorphous solid 
solutions.  Therefore, it is important to have a good understanding of the miscibility and 
solubility of the API in the polymer excipient, in order to assure that the binary system 
evaluated is a solid solution and not a solid dispersion.   
The binary system comprising INM and PVCap-PVAc-PEG is expected to be 
miscible.  The solubility parameter approach and criterion, although it has its limitations, 
suggests that this system is likely to be miscible.  The difference in solubility parameters 
(Δδ) between INM and PVCap-PVAc-PEG is 2.7 MPa1/2.  In general the smaller this 
difference the higher the probability for a given API-polymer pair to be miscible.  
Specifically, Greenhalgh et al. (Greenhalgh et al. 1999) proposed that miscible systems 
have a Δδ between 1.6 and 7.5 MPa1/2, Forster et al. (Forster et al. 2001) on the other 
hand stated more conservatively that Δδ has to be less than 2. 
In addition to the solubility parameter approach, by analyzing the chemical 
structures of INM and PVCap-PVAc-PEG [see Figures 3.1 (a) and 3.2 (b)] it is evident 
that these two molecules are capable of forming hydrogen bonds.  The possibility of 
specific interactions between API and polymer could potentially facilitate drug 





INM has one proton donor (a hydrogen atom) and two proton acceptors (two oxygen 
atoms) in the carboxylic group.  PVCap-PVAc-PEG has several proton acceptors capable 
of forming hydrogen bonds; oxygen atoms are available along the PEG backbone (see 
Figure 4.1 a) as well as along the branches of PVAc and PVCap (see Figures 4.1 b and c, 
respectively).  Additionally, a nitrogen atom is also present on the PVCap braches but is 
most likely not accessible due to steric hindrance.  In addition, by comparing the dipole 
moments of the bonds containing the proton acceptor atoms in the polymer (see Table 
4.1) it is evident that the most favorable sites are the oxygen atoms forming double bonds 
with carbon (C=O) along the branches of PVCap and PVAc, followed by the other 
oxygen atoms in the PVAc branches and along the PEG backbone.  A bond with larger 
dipole moment has a higher polarity and is thus more prone to donate or accept the 
positive charge or proton.  This will also result in stronger hydrogen bonding.  The effect 
of hydrogen bonding between INM and PVCap-PVAc-PEG on API release is presented 
in section 4.2.1. 
 
 
(a) (b) (c) 
Figure 4.1  Possible hydrogen bonds between INM and the different blocks of PVCap-
PVAc-PEG terpolymer.  (a) INM and PEG backbone, (b) INM and PVAc branch, and (c) 
































Table 4.1  Dipole Moments of Bonds of the Proton Donors and Acceptors in INM and 
PVCap-PVAc-PEG 





Source: (Wade 1993) 
The solubility of INM in PVCap-PVAc-PEG is evaluated through binary blends 
with drug loadings of 10, 30, 50 and 75 wt% prepared through HME and designated 
S10INM, S30INM, S50INM and S75INM, respectively.  The morphological state of the 
API in the extrudates is determined by combining three characterization techniques 
described in the previous Chapter: POM, DSC and FT-IR.  Since each technique has its 
own limitation and/or level of sensitivity in detecting the crystalline content, several 
techniques are combined in order to have a higher level of confidence regarding the 
morphological state of INM after HME.  For example: POM is limited by the resolution 
of the microscope, which is diffraction-limited and thus features smaller that light’s 
wavelength cannot be detected using this technique (Campbell et al. 2000).  In the case of 
DSC, Leuner and Dressman (Leuner and Dressman 2000) observed the lowest detection 
limit for residual crystallinity is ~2 %. 
POM allows detecting the presence of crystals in a sample through birefringence.  
Through this technique a specimen is placed between two polarizing plates oriented 
perpendicularly to each other resulting in no light transmission and a dark field.  





stresses or two or more phases with different refractive indices, the light is scattered and 
bright spots or color fringes are evident (Campbell et al. 2000).  Figure 4.2 shows the 
POM images of the extrudates containing 10, 30, 50 and 75 wt% of INM loading.  
Among all the samples bright particles are only visible throughout the highest API 
concentration sample, i.e. the S75INM.  These bright particles correspond to INM 
crystals, suggesting that only S75INM extrudates have residual crystallinity after HME.  
In other words, INM was fully dissolved in PVCap-PVAc-PEG in the S10INM, S30INM 




Figure 4.2  POM images of four HME extrudates: (a) S10INM, (b) S30INM, (c) 





FT-IR spectroscopy has been widely used to differentiate between drug 
polymorphs with high precision (Matsuda et al. 1994; Taylor and Zografi 1997; Otsuka et 
al. 1999; Rustichelli et al. 2000; Brittain 2009).  As other spectroscopic techniques FT-IR 
allows the identification of different API polymorphs through shifts in the absorption 
frequency of specific functional group within the compound.  These changes are caused 
by the intra-molecular coupling effect (i.e. interaction between vibrating groups) 
(Campbell et al. 2000).  Packing or spatial arrangement of the API molecules differs 
among crystalline polymorphous and amorphous state, resulting in slight changes in the 
environment of a given functional group.  Thus, the interactions between vibrating groups 
differ and hence the position of the absorption peak varies.  In the case of INM, as 
summarized in Table 4.2, the locations of the absorption peaks of C=O in the carboxylic 
and benzoyl groups allow to clearly differentiate between amorphous, γ-INM and α-INM 
(Taylor and Zografi 1997).   
Table 4.2  FT-IR Positions and Assignments of INM Characteristic Absorption Peaks 
Assignment 
Position of the Absorption Peaks [cm-1] for 
γ-INM α-INM Amorphous INM 
Asymmetric stretching of hydrogen-
bonded acid C=O in a cyclic dimer 
1717 s - 1710 sh 
Asymmetric stretching of hydrogen 





Stretching of non-hydrogen bonded acid 
C=O 
- 1735 w-m 1735 sh 
Stretching of benzoyl C=O 1692 s 1688 s 1684 s 





Figure 4.3 shows the FT-IR spectra of the four physical mixtures (PM) and the 
corresponding extrudates of S10INM, S30INM, S50INM and S75INM.  By comparing 
the spectra of crystalline INM (γ-INM) with those of the physical mixtures              
[Figure 4.3 (a)], it is evident that in all cases INM is crystalline and in its γ-form.  In all 
PMs, two sharp peaks can be clearly observed at 1692 and 1718 cm-1.  These peaks 
correspond to the benzoyl group stretching vibration and asymmetric stretching vibration 
of hydrogen-bonded acid C=O in a cycle dimer, respectively (see Table 4.2).  In addition, 
the intensity of the peaks associated with INM increases with respect to the peaks 
associated with PVCap-PVAc-PEG as APIs concentration is increased.  In S50INM and 
S75INM the absorption peaks of the polymer are no longer visible.  
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Figure 4.3  Comparison of the FT-IR spectra of the binary systems S10INM, S30INM, 
S50INM and S75INM: (a) Physical mixtures and (b) HME extrudate samples. Spectra of 






In the case of the HME samples [see Figure 4.3 (b)], the peak at 1692 cm-1 
associated with γ-INM is no longer present in S10INM, S30INM and S50INM; but a new 
peak appears at 1683 cm-1.  This is a clear indication that INM is amorphous in these 
samples.  The peak at 1683 cm-1 can be observed in the spectrum of amorphous INM in 
Figure 4.3 and as indicated in Table 4.2 it corresponds to benzoyl group’s stretching 
vibration in amorphous INM.  
On the other hand, the spectrum of the S75INM extrudate shows evidence of the 
presence of both amorphous as well as crystalline INM.  The characteristic peak of         
γ-INM at 1692 cm-1 can be clearly seen.  In contrast, the peak associated with asymmetric 
stretching vibration of hydrogen-bonded acid C=O in a cyclic dimer is observed at           
1715 cm-1, which is between the normal wavelengths of amorphous and γ-INM.  This 
shift is due to the contribution of both forms.   
Table 4.3 shows a summary of the DSC-determined thermal properties of the 
HME extrudates of the four binary systems.  The properties of pure INM and PVCap-
PVAc-PEG are also shown as reference.  Figure 4.4 shows characteristic first heating 
thermograms of PVCap-PVAc-PEG and the HME samples S10INM, S30INM, S50INM 
and S75INM.  In the case of INM, both first heating and second heating thermograms are 
shown.  From the DSC analysis of the extrudates it is evident that S10INM, S30INM and 
S50INM have only one thermal transition during their first heating, corresponding to 
their glass transition temperatures.  On the other hand, the S75INM extrudate showed two 
thermal transitions: a glass transition and endothermic peak in the high temperature 
region.  These can be seen as an evidence of the presence of two phases, as observed 





Table 4.3  Summary of the Thermal Transitions Determined from DSC First Heating of 











PVCap-PVAc-PEG 0 73 ± 2 - - - 
S10INM 10 68 ± 1 - - - 
S30INM 30 62 ± 1 - - - 
S50INM 50 61 ± 2 - - - 
S75INM 75 53.0 ±0.2 147.4 ± 0.3 159 ± 1 6.7 ± 0.9 
INM 100 46.33 ± 0.07* 159.5 ± 0.2 161.0 ± 0.3 109 ± 5 
*Value determined through DSC second heating 
Besides S75INM, the only other sample that shows an endothermic peak during 
DSC first heating is INM (see Figure 4.4).  These endothermic regions correspond to the 
melting of crystalline INM.  In the case of pure INM [see Figure 4.4 (g)], the 
experimentally determined peak melt temperature is 161.0 ± 0.3 °C, which is in very 
good agreement with literature reported values for γ-INM (Otsuka et al. 2001).  On the 
other hand, during INM melting in the S75INM extrudate, a depression in melting point 
is observed (12° and 2 °C depression in the onset and peak melting temperatures, 
respectively), as well as lower melting enthalpy compared to pure INM melting (see 
Table 4.3).  Making the experimentally supported assumption that during the HME 
process the solubility limit of INM in the excipient was exceeded, then the depression in 
melting point may result from a reduction in size and or quality of the crystalline particles 
during HME, as a consequence of INM’s partial dissolution.  The lower melting enthalpy 
results from a smaller amount of crystalline INM in the samples.  It should be noted that 
although enthalpy values are normalized by weight, this normalization corresponds to the 





the total weight of the samples only 75 wt% corresponds to INM and not all of this 
amount is in crystalline form after the HME process; at least 66.67 % of INM was 
dissolved during processing (which corresponds to 50 wt% of INM loading).   
In the case of S10INM, S30INM and S50INM the absence of an endothermic 
peak is indicative of the fact that the API was completely dissolved during the HME 
process.  In addition, the results shown in both Figure 4.4 and Table 4.3 indicate that all 
HME extrudate samples have a single glass transition region with Tg values between that 
of the polymer and the API.  Lower Tg of the extrudates than that of the pure polymer 
suggests that INM has been dissolved into the PVCap-PVAc-PEG during melt mixing, 
and that it acts as a plasticizer.  Additionally, a single glass transition suggests one phase, 
thus, an amorphous solid solution. 















































Figure 4.4  Characteristic 1st heating thermograms (unless otherwise indicated) of: (a) 
PVCap-PVAc-PEG, (b) S10INM, (c) S30INM, (d) S50INM, (e) S75INM, (f) INM (2nd 





The effects of incorporating low molecular-weight APIs on a polymer’s Tg have 
been widely studied and can be found in the literature (Chokshi et al. 2005; Chokshi et al. 
2008; Guo et al. 2010; Liu 2010; Yang et al. 2011).  In general, a shift in Tg is expected 
when the API is dissolved into the polymeric excipient: on the other hand the polymer’s 
Tg will not change if the two compounds are not in one phase and the API remains 
crystalline.  The effect of dissolved API molecules on a polymer’s Tg can be viewed in 
terms of molecular interactions or free volume.  The free volume theory assumes that 
there is “free space” distributed between polymer molecules and that the free volume 
increases with molecular mobility.  When a small molecule such as INM dissolves into 
the polymer, it increases the free volume among the polymer chains and, thus, the glass 
transition temperature of the system decreases (Sears and Touchette 1985; Crowley et al. 
2007).  From the intermolecular interaction perspective, by dissolving a low molecular-
weight compound in a polymer, its inter-chain interactions are disrupted and replaced by 
new secondary bonds, such as the API-polymer interactions.  The mobility of the systems 
is altered due to the change of intermolecular interactions, resulting in either an increase 
or depression of the Tg (Chokshi et al. 2005; Zhang et al. 2005; Andrews et al. 2008).  In 
some cases, as observed in the present case for the binary systems of INM and PVCap-
PVAc-PEG, the glass transition temperatures of the mixtures are lower than that of the 
pure excipient (Chokshi et al. 2005; Huang et al. 2006; Chokshi et al. 2008; Qi et al. 
2008) (a phenomenon often referred to as plasticization effect).  In other cases (often 
referred to as anti-plasticization effect), the Tg of the system may be higher than that of 





components in the formulation (Chokshi et al. 2005; Chokshi et al. 2008; Liu 2010).  The 
last case may occur when the API-polymer interactions are very strong. 
Since DSC results show that INM acts as a plasticizer for PVCap-PVAc-PEG, it 
is then expected that as a larger amount of INM is dissolved in the polymer, then the Tg 
of the solid solution will decrease further.  And as it can be seen in Table 4.3 and     
Figure 4.4, as INM’s loading is increased, the Tg of the solid solution is decreased 
correspondingly.  It is interesting to note that even though 75 wt% of INM is not fully 
dissolved during HME, S75INM has a lower Tg than S50INM.  This suggests that the 
solubility limit of INM in PVCap-PVAc-PEG is between 50 and 75 wt%. 
Using the Gordon-Taylor model (see equation 4.1) and Tg values reported in 
Table 4.3, it is possible to estimate the solubility if INM in PVCap-PVAc-PEG.  This 
model has been used to describe and predict the dependence of Tg with composition of 
random copolymers, polymer blends (Schneider et al. 1997) and in API-polymer solid 
solutions (Chokshi et al. 2005; Chokshi et al. 2008; Malaj et al. 2010).     
 
T , = w T + Kw Tw + Kw  (4.1) 
 
K = ρ ∆αρ ∆α  (4.2) 
 
Where sub-indexes 1 and 2 refer to the components of the blend, Tgi is the glass 
transition, wi the weight fractions of component 1 and 2,  K is a system specific constant 
defined in equation 4.2, ρi is the density at Tg, and Δαi=αmelt-αglass the increase of the 





Since the Gordon-Taylor model is based on an ideal solution behavior, and, thus, 
any kinds of interaction between components are neglected, deviation from the model are 
often seen (Schneider et al. 1997; Chokshi et al. 2005; Liu 2010; Malaj et al. 2010).  
Therefore the value of K for this system was determined as 1.2 by fitting the 
experimentally determined Tgs of pure materials and those of the solid solutions 
(S10INM, S30INM and S50INM) in equation 4.1, instead of using equation 4.2.  This 
approach was also used by Schneider et al. (Schneider et al. 1997), to correct for the ideal 
solution assumption.  Figure 4.5 shows the experimental data together with the Gordon-
Taylor fitting.  Then using equation 4.1 with K = 1.2 and Tg1,2= 53.0 – which corresponds 
to the experimentally determined Tg for the S75INM extrudate – the amount of INM 
dissolved in this sample is determined to be 71 wt%. 
 
Figure 4.5  Tg vs. composition of the binary system INM/PVCap-PVAc-PEG.  Points 
represent experimentally determined Tg values and the dashed line represents the “fit” by 





















In summary, all three characterization techniques (POM, DSC and FT-IR) 
indicate that the solubility of INM in PVCap-PVAc-PEG is between 50 and 75 wt% 
(most likely 71 wt% as estimated by the Gordon-Taylor equation).  In all cases INM was 
not fully dissolved in S75INM while in S50INM the API was fully dissolved.   
4.2 General Properties of the Binary System S30INM 
4.2.1 Effect of pH on INM’s Release 
The release profiles of INM from three different dosage forms containing an average of 
24 mg of drug loading are presented in Figure 4.6.  As described in Chapter 3 (Table 
3.10) pure INM and the physical mixture (PM) S30INM are analyzed by filling the 
powder into Hydroxypropyl Methylcellulose (HPMC) capsules, while HMM S30INM 
samples are analyzed as compression molded disks of 5∅ x 1 mm.  In addition, it is 
important to note that the INM loaded into the capsules is crystalline – in its γ-form.  On 
the other hand in the HMM samples INM is amorphous, forming a solid solution with the 
polymer excipient.  The in vitro dissolution tests are conducted in a pH 7.4 phosphate 
buffer solution and in a pH 1.2 hydrochloric acid buffer solution.  The results are 
discussed first in terms of the pH and then in terms of the type of sample used.  
It can be seen from Figure 4.6 that the release rate of INM is pH-dependent.  
Regardless of the type of sample, higher pH leads to faster release rate and a greater 
amount of INM been released.  In the case of pure INM and PM, the pH-dependence is 
due to the ionizable character of the carboxylic group.  Higher percentage of the 
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Figure 4.6  Release profiles of pure INM in capsules (black circles), physical mixture 
(PM S30INM) in capsules (pink triangles), and HMM S30INM sample (green squares) at 
pH 7.4 (continuous lines) and at pH 1.2 (dashed lines).  Dissolution tests obtained using a 
USP apparatus 1, and tests were performed in triplicate. 
Similarly to pure INM and the physical mixture, the release profile of INM from 
the HMM-prepared samples also shows pH-dependency.  The percentages of INM 
released within 1 h at pH 7.4 and 1.2 are 90 % and 0.02 %, respectively.  There was no 
evident erosion or gel formation at pH 1.2, except for the 5 % weight increase due to 
water absorption, after 1.5 h in the buffer solution.  It should be mentioned that pure 
PVCap-PVAc-PEG is soluble at both pHs.  The apparent insolubility of the polymer in 
the HMM sample is due to hydrogen bonding between the carboxylic group in INM and 
the oxygen atoms in the polymer.  The effect of hydrogen bonds on the polymer’s 
solubility has been studied for mixtures comprising Polyethylene Oxide and another 





polymethacrylic acid) (Smith et al. 1959; Hemker and Frank 1990; Doseva et al. 1997; 
Ozeki et al. 1998; Lele and Hoffman 2000).  Both polymers are individually soluble in 
deionized water but become insoluble due to hydrogen bonding (Smith et al. 1959; Ozeki 
et al. 1998; Lele and Hoffman 2000) once mixed together.  However, by increasing the 
pH of the aqueous solution, the acid functional groups are ionized and the complex 
becomes unstable and the mixture becomes soluble (Smith et al. 1959; Hemker and Frank 
1990; Doseva et al. 1997; Ozeki et al. 1998; Lele and Hoffman 2000).   
Therefore, as reported for some polymer blends, hydrogen bonding between INM 
and PVCap-PVAc-PEG hinders the dissolution of the polymer at pH 1.2.  However, once 
the pH of the solution is increased above the INM’s pKa (which is 4.5 (Yazdanian et al. 
2004)), as is the case at pH 7.4, the interactions between API and polymer are reduced by 
ionization of the INM’s carboxylic groups, allowing the dissolution of the system.  In 















The acid dissociation constant (ka) can be defined by equation 4.4.  Rearranging 
equation 4.4, the relationship between pH and the concentrations of INM in various 
forms can be obtained according to equation 4.5. 
 
k = RCOO HRCOOH  (4.4) 





Where, [RCOO-] and [RCOO] are the molar concentrations of ionized INM and 
non-ionized INM, respectively. 
Finally, since INM cannot be released from the solid solution until its carboxylic 
group is ionized, and thus reducing the polymer-API interaction allowing dissolution of 
both components, equation 4.5 is used to estimate the amount of INM that can be 
released from the solid solution (i.e. HMM-prepared S30INM) as a function of pH of the 
solution.  As shown in Figure 4.7, at pH 1.2 only 0.05% of INM can be released, while at 
pH 7.4 99.9% INM can be released, which is in agreement with the results presented in 
Figure 4.6 for the melt mixed samples.   
 
Figure 4.7  Expected amount of INM to be released from a solid solution such as the 
HMM S30INM sample as a function of pH. 
It should be mentioned that strong physical interactions between a drug and a 
polymer are in general desirable in HMM/HME products because they help to stabilize 
the API in the amorphous state during the shelf life of the product.  However, in this case, 
the strong physical interactions make it difficult for the polymer to dissolve in acidic 



























In addition to the pH effect, Figure 4.6 also shows the impact of different oral 
delivery forms.  At pH 7.4, the fastest release rate of INM is observed from the HMM-
prepared compression molded samples, followed by γ-INM in capsules, and then the PM 
in capsules.  The percentage of INM released in 1 h is 91 ± 3 % from the HMM sample, 
65 ± 7 % for γ-INM in capsule, and 37 ± 8 % for the PM in capsule.  The fastest release 
rate associated with the HMM sample is due to INM been in its amorphous state.  
Dissolution of a material in the amorphous state, compared to its crystalline counterpart, 
is facilitated by the lack of lattice structure.  In the amorphous state the lattice energy 
does not have to be overcome in order to dissolve the API (Leuner and Dressman 2000).  
In addition, also due to the lack of lattice structure, an amorphous API has a higher free 
energy compared to its crystalline counterpart (Bhugra and Pikal 2008), facilitating 
dissolution is the former case.  
It is important to mention that INM concentration determined through UV 
analysis most likely corresponds to only truly dissolved API, since micellar INM was 
probably blocked during filtration.  When studying the dissolution behavior of PVCap-
PVAc-PEG, no UV signal of the polymer was observed when the PVDF filters with pore 
size of 0.45 μm were used, even though the PVCap-PVAc-PEG is a chromophore.  The 
dissolution profiles of pure PVCap-PVAc-PEG are presented in section 4.6.2, were 
obtained through UV analysis without filtration.  This observation suggests that the 
PVCap-PVAc-PEG micelles cannot pass through the filter. 
In the case of crystalline INM at pH 7.4, after 1.5 h, complete dissolution is not 
obtained even though the amount used is significantly below its solubility limit.  The 





to be 1300 mg/L at pH 7.4 (Yazdanian et al. 2004).  This is due to the slow dissolution 
rate of crystalline INM. The remaining un-dissolved INM particles precipitated to the 
bottom of the dissolution vessel.  
Surprisingly, at pH 7.4 INM release rate from the physical mixture is slower than 
that of the pure crystalline INM.  Because the PVCap-PVAc-PEG is a surfactant, an 
opposite result was expected.  INM is a crystalline powder in both cases and its 
difference in the release rate can be attributed to the presence of the polymer.  This 
phenomenon can be explained through a combination of two factors: polymer gelation 
and a low pH micro-environment.  Once the physical mixture is wetted by the aqueous 
solution, the polymer rapidly forms a gel which encapsulates the crystalline INM 
particles.  Because the polymer gel has a much higher viscosity than the aqueous 
solution, it slows down the diffusion rates of the solvent and API.  In addition, the 
microenvironment surrounding the INM particles probably has a slightly lower pH than 
the bulk solution.  Information appearing in PVCap-PVAc-PEG data sheet from the 
manufacturer states that the polymer solution has a pH of 3~5.5.  It should be mentioned 
that other researchers have incorporated pH controlling additives into their formulations 
to generate a specific micro-environment around the API to control its release rate 
(Doherty and York 1989; Govindarajan et al. 2006).  In some cases the chemical nature 
of the API itself is responsible for the slightly different pH of the micro-environment 
from that of the dissolution medium (Bruce et al. 2005). In this study, the acidic 
microenvironment and the gel caused by the presence of the polymer slowed down the 
INM’s release rate.  The 5 min delay in the dissolution curves of pure INM and PM 





4.2.2 CO2 Solubility in the S30INM Binary System 
The solubility of physical blowing agents in a polymer is of great importance during 
foaming operations.  Gas solubility has also a direct impact on the rheological properties 
of the material, and thus the morphology and final properties of the foamed product.  
Various in-line and off-line methods have been used to measure the solubility of PBA in 
polymers.  In-line gas solubility determination techniques are generally based on 
viscosity measurements (Todd et al. 1998; Lee et al. 1999; Choudhary et al. 2005) and 
optical methods (Zhang and Xanthos 2004; Faridi and Todd 2007).  Pressure decay and 
gravimetric methods are the most commonly used off-line measurement techniques (Sato 
et al. 2001; Tomasko et al. 2003; Faridi and Todd 2007).  These methods provide 
between 5-7 % accuracy in the solubility determination (Tomasko et al. 2003).   
In this study a gravimetric method is used to determine the solubility of CO2 in 
the HME-produced binary system S30INM, wherein the amount of gas dissolved is 
determined by weight difference of the samples before and after 24 h gas saturation at 
various pressures and temperatures.  It is important to note that samples are weighed 
under ambient conditions, after removing them from the high pressure vessel, in order to 
avoid gas loss due to diffusion; thus bubbles are not observed at any of the conditions 
evaluated.  This methodology has been used by other authors to successfully measure the 
solubility of PBAs in different polymers (Faridi and Todd 2007; Brown et al. 2011).   
Figure 4.8 shows the measured CO2 solubility in S30INM as a function of 
pressure and at three different temperatures.  Two of the temperatures tested are 
significantly below the Tg of the binary system, while the third corresponds to the 





However, it should be noted that the Tg of the ternary system S30INM containing CO2 is 
expected to be lower than that of the binary system S30INM, since it is known that CO2 
acts as a plasticizer for many polymers lowering their Tg (Tomasko et al. 2003).  Thus, it 
can be assumed that these measurements are performed at both above and below of the 
system’s Tg. 
 
Figure 4.8  CO2 solubility (S) in S30INM as a function of CO2 pressures (PCO2) at 
different temperatures:  39.6 °C,  52.2°C and  62.9 °C.    
Results presented in Figure 4.8 indicate that the solubility increases as the 
pressured increases, but decreases as the temperature is increased.  The latter is due to 
increased mobility of both the gas and solid phases, making it more difficult for the gas to 
remain within the solid phase.  On the other hand, the pressure dependence of solubility 
of gases in polymers is known to follow Henry’s law (Lee et al. 1999; Zhang and 
Xanthos 2004; Faridi and Todd 2007; Brown et al. 2011), through the following 
expression: 
 =  (4.6) 
S = 5.9008 PCO2
R² = 0.9703
S = 4.9349 PCO2
R² = 0.9886



























Where S is the volume of gas dissolved at STP (standard temperature and pressure 
– 237 K and 1 atm) conditions per unit weight of the S30INM disk [cm3(STP)/g], kp is the 
Henry’s Law constant, and is the saturation pressure. 
Values of Henry’s law constant for the CO2 - S30INM ternary system are 
calculated by fitting the solubility data with equation 4.6 and are reported in Table 4.4.  
These calculated values are of the same order of magnitude with those reported in the 
literature for other CO2 - polymer systems not containing APIs (Faridi and Todd 2007; 
Brown et al. 2011).   
Table 4.4  Calculated Henry’s Law Constant Values for CO2 - S30INM Ternary System 
Temperature [°C] kp [cm3(STP)/g MPa] 
39.6 ± 0.9 5.9 ± 0.1 
52.2 ± 0.5 4.9 ± 0.1 
62.9 ± 0.3 4.17 ± 0.01 
 
Furthermore, the temperature dependence of kp follows an Arrhenius expression 
as follows: 
= −  (4.7) 
 
Where kpo is the temperature independent Henry’s law constants, Es is the heat of 
solution, T is the absolute temperature and R is the universal gas constant. 
Using equation 4.7 to fit the kp values reported in Table 4.4, it is determined that 
kpo and Es for CO2 - S30INM are 0.04 cm
3(STP)/g MPa and -128.2 L atm/mol K, 





S30INM at different temperatures and pressures relevant to foaming processing 
conditions can be estimated. 
4.3 Crystallization of Amorphous INM in the Presence of ScCO2  
As mentioned in Chapter 2, supercritical fluids and especially supercritical CO2 (ScCO2) 
have been used to induce polymorphic transitions in APIs (Edwards et al. 2001; Moribe 
et al. 2008; Brittain 2009) and as processing aids during manufacture of solid 
solution/dispersions by different techniques (Sethia and Squillante 2004; Verreck et al. 
2006a; Lyons et al. 2007; Moribe et al. 2008; Nagy et al. 2012).  Given that it has already 
been established in the literature that ScCO2 is capable of inducing polymorphic changes 
in an API, it is relevant to this work to study its effect on the morphology of INM.  To 
accomplish this, the batch foaming apparatus and process are used to evaluate the 
crystallization of INM from its amorphous state.  Samples of amorphous INM were 
prepared by compression molding at 165°C, and a picture of an amorphous INM sample 
can be seen in Figure 4.9 (a). 
Amorphous INM samples were heated with and without ScCO2.  The samples 
heated without ScCO2 were intended to be control samples.  Figures 4.9 (a) and (b) show 
the effect of temperature on amorphous INM.  At 25°C, the samples remain amorphous, 
being transparent glasses.  But when heated for 15min at 100°C the sample partially 
crystallizes.  In contrast, in the presence of ScCO2 the crystallization process is 
accelerated as is shown in Figures 4.9 (c) and (d).  Even at 25°C, temperature at which 
INM can remain amorphous for several weeks (Andronis and Zografi 2000) the sample 






 (a) (b) 
(c) (d) 
Figure 4.9  Photographs of INM samples: (a) Initial amorphous INM sample at 25 °C, 
(b) sample after heating amorphous INM to 100 °C for 15 min, (c) sample after treating 
amorphous INM with ScCO2 at 25 °C and 10.34 MPa for 15 min, and (d) sample after 
treating amorphous INM with ScCO2 at 100° C and 10.34 MPa for 15 min. 
FT-IR is used to study in more detail the state of INM on each of the samples 
shown in Figure 4.9.  The spectra for all the samples appear in Figure 4.10.  The 
spectrum of the sample treated with ScCO2 at 25°C [Figure 4.10 (c)] is a mixture of all 
three forms (i.e. amorphous, α-INM and γ-INM).  The shoulder observed at 1736 cm-1 
and the peak at 1692 cm-1 belong to the amorphous and γ-INM, respectively [see       
Table 4.2 and Figures 4.10 (a) and (b)].  The weak band at 1650 cm-1 is due to the 
asymmetric stretching of hydrogen-bonded acid C=O in α-INM.  The other peaks 
observed correspond to coupling of two forms.  For example the one at 1715 cm-1 





(see Table 4.2) and is observed between the normal position for the amorphous and        
γ-forms; the shift is due to the presence of both species in the sample.   


































Figure 4.10  FT-IR spectra of INM:  (a) γ-INM, (b) amorphous sample prior to thermal 
treatment, (c) INM after treating the amorphous sample at 25 °C with ScCO2 for 15 min, 
(d) INM after heating the amorphous sample at 100 °C for 15 min, and (e) INM after 
treating the amorphous sample at 100 °C with ScCO2 for 15 min. 
Since the sample treated at 100 °C for 15 min [see Figure 4.10 (d)] also resulted 
in a mixture of the three forms (amorphous, γ-INM and α-INM), its spectrum is very 
similar to the one of the sample treated with ScCO2 at 25 °C [Figure 4.10 (c)].  However, 
the relative intensity of the peak is affected and the influence of α-INM becomes more 
dominant.  For example: the shoulder at 1736 cm-1 associated with the stretching 
vibration of the non-hydrogen bonded acid C=O in amorphous INM, becomes a well-





change observed is the reduction in intensity of the 1692 cm-1 peak of γ-INM.  The 
predominance of α-INM in this sample is due to the significantly faster crystal growth 
rate of α-INM compared to γ-INM at 100 °C (Andronis and Zografi 2000). 
Finally, the sample treated for 15 min at 100 °C with ScCO2 [Figure 4.10 (e)] is 
completely crystalline and composed of γ and α-INM.  The disappearance of the peak at 
1715 cm-1 is evidence of the absence of amorphous INM and predominance of α-INM. 
4.4 Foam Extrusion of S30INM Binary System  
As mentioned in section 2.3, one of the primary interests of the pharmaceutical industry 
in foam extrusion technology is to facilitate the milling operation of HME products.  
Currently, the HME process is mainly used to produce intermediate drug products; 
however final dosage forms are seldom in the form of an extrudate.  In general, the HME 
product (i.e. the extrudate) in the vast majority of the cases has to be milled and blended 
with other excipients to tailor the product performance and/or to improve tableting 
operations.  Few exceptions can be found where the final drug product is an HME 
extrudate. Only few examples include: NuvaRing, Implanon and Lacrisert® (Zhang and 
DiNunzio 2010; DiNunzio 2011).  However, these drug products are not oral dosages but 
implants or medical devices.  Therefore, the objective of this section is to understand the 
effect of the morphology of the cellular structure on the milling efficiency of extrudates, 
as well as, hopefully, improve the quality of the milled products.  By varying the foam 
extrusion conditions two foam morphologies were produced and their performance (in 
terms of milling efficiency and release rate) was compared to the un-foamed extrudate of 





4.4.1 Cellular Morphology in Foamed Samples 
Prior to analyzing and discussing the cellular morphology of the foam-extruded samples 
it is important to bear in mind that it was not the objective of this work to perform a 
detailed parametric study of the effect of the processing variables on the foam 
morphology, which has already been studied by other researchers (Han et al. 2002; 2003; 
Kaewmesri et al. 2006; Nagy et al. 2012).  However, it is of interest to use the already 
existing knowledge to produce different cellular morphologies in order to evaluate the 
effect of the cellular morphology on the performance of HME products.  
A summary of the properties of un-foamed and foamed extrudates is presented in 
Table 4.5.  Figures 4.11 and 4.12 show pictures of the extrudates and SEM images of 
their cross-sectional surfaces, respectively.  The un-foamed samples are designated as 
HME, and were produced without injecting CO2 during the HME process.  On the other 
hand, foamed extrudates (referred to as fHME) were produced by injecting CO2 as PBA 
into the extruder during the HME process.  As can be seen in Table 4.5, by varying the 
concentration of CO2 injected during the foam extrusion process it was possible to 
produce foamed extrudates with different densities, and in particular one high density 
foamed extrudate (HD-fHME) and a low density foamed extrudate (LD-fHME).  
 
Table 4.5  Summary of the Characteristics of the Un-foamed and the Foamed Extrudates 










HME 0 1.01 ± 0.05 - - 
HD-fHME 12 0.24 ± 0.05 774-2165 9.8-153.5 








Figure 4.11  Photographs of the S30INM extrudates: (a) un-foamed extrudate – HME – 
(b) HD-fHME extrudate, and (c) LD-fHME extrudate.  
As can be seen in Figures 4.11 (a) and 4.12 (a) the un-foamed extrudates (HME 
sample) are non-porous.  On the other hand, extrudates produced by foam extrusion (HD-
fHME and LD-fHME) are porous, as seen in Figures 4.12 (b) and (c).  The densities of 
the foamed extrudates are 4 and 14 times lower than the density of the un-foamed 
extrudates, which corresponds to reduction in density of 76 and 93%, respectively (see 
Table 4.5).  These reductions in density resulted from the creation of closed cells in both 
HD-fHME and LD-fHME extrudates as shown in Figures 4.12 (b) and (c). 
Based on the mass flow rates of polymer, API and CO2 fed to the extruder it is 
possible to determine a theoretical or minimum density that could be achieved for the 
foamed samples.  The values reported in Table 4.6 (see Appendix C for the detailed 
calculations) allow to give a semi-quantitative understanding of the morphologies of the 
extrudates.  As can be seen in Table 4.6, in both cases the theoretical density is lower 
than the measured density.  While in the case of the HD-fHME extrudate the theoretical 
density is two orders of magnitude lower than the experimental density; in the case of the 





most likely due to small CO2 losses as the melt flows through the die.  In the case of the 
HD-fHME sample a significant amount of gas is lost due to flow instabilities as will be 




Figure 4.12  SEM images of a cross-sectional surfaces of the S30INM extrudates (100X 
in the left column and 500X in the right): (a) un-foamed extrudate – HME –, (b) HD-





Table 4.6  Comparison Between the Calculated Ideal Densities and Experimentally 
















HD-fHME 1 2 990 120000 0.008 0.24 ± 0.005 
LD-fHME 1.5 1 1485 60000 0.024 0.071 ±0.004 
*Calculations carried out used a density of S30INM as 1.01 g/cm3 
**Calculations carried out using the density of CO2 at measured melt temperature and 0.101MPa in both 
cases it is 0.001 g/cm3 (NIST 2011).  
The results summarized in Table 4.5 and the SEM images shown in Figure 4.12 
clearly indicate that increasing the concentration of CO2 from 4 to 12 w/w% resulted in a 
cellular structure with higher density, bigger cells and thicker cell walls.  However, these 
results are counterintuitive, since homogenous nucleation theory predicts that higher PBA 
concentration leads to higher number of nuclei and therefore more and smaller cells 
(Colton and Suh 1987; Han et al. 2002).  The opposite trend is observed in the present 
case because the gas concentrations utilized are above the estimated solubility limit of 
CO2 in the S30INM system (see Table 4.7).  It is important to point out that process 
instabilities commonly occur when gas concentrations exceed its solubility; as will be 
discussed in more detail below. 
Figure 4.13 schematically represents the physical aspects of cell nucleation and 
growth during a typical foam extrusion process along a capillary die.  As shown, the 
pressure drop between the die entrance and its exit can be approximated by a linear 
pressure drop along the die (Lee 2000).  Ideally the gas is fully dissolved in the melt 
forming a single phase with the molten polymer as it enters the die.  As a result of this 
rapid depressurization cell nucleation is triggered, by a drop in gas solubility in the melt 





(Pc) is reached; at Pc the gas-polymer systems becomes oversaturated (Han et al. 2002; 
2003).  Then, once the nuclei reach a critical size (which has been found to be in the 
order of 0.3 μm in radius for polystyrene (Lee 2000)) cellular growth takes place through 
diffusion of the gas in the bulk toward and into the CO2 bubbles.  For a stable process, 
nucleation should occur as close as possible to the die exit. 
 
Figure 4.13  Schematic representation of the pressure profile in a capillary die and the 
foaming mechanism during a foam extrusion process.  Nucleation starts at a critical 
pressure (Pc) where the system becomes oversaturated with CO2. 
As mentioned above, the processing conditions used lead to gas loadings most 
likely above its solubility limit.  The estimated solubility values of CO2 in the S30INM 
system presented in Table 4.7 are calculated using Henry’s law, with the parameters 
determined in section 4.2.2 for the ternary system CO2 – S30INM.  The temperature and 
pressure values used to calculate the gas solubility correspond to the experimentally 
measured values of melt temperature and the die pressure, which are also reported in 
Table 4.7.  It is important to point out that this estimated solubility values may have 





the molten state compared to the “semi-solid” state at which solubility measurements 
were performed (at the highest measured temperature the samples were softened but did 
not show flow). 





Tmelt [°C] Padie [MPa] 
Estimated CO2 
Solubility b [w/w %] 
HD-fHME 12 102 3.65-3.72 1.85 - 1.88 
LD-fHME 4 97 3.03-3.50 1.63 – 1.88 
a Maximum and minimum experimental die pressures measured during foam extrusion runs. 
b Upper and lower solubility limit were calculated using maximum and minimum die pressure values. 
In the case of the HD-fHME sample, the amount of gas injected was 12 w/w%, 
which exceeds the estimated gas solubility in the S30INM system (1.85 – 1.88 w/w%, see 
Table 4.7) at the processing conditions used for this sample.  In the case of the LD-fHME 
sample, the difference between the amount of gas injected (4 w/w%) and the estimated 
solubility is not as significant; the estimated solubility of CO2 at the processing 
conditions is 1.63 – 1.88 w/w% (see Table 4.7).  Therefore, before depressurization along 
the die (which is the driving force for cell nucleation during the foam extrusion process 
(Han et al. 2002; 2003)), the gas was not fully dissolved in the melt.  Thus, two phases 
were most likely present, namely: (1) a homogenous continuous phase foamed by CO2 
and S30INM melt, and (2) a dispersed phase containing the CO2 that was unable to 
dissolve.  In other words, gas bubbles were already present in the melt prior 
depressurization.  As the melt flowed through the die and the pressure drops to 
atmospheric conditions (~0.101 MPa) the gas bubbles that were already present in the 
melt expanded.  Consequently, cellular growth takes place along the die without the need 





Carrying out calculations similar to those used for the estimation of the theoretical 
densities of the extrudates, it is possible to roughly estimate the volume fraction occupied 
by un-dissolved CO2.  As shown schematically in Figure 4.14, in the case of HD-fHME 
with 12 w/w% of CO2 injected, 10 w/w% remains most likely un-dissolved and, at the 
pressure and temperature at the capillary die entrance it occupies 64 % of the volume of 
the two phase stream.  As the pressure decreases along the die these un-dissolved gas 
regions of complex morphology expand, increasing the volume fraction occupied by 
them.  Moreover, dissolved CO2 will tend to diffuse into these gas regions, due to further 
reduction of its solubility in the melt.  For example, at a pressure of 1.8 MPa (which 
corresponds to approximately half-length of the die – when assuming linear pressure 
drop), the amount of un-dissolved CO2 is estimated to be 11 w/w% which corresponds to 
81 % of the volume.  The presence of the expanding gas phase promotes axial 
acceleration of the melt / CO2 two-phase stream and, because of the very large difference 
in viscosities between the melt and the dispersed gas phase, the morphology of the 
“blend” is very complex leading to flow instabilities.  These favor the escape of CO2 
before the stream exits the die, for example, through CO2 “channeling” forming a 
continuous streak of CO2 from an upstream location of the capillary die to the exit.  Such 
“channels” most likely appear at the die-melt stream interphase, since the number of 
nuclei per unit volume tends to be much higher toward the extrudate “skin” than along its 
core during the foam extrusion process (Lee 2000).  As shown in the Optical Microscope 
images of HD-fHME in Figure 4.15 open cells can be seen along the edges of the cross-






Figure 4.14  Schematic representation of the pressure profile and two-phase melt stream 
morphology along the die during foam extrusion of HD-fHME sample.  Point A indicates 




Figure 4.15  Optical Microscope images of a HD-fHME extrudate: (a) extrudate surface, 
and (b) cross-sectional surface.  
It should be noted that although the pressure profiles along the die can be 





dashed line is Figure 4.14, may prevail.  This deviation may be due to two factors: (1) 
increase in melt viscosity as the gas diffuses from the melt into the bubble, and (2) higher 
gas pressure inside the bubble compared to the melt and local pressure build up, 
sometimes referred to in literature as “superheat” (Lee 2000). 
In the case of the LD-fHME sample, some of this flow instabilities may also 
occur but to a lesser degree.  Performing the same calculations described above it was 
found that before entering the die only 2.1 w/w% CO2 remains un-dissolved, and this 
would correspond to only 29 % of the volume of the melt stream.  Again at 
approximately half the length of the die, the amount of un-dissolved gas is expected to be 
2.3 w/w% (48 % of the volume).  However, as mentioned above, local pressures along 
the die are most likely higher than predicted by the linear approximation; thus, the gas 
expansion inside the die should be less than estimated.  Having this in mind and knowing 
that critical nuclei sizes are in the submicron level (Lee 2000),  significantly lower gas 
losses are expected through the die due to the flow instabilities in the case of LD-fHME 
compared to the processing conditions used for the HD-fHME sample, as the semi-
empirical analysis on the densities also suggests.  In addition, open cells were not 
observed along the surface of the LD-fHME extrudates using both SEM and Optical 
Microscopy (see Figure 4.16).   
Based on the discussion above then it is evident that due to the flow instabilities 
which most likely result in extensive gas loss along the die at the processing conditions 
used for HD-fHME extrusion, the foam structure resulted in the formation of few and 
very big cells ranging from 0.77 to 2.2 mm, as seen in Table 4.5 and Figures 4.12 (b) and 






Figure 4.16  Optical Microscope image of the cross-sectional surface of a LD-fHME 
extrudate.  
Conversely, the processing conditions used to produce the LD-fHME sample 
resulted in a more stable process with minimal gas loss.  Therefore, in this case 
significantly smaller cells were produced, with sizes in the rage between 27 – 320 μm.  In 
addition, by comparing Figures 4.12 (c) with (b) it is evident that the LD-fHME sample 
has a significantly higher number of cells per unit area than the HD-fHME sample.  
It should be mentioned that a foam extrusion condition where the PBA content 
exceeds its solubility in the melt would not be used in an industrial manufacturing setting, 
since it results in process and product variability.  However, further optimization of the 
processing conditions used for the LD-fHME samples were not possible due to 
equipment and material limitations.  On the other hand, HD-fHME samples were used – 
notwithstanding the limitations associated with the process – since it provided the 
opportunity to compare the performance of a drastically different morphology with 
respect to the LD-fHME extrudates, and, therefore, making it possible to observe tangible 
differences between the milling and dissolution performance of the two foam 





The differences in morphology observed among the extrudates are expected to 
affect their milling efficiency, as well as the morphology of the particles produced, and 
therefore the in vitro dissolution/release performance of the S30INM system.  These 
aspects are discussed in detail in the next sections. 
4.4.2 The State of INM and Content Uniformity in Foamed Extrudates  
Since two independent feeders were employed during the foam extrusion process it is 
important to confirm that the drug loading after compounding was in fact 30 wt%.  In 
addition, by determining the concentration of INM in randomly collected samples for 
each condition, it would be possible to detect variability on the drug loading as a function 
of time due to either feeding non-uniformities or poor axial mixing by the extruder.  As 
can be seen in Table 4.8, the experimentally determined amount of INM in the extrudates 
is between 28 and 30.4 wt% (30 wt% was the intended and nominal drug loading).  In 
addition, variability within each processing condition is less that 3.4 % in all cases.  
These results reflect good content uniformity and are within the requirements established 
in USP Monograph for the different INM’s dosage forms (i.e. capsules, suppositories and 
oral suspensions).  The monograph states that the content of INM in a dosage form can 
not be less than 90.0 % and no more than 110 % with respect to the theoretical amount. 
 
Table 4.8  Determined Drug Loading in the Extrudates Through Content Uniformity 
Analysis 
Sample CO2 Concentration [w/w%] INM Concentration [wt %] 
HME 0 29 ± 1 
HD-fHME 12 28.7 ± 0.6 






In section 4.1 it was shown that solubility limit of INM in PVCap-PVAc-PEG is 
significantly higher than 30 wt% (with INM’s estimated solubility being 71 wt%).  
Additionally, in the same section it was also shown that the S30INM system compounded 
in a twin screw extruder is an amorphous solid solution, that is, all of the INM has been 
dissolved.  However, it is known that gases injected during the extrusion process affect 
the properties of the melt. For example, the melt viscosity and surface tension tend to 
decrease (Goel and Beckman 1994a; Elkovitch and Tomasko 2000; Lee 2000; Tomasko 
et al. 2003; Sauceau et al. 2011).  These changes in material properties could potentially 
affect the dissolution process of the API in the polymer, because they are translated into 
changes in the capillary number of the melt and in the viscosity ratio between materials 
been blended; these critical parameters during melt compounding with polymers 
(Tomasko et al. 2003; Tadmor and Gogos 2006).  For example, Elkovitch and Tomasko 
(Elkovitch and Tomasko 2000) observed significant changes in the morphology of a 
blend of two immiscible polymers by injecting CO2 during melt compounding.  Verreck 
et al. (Verreck et al. 2007) observed for some conditions incomplete dissolution of 
Itraconazole in Ethyl Cellulose during foam extrusion while complete dissolution was 
observed by conventional HME.  Another factor that may affect API dissolution is 
associated with the necessary changes which have to be made in the process variables to 
have successful foam extrusion.  Compared to the conventional HME process, during 
foam extrusion the melt temperatures needs to be lower in order to provide the necessary 
melt strength needed to prevent rupture of the expanding cells during foaming or 
consequent collapse of the cellular structure.  This reduction in temperature may also be 





may be detrimental to the dissolution rates and solubility of the API in the excipient.  
Additionally, as mentioned before in Chapter 2 in section 2.4, CO2 it is known to act as 
anti-solvent for some APIs and also to promote polymorphic transformation of some 
APIs.  Specific to INM, in section 4.3, it was shown that CO2 facilitates INM’s 
recrystallization from the amorphous state.  Therefore, it is important to establish if the 
presence of CO2 during HME process, where foamed S30INM extrudates were produced, 
affected the dissolution of INM in the excipient.  The state of INM in the S30INM binary 
blends was analyzed through FT-IR, and the spectra obtained are shown in Figure 4.17. 



































Figure 4.17  Comparison of the FT-IR spectra of the un-foamed and the foamed S30INM 
systems produced by HME and foam extrusion.  Spectra of pure PVCap-PVAc-PEG, 







As discussed in detail before in section 4.1, FT-IR allows to accurately 
differentiate between amorphous INM, γ-INM and α-INM.  In the case of the S30INM 
systems, the shifts in the peak associated with the stretching vibration of the C=O bond in 
the benzoyl group has shown to be the best indicator to identify the state of INM in the 
blends.  This peak is not overlapped or affected by peaks associated with the excipient 
and it has a strong intensity.   
By comparing the location of the benzoyl peak in the extrudates with its location 
in the PM and γ-INM, it is evident that in all the extrudates (foamed and non-foamed) the 
drug was in amorphous state.  This peak is located at 1683 cm-1 in all the extrudates, 
while in the samples were INM is crystalline is seen at 1692 cm-1.  The first peak 
corresponds to amorphous INM while the latter to the crystalline γ-INM (see Table 4.2 
and Figure 4.17).   
4.4.3 Effect of Foam Cellular Structure on Milling  
As described in Chapter 3, milling of the extrudates was carried out in batches of 25 g for 
20 s in a laboratory coffee grinder.  Figure 4.18 shows the particle size distribution (PSD) 
obtained by milling the un-foamed and foamed extrudates.  From these results it is 
evident that milling of the foamed extrudates lead to narrower PSDs.  The PSD of the 
ground un-foamed extrudates presented in Figure 4.18 (a) clearly shows a tail of very big 
particles, lager than 1.8 mm, which is above the maximum detection limit of the 
instrument.  A summary of the characteristics of the milled extrudates is shown in Table 
4.9.  In addition, the morphology of the particles produced can be seen in the SEM 






Figure 4.18  Particle size distribution (PSD) of the three milled extrudates:  (a) ground 
HME sample, (b) ground HD-fHME sample, and (c) ground LD-fHME sample. 
Combining the results presented in Figure 4.18 and Table 4.9 it is clear that the 
smallest particles with the tightest PSD were produced by milling the LD-fHME 
extrudate, followed by the HD-fHME extrudate and finally the HME extrudate.  As 
expected the bulk density of the milled samples follows the same trend as the particle 
size, that is, lower bulk density as the particles become smaller with narrower PSD.  
 
Table 4.9  Summary of the Properties of the Milled Extrudates 
Property 
Sample 
HME HD-fHME LD-fHME 
CO2 concentration [w/w%] 0 12 4 
Bulk density [g/cm3] 0.69 ± 0.01 0.55 ± 0.01 0.21 ± 0.01 
d10 [μm] 72 ± 1 50 ± 6 16.4 ± 0.2 
d50 [μm] 296 ± 7 206 ± 10 67 ± 1 



























It is interesting to note that the size of the particles produced by milling the LD-
fHME extrudate tends to be bigger that the cell wall thicknesses measured from the SEM 
images of the cross-section of the extrudates.  The median particle size was determined to 
be 16.4 ± 0.2 μm, while the cell wall thicknesses are in the range 0.4 – 7.7 μm (see 
Tables 4.9 and 4.5, respectively).  This result suggests that even after milling some of the 
cellular structure was retained in the particles.  Evidence of this can be seen in Figures 
4.19 (e) and (f) where some of the cellular structure is still present although now, after 
milling, with open cells; this was also observed by Nagy et al. (Nagy et al. 2012).  The 
incomplete destruction of the cellular structure could bring additional benefits to the drug 
product.  On one hand, the presence of cells can potentially aid tableting operations of the 
product by facilitating particle deformation during compression of otherwise tough and 
brittle particles, and on the other hand, the remaining cellular structure results in particles 
with higher surface area thus dissolution rate enhancement is possible.  The higher 
surface area of the particles produced by milling foamed extrudates compared to un-
foamed ones has also been observed in other HME products (Verreck et al. 2005; 
Verreck et al. 2006b; Verreck et al. 2007).   
Results shown in Figure 4.18 and Table 4.9 indicate that even though the milled 
HD-fHME sample has a “tighter” PSD, at least up to the mean particle size, its 
distribution (although with a slight shift to smaller particles) is comparable to the one 
obtained for the un-foamed extrudate characterized by a larger particulate size tail, as 
seen in Figures 4.18 (a) and (b).  In addition, by comparing the SEM images of the 
particles obtained from these two samples in Figures 4.19 (b) and (d) it can be seen that 








Figure 4.19  SEM images of milled S30INM extrudates. Ground HME sample: (a) 
1.00kX and (b) 500X; ground HD-fHME: (c) 1.00kX and (d) 500X; and ground LD-





The improvement in milling efficiency observed for the S30INM system by 
utilizing the foam extrusion technology has also been observed for pure excipients and 
solid solutions (Verreck et al. 2005; Verreck et al. 2006b; Verreck et al. 2007).  
Milling of an extrudate becomes easier upon foaming due to the void fraction in 
the foam, which affects the stress levels acting on the material during milling.  In a 
foamed extrudate the effective area on which an applied force is acting is very small 
compared to the same force acting in an un-foamed extrudate.  Thus, the effective stress 
acting on the extrudate is higher in a foamed sample than in a un-foamed one.  In 
addition, if the cells are small enough to act as stress concentrators, then the milling 
efficiency can be further increased.  The same reasoning can be used to understand the 
change in milling efficiency between the two foamed samples.  On one hand, the LD-
fHME samples have thinner walls than the HD-fHME samples (two orders of magnitude 
difference in the thickest walls, see Table 4.5).  On the other hand, the density of the LD-
fHME extrudate is one order of magnitude lower than in the HD-fHME sample, thus the 
former has a significantly higher void fraction.  Therefore, the LD-fHME extrudate will 
be subjected to much higher stress levels during milling than the HD-fHME extrudates.   
Another approach that can be used to understand the effect of foaming and 
cellular morphology on the change in milling efficiency is through understanding the 
changes in their mechanical properties due to cell morphology.  The type of cells (i.e. 
open vs. closed cells), cell size, and foam density are known to affect the mechanical 
properties of a foam (Shutov 1991; Sun et al. 2002; Wolff et al. 2011).  In general, as the 
density of the foam decreases, the elastic modulus and the strength of the foam tend to 





In summary, it is found that the milling efficiency of HME extrudates is increased 
through cellular structures.  Foamed extrudates compared to un-foamed extrudates 
allowed, under the same milling conditions, to produce smaller particles with a narrower 
particle size distribution and lower bulk density.  However, by simply introducing some 
degree of porosity in the extrudate without actually producing a foamed structure with 
closely packed cells and thin walls, the particles produced by milling the extrudate are 
very similar to the ones produced by milling an un-foamed extrudate.  
4.4.4 Release of INM from Milled Extrudates 
The release profiles of INM from HPMC capsules containing an average of 25 mg of 
drug are presented in Figure 4.20.  While the API in the capsules containing pure INM is 
in its crystalline γ-form, in the ones containing the milled extrudates INM is amorphous 
having formed a solid solution with the excipient during extrusion, as was shown in 
section 4.4.2.  The in vitro dissolution tests are conducted in a phosphate buffer solution 
with pH 7.4.  The release profiles in Figure 4.20 clearly indicate that INM is released 
faster from the milled extrudates in capsules, than from capsules containing pure 
crystalline INM.  In 30 min the amount of INM released from capsules containing pure γ-
INM is 50 ± 5 %, while from the milled extrudates it is 95 ± 3 % for ground HME 
sample, 97 ± 1 % for ground HD-fHME and 96 ± 2 % for ground LD-fHME.  Since INM 
is amorphous in the milled extrudates its release is faster compared to the crystalline 
samples.  As mentioned before in section 4.2.1, dissolution of a material in the 
amorphous state, compared to its crystalline counterpart, is facilitated by the lack of 









































Figure 4.20  Release profiles from HPMC capsules of pure INM (▼), ground HME 
sample (), ground HD-fHME sample (), and ground LD-fHME sample () in 
phosphate buffer solution with pH 7.4.  Dissolution tests obtained using a USP apparatus 
2.  Tests were performed in triplicate. 
From a general perspective, it can be seen that the release profile of pure INM is 
characterized by a delay in API’s release of approximately 5 min.  During this time no 
API was detected by the UV analysis.  In section 4.2.1 this was attributed to the 
dissolution of the HPMC capsule.  However, in this case all the samples were analyzed 
by placing the powder in the capsules, since the milled extrudates also showed a delay in 
the API release, although shorter of ~2min, then, it can be concluded that for the pure 
INM this delay is not only due to the dissolution of the capsule, but also results from 
slower wetting of the crystalline API compared to the amorphous solid solution particles.  
In the latter case, the amorphous API was embedded in a polymer which is highly 
hydrophilic and soluble in the buffer solution, thus wetting was favored in the solid 





Up to this point, the release profiles of milled extrudates have been compared to 
the release profile for pure crystalline INM, and as expected the release rate of the API 
was accelerated through the formation of an amorphous solid solution during extrusion 
processing.  .  
By comparing the release profiles of milled extrudates shown in Figure 4.20 it is 
clear that ground LD-fHME leads to the fastest INM release, while the release profiles of 
ground HME and HD-fHME samples are very similar and their release profiles overlap.  
The amount of INM released in 10 min from ground LD-fHME sample is 93 ± 4 %, from 
ground HD-fHME sample is 51 ± 5 % and from ground HME sample 42 ± 2 %.  These 
results suggest that there is a direct correlation between release rate and particle size.  
Other reports can be found in the literature, where it has been shown that solid solution 
particles produced from milling foam extrudates lead to faster dissolution/release rate 
than particles produced by milling un-foam extrudates (Lyons et al. 2007; Verreck et al. 
2007; Nagy et al. 2012), the same results have also been reported for placebo 
formulations (Verreck et al. 2006b).   
In the literature, numerous mathematical models have been proposed to describe 
API release/dissolution (Higuchi et al. 1965; Nogami et al. 1970; Ritger and Peppas 
1987a; b; Peppas and Sahlin 1989; Narasimhan 2000; Costa and Sousa Lobo 2001).  All 
these models, regardless of the API release mechanism, show a correlation between 
dissolution/release rate and either a characteristic dimension or the surface area of the 
particles.  In general, a reduction in particle size or an increase in surface area is expected 
to result in faster release/dissolution rates.  As shown in section 4.4.3, the smallest 





Table 4.9) and thus this sample showed the fastest API release.  On the other hand, the 
ground HME and HD-fHME samples have very similar particle size distributions, and 
thus their release profiles are also very similar.  However, the release from ground HD-
fHME is slightly faster than from the milled un-foam extrudates, because the former has 
slightly smaller particles and higher surface area.  Similar results were obtained by Nagy 
et al (Nagy et al. 2012) for the solid solution of Carvedilol with EPO, with 20 wt% of 
drug loading.  Andrews et al. (Andrews et al. 2010), on the other hand, did not observe 
any difference between the release profiles from milled foamed and un-foamed samples; 
the systems evaluated being also  solid solutions comprising Celecoxib and Polyvinyl 
pyrrolidone with 30wt% of drug loading.   
4.5 Impact of Foamed Structure and Morphology on API Release Rates from 
Binary Systems with Different API Release Mechanisms 
The impact of foamed structures on the release rate of several API has been reported in 
the literature, where publications have shown two main trends: in the majority of cases it 
has been reported that the API release rate is increased upon foaming (Fukuda et al. 2006; 
Lyons et al. 2007; Verreck et al. 2007; Andrews et al. 2010); on the other hand, few 
reports indicate that the cellular structures have very little influence or do not affect the 
API release rate (Fukuda et al. 2006; Lyons et al. 2007; McKelvey et al. 2010).  
Therefore, it is natural to question if there is some degree of system specificity regarding 
the impact of a cellular morphology on API release.  Therefore the main objective of this 
section is to study the impact of foaming on the API release profile from different binary 
systems, and more specifically, examine if a correlation exists between API release 





In order to do this three binary systems are evaluated: PVCap-PVAc-PEG loaded 
with 30 wt% of INM (S30INM), PVCap-PVAc-PEG loaded with 15 wt% of CBZ 
(S15CBZ), and EPO loaded with 30 wt% of INM (EPO30INM). 
4.5.1 Characterization of the Binary Systems: S30INM, S15CBZ and EPO30INM 
The state of the API in the three binary systems is characterized combining thermal 
analysis, FT-IR and XRD.  A summary of the glass transitions of S30INM, S15CBZ and 
EPO30INM obtained by DSC and MTDSC is shown in Table 4.10.   
Thermal analyses indicate that in all cases the API is in the amorphous state; no 
endothermic peaks are observed due to melting and/or API dissolution in the polymeric 
excipient during the first heating of the HME-prepared samples (see Figure 4.4 in    
section 4.1, and Figures 4.21 and 4.22 below).   
 
Table 4.10  Summary of the Glass Transition Temperatures (Tg) of the HME-Prepared 
Binary Systems: S30INM, S15CBZ and EPO30INM 
System Tg [°C] 
S30INM* 62 ± 1 
S15CBZ* 72 ± 1 and 63 ± 1 
EPO30INM** 47.8 ± 0.5 
Thermal analyses performed by *DSC and **MTDSC 
The S30INM and EPO30INM systems showed a single glass transition 
temperature (Tg).  This indicates that an amorphous solid solution is produced through the 
HME process.  In other words, the API was fully dissolved in the excipient during 
compounding and both materials are in amorphous state forming a single phase.  
Additionally, in both cases a Tg shift with respect to the polymer’s glass transition 





resulting Tg is ~11°C lower that PVCap-PVAc-PEG due to the plasticizing effect of INM 
on the excipient.  Conversely, the Tg of the EPO30INM systems is ~ 3°C higher than 
EPO’s, which has also been reported by other authors and results from very strong 
interactions between INM and EPO (Chokshi et al. 2005; Liu 2010).   
 





















Figure 4.21  Characteristic 1st heating MTDSC thermogram of HME-prepared 
EPO30INM binary system.  
On the other hand, S15INM showed two glass transition temperatures one at      
63 ± 1 °C and the other at 72 ± 1 °C; thus a two phase amorphous system is produced 
through HME process (i.e. an amorphous solid dispersion).  The latter is within the range 
of PVCap-PVAc-PEG (i.e. 73 ± 2 °C) and the former is between the Tgs of the excipient 
and CBZ.  The Tg of CBZ has been reported by other authors to be in the range between 
53° and 56 °C (Li et al. 2000; Patterson et al. 2005).  These results suggest that CBZ 
dissolved in the polymer during the HME process, but it is not homogeneously 
distributed along the matrix.  However, this is not indicative of incomplete mixing; 
content uniformity analysis indicated good content uniformity (14.3 ± 0.5 wt% in the 





reflect that CBZ is being dissolved within preferential sites within the terpolymer.  Since 
PVCap-PVAc-PEG is a graft terpolymer, then CBZ may be driven to dissolve 
preferentially in one of the blocks giving rise to two Tgs. 
While the S30INM system was already analyzed in detail in sections 4.1 and 4.2 
and the system EPO30INM was studied in detail by Liu (Liu 2010), the S15CBZ systems 
has not been studied before.  Therefore this discussion is mostly concerned with the 
properties of this last blend.   
Characteristic 1st heating thermograms of CBZ, HME-prepared S15CBZ, and 
PVCap-PVAc-PEG are shown in Figure 4.22.  The two glass transition temperatures for 
the HME-prepared S15CBZ are clearly shown in the low temperature region of the 
thermograms in Figure 4.22 (a).  In the high temperature region of the thermograms – see 
Figure 4.22 (b) – it is evident that the HME sample does not have any thermal transitions 
in this region.  On the contrary, pure CBZ shows two endotherms and one exotherm 
during its 1st heating.  The first endoderm corresponds to the melting of p-Monoclinic 
CBZ, with onset and peak temperatures of 174.5 ± 0.3° and 175.6 ± 0.2 °C, respectively.  
Following this endotherm, CBZ immediately crystallizes as Triclinic CBZ (peak 
crystallization temperature of 176.5 ± 0.4 °C).  The melting peak for this form is seen as a 
second endotherm with onset and peak temperatures of 190.4 ± 0.2° and 191.5 ± 0.2 °C, 
respectively.  Similar behavior has been reported extensively in the literature for 
commercially available CBZ (Otsuka et al. 1999; Rustichelli et al. 2000; Sethia and 
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Figure 4.22  Characteristic 1st heating DSC thermograms of PVCap-PVAc-PEG,      
HME-prepared S15CBZ, and CBZ.  (a) Low temperature region, and (b) high 
temperature region 
Another commonly used characterization technique to assess the state of the APIs 
in the samples is FT-IR.  In the case of INM, FT-IR has been shown to be a very accurate 
characterization technique to differentiate between its three forms.  Figure 4.23 shows the 
characteristic spectra for both systems containing INM (i.e. S30INM and EPO30INM).  
As can be seen in Figures 4.23 (a) and (b) in both S30INM and EPO30INM, respectively, 
the API is in its amorphous state in the extrudates and it remains amorphous after 
foaming (spectra f-S30INM and f-EPO30INM).  As mentioned above, the peak for the 
stretching vibration of the benzoyl group is seen at 1683 cm-1 which corresponds to 
amorphous INM (see Table 4.2 in section 4.1 and Figure 4.23 below).  On the other hand, 
in the physical mixtures and γ-INM this peak can be seen at 1692 cm-1, since the API is 
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Figure 4.23  FT-IR spectra of the binary systems: (a) S30INM and (b) EPO30IM.  The 
prefices PM, HME and f are used to indicate the physical mixture, the HME-prepared and 
foamed samples, respectively.  Spectra of the pure excipients PVCap-PVAc-PEG and 
EPO as well as INM (in its γ-form and amorphous state) are shown as reference. 
FT-IR has also been widely used to identify the different polymorphic forms of 
CBZ (Matsuda et al. 1994; Otsuka et al. 1999; Rustichelli et al. 2000; Kipouros et al. 
2006).  The region between 3400 – 3600 cm-1 shows the most characteristics differences 
between the different forms of CBZ (Kipouros et al. 2006).  In this region the peaks 
associate with the stretching vibration of N-H bond in the primary amide group in CBZ 
can be found (Rustichelli et al. 2000; Sethia and Squillante 2004; Kipouros et al. 2006).  
In the case of p-Monoclinic this peak appears between 3464 - 3466 cm-1 (Rustichelli et al. 
2000; Kipouros et al. 2006). 
As can be seen in Figure 4.24 (a), crystalline CBZ and the physical mixture 
(PM_S15CBZ), show a strong and sharp peak at 3466 cm-1.  Since in both these samples 





p-Monoclinic.  This finding is in agreement with the DSC results presented above.  It is 
interesting to note that the peak at 3466 cm-1 is no longer present in the spectra of the un-
foamed and foamed S15CBZ samples (HME_S15CBZ and f-S15CBZ, respectively).  
The absence of this peak indicates that CBZ’s amide group is no longer forming 
hydrogen bonds with itself but with PVCap-PVAc-PEG.  The same has been reported for 
dihydrate CBZ where the CBZ-CBZ hydrogen bonds are replaced with CBZ-H2O 
hydrogen bonds (Otsuka et al. 1999), as well as when solid solutions of CBZ and 
Polyvinyl pyrrolidone (PVP) have been produced (Nair et al. 2001; Sethia and Squillante 
2004).   
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Figure 4.24  FT-IR spectra of the binary system S15CBZ, (b) shows a detail of (a).  The 
prefices PM, HME and f are used to indicate physical mixture, HME-prepared and 
foamed samples, respectively.  Spectra of the pure PVCap-PVAc-PEG as well as 





As described in section 4.1 for the pair INM / PVCap-PVAc-PEG CBZ and 
PVCap-PVAc-PEG are also capable of forming hydrogen bonds.  The amide group in the 
API has two proton donors (–NH2) capable of participating in hydrogen bonding.  
However, hydrogen bonds formed between CBZ and PVCap-PVAc-PEG are expected to 
be weaker than those formed between this excipient and INM.  The dipole moment of the 
O-H bond in INM is 1.53 D while the N-H bond in CBZ has a dipole moment of 1.31 D 
(Wade 1993).   
As described also in section 4.1, the most favorable site for CBZ to be hydrogen-
bonded with the excipient are the oxygen atoms double bonded with carbon (C=O) along 
the branches of PVCap and PVAc, followed by the oxygen atoms in the PVAc branches, 
and along the PEG backbone.  The characteristic FT-IR peaks for these functional groups 
are indicated in the spectrum of PVCap-PVAc-PEG in Figure 4.24.  The peaks seen at 
1738 cm-1 and 1246 cm-1 are characteristic to PVAc, the former corresponds to the C=O 
stretching vibration and the second one is due to the asymmetric stretching of the acetate 
(C-O-C) group.  The band seen at 1638 cm-1 is characteristic of the C=O stretching 
vibration in the PVCap.  Finally, the band at 1110 cm-1 results from the asymmetric 
stretching vibration of the C-O-C in PEG (Socrates 2000).  Shifts in these peaks are 
expected, as hydrogen bonds between CBZ and the polymer are formed.  However, in 
Figure 4.24 (a) it is only in the region between 1710 and 1500 cm-1 that appreciable 
differences can be seen between the spectra of the PM and solid dispersions.  These 
changes in the spectra can be seen more clearly in Figure 4.24 (b) where detail of the 





The peaks observed in the spectrum of CBZ in Figure 4.24 (b) at 1676 cm-1 
correspond to the stretching vibration of hydrogen bonded C=O (Otsuka et al. 1999; 
Rustichelli et al. 2000).  This peak is still detectable in the spectrum of the PM_S15CBZ.  
After compounding this peak shifted to higher waive number; in the HME_S15CBZ and 
f-S15CBZ samples this peak can be seen at 1689 cm-1.  Since CBZ is now dissolved in 
the polymer, its carbonyl group is no longer participating in hydrogen bonding and the 
position of this characteristic peak is changed.  Prior to compounding CBZ is forming 
hydrogen bonds with itself through the primary amide group, where its oxygen atom (i.e. 
oxygen in the carbonyl group C=O) is the proton acceptor and the hydrogen atoms (-
NH2).  As mentioned before, after compounding the hydrogen bonds are formed between 
CBZ’s proton donors and PVCap-PVAc-PEG’s proton acceptors, as a result CBZ’s 
proton donor (C=O) is not involved in the newly hydrogen bonding between CBZ and the 
polymer excipient.  
Another evident change with respect to the spectra of CBZ and the physical 
mixture is the disappearance of the double peak at 1606 and 1595 cm-1.  These two peaks 
are also associated with vibrations of the C=O and N-H bonds.  Since the former does not 
participate in hydrogen bonding after compounding and the latter now forms hydrogen 
bond with the polymer, then these peaks are no longer clearly visible in the HME and f-
S15CBZ samples.  Finally, with respect to the characteristic peak of PVCap at 1638 cm-1, 
although a peak shift is not observed after the HME and foaming processes, this peak 
appears narrower, probably due to interaction between the excipient and CBZ.  
In addition to thermal and FT-IR analyses, XRD was also performed for the 





before.  Figure 4.25 shows the XRD diffraction patterns for crystalline CBZ, the 
PM_S15CBZ, HME-prepared S15CBZ, and PVCap-PVAc-PEG.  These results clearly 
show sharp peaks associated with the presence of a crystalline phase only in the PM and 
crystalline CBZ.  However, in the former the peaks are less intense and the baseline is not 
as flat as for pure CBZ due to the presence of 85 wt% of PVCap-PVAc-PEG which is an 
amorphous material.  In agreement with DSC and FT-IR results, the XRD pattern of the 
HME-prepared S15CBZ sample indicates that this system is totally amorphous.   
















Figure 4.25  XRD patterns of crystalline CBZ, S15CBZ samples – physical mixture 
(PM_S15CBZ), and HME-prepared sample (HME_S15CBZ) – and PVCap-PVAc-PEG. 
In summary, combining thermal and spectroscopic characterization techniques it 
is shown that the S30INM and EPO30INM systems are amorphous solid solutions.  On 
the other hand, characterization of the S15CBZ system by DSC, FT-IR and XRD 





4.5.2 Cellular Morphology in the Foamed Binary Systems: S30INM, S15CBZ and 
EPO30INM 
As described in section 3.2.3 in Chapter 3 following HME process, the extrudates are 
ground and compression molded into disks of 19 ∅ x 0.3 mm.  Since molding is carried 
out above the glass transition temperature of the systems and under pressure, flow and 
consolidation are possible and thus the resulting samples are continuous and lacking 
porosity, as can be seen in Figure 4.26 (a) for the S30INM’s sample.  Then, through batch 
foaming process using ScCO2 as PBA, cellular structures were produced as shown the 
one in Figure 4.26 (b).  Foamed samples showed density reductions between 94.3 and 
96.5 % (see Table 4.11) with respect to their original compression molded density (i.e. 
un-foamed disks) due to the high degree of foaming expansion induced by the dissolved 
ScCO2 coming out of solution with the sudden decompression.   
 
(a) (b) 
Figure 4.26  SEM images of cross-sectional surfaces of the S30INM samples: (a) un-
foamed disk of 19 ∅ x 0.3 mm, and (b) foamed disk. 
All foamed samples have predominantly closed cell morphology, as can be seen 
in all SEM images of the cross-sectional area of foamed samples (see Figures 4.27, 4.28 





sections of the foamed samples have honeycomb-like morphology.  The foamed S30INM 
and S15CBZ samples (f-S30INM and f-S15CBZ, respectively) have very similar cellular 
morphologies.  As can be seen in Table 4.11 their densities, cell size and wall thickness 
are very similar. 
 
Table 4.11 Summary of the Characteristics of the Foamed Binary System: S30INM, 
S15CBZ, and EPO30INM  
Property 
Binary System 
S30INM S15CBZ EPO30INM 
Density of the un-foamed disk [g/cm3] 1.01 ± 0.05 1.09 ± 0.03 1.11 ± 0.02 
Density of the foamed disks [g/cm3] 0.038 ± 0.001 0.038 ±0.005 0.06 ± 0.02 
Density reduction after foaming [%] 96.2 96.5 94.3 
Cell size range [μm] 16-130 14-128 7-215 
Wall thickness range [μm] 0.4-1.7 0.8-2.1 0.5-10.6 
 
(a) (b) 
Figure 4.27  SEM images of cross-sectional surfaces of a f-S30INM disk: (a) 20.00kX 
and (b) 100X. 
 
The foamed EPO30INM samples (f-EPO30INM) have slightly different 





summary presented in Table 4.11 it is evident that the f-EPO30INM samples have a 
broader cell size and wall thickness distributions, with overall bigger cells and thicker 
walls, which lead to a smaller reduction in density upon foaming than the other two 
systems.  In addition, in the high magnification SEM images of the cross-section of the 
samples it is evident that the surfaces of the cells of the f-EPO30INM samples are 
smooth, [see Figure 4.29 (a)], while the surfaces of the cells of the f-S30INM and f-
S15CBZ samples have regularly rough (ribbed) patterns [see Figures 4.27 (a)                
and 4.28 (a), respectively].   
(a) (b) 
Figure 4.28  SEM images of cross-sectional surfaces of a f-S15CBZ disk: (a) 5.00kX and 
(b) 40X 
(a) (b) 






In all three cases batch foaming is performed above the Tg of the systems (38 °C 
in the case of S30INM and 47 °C in the other two cases).  At these foaming temperatures 
the materials are in a rubbery state, which is quite elastic and thus not capable of purely 
viscous flow.  During cellular growth the material is subjected to bi-axial tension and 
deformation.  Therefore the rough patterns observed in the f-S30INM and f-S15CBZ 
samples can be attributed to the rheological properties of the excipient at the foaming 
conditions.  Since PVCap-PVAc-PEG has significantly higher viscosity than EPO – e.g. 
at 170°C the zero shear rate viscosities are 3.5 x 103 Pa⋅s (see Appendix D) and 5 x 102 
Pa⋅s (Liu 2010), respectively; then elongational flow is easier for EPO30INM than for 
S30INM and S15CBZ, and thus smother surfaces without elastic instabilities are 
generated during batch foaming.   
As mentioned above, the f-EPO30INM samples have predominantly closed cells; 
close inspection of the surface of the samples however showed the presence of open cells 
or porosities along the face of the samples that is contact with the heated surface of the 
mold during the batch foaming process, that is, the “bottom” face in Figure 4.30 (a).  The 
other surface – the “top” or free surface during the batch foaming process – has only 
closed cells, with no open cells visible in Figure 4.30 (b).  This fraction of open cells on 
the bottom surface in the EPO30INM system is expected to have an impact in INM 






Figure 4.30  Optical microscope images of: (a) bottom face and (b) top face of a          
f-EPO30INM disk. 
4.5.3 Mathematical Models Describing API Release from Continuous Non-porous 
Planar Polymer Sheet 
From a general physical perspective, the release mechanism of an API from an 
amorphous solid solution or dispersion into a “solvent” involves the following processes: 
(1) surface wetting, (2) solvent penetration into the system, (3) polymer swelling, (4) API 
diffusion, and (5) polymer dissolution (if polymer dissolution is possible) (Narasimhan 
and Peppas 1997; Narasimhan 2001; Siepmann and Peppas 2001).  The three mass 
transfer processes involved (i.e. solvent penetration, API diffusion and dissolution) are 
schematically presented in Figure 4.31. 
All three mass transfer processes take place during the API release from any 
delivery system where the API in imbibed in a polymeric matrix.  However, one will be 
the rate limiting step and thus the controlling mechanism.  There are three main 
mechanisms that control API release, these are: (1) diffusion controlled, also known as 
Fickian or Case I release; (2) relaxation-controlled, also known as Case II, swelling 
controlled, zero order release or mass erosion; and (3) anomalous transport.  Well 





controlling models and are discussed in more detail below.  Additionally, empirical and 
semi-empirical mathematical models can be used to identify the controlling release 
mechanism for an API in a given formulation; one of which is discussed in detail in 
section 4.5.4. 
 
Figure 4.31  Schematic representation of the API release mechanism from solid solution.  
On the left, the three mass transfer processes are indicated (i.e. solvent penetration, API 
diffusion, and polymer dissolution).  On the right, the difference between (1) the glassy 
core region (dry region) and (2) the swollen surface layers are illustrated.  The green dots 
represent the API molecules dissolved in the polymer; the polymer chains are shown as 
gray lines, and the solvent in blue. 
 
4.5.3.1 Mathematical Model Describing API Release from a Thin Polymer Film 
Through Fickian Diffusion.  Equation 4.8 represents Fick’s second law in the case of a 
thin film or slab, where one-dimensional diffusion in the x direction and constant 






Where C represents the API concentration, t represents time, and x the diffusional 
direction. 
Then, equation 4.8 can be solved considering the appropriate boundary conditions 
for API release from a thin polymer sheet or slab of thickness 2L (with a symmetry line 
at x=0).  In the present case, initially the concentration of API in the slab is considered to 
be uniform and constant and defined as C1, and the concentration of API at the surface is 
maintained constant as Cs.  These boundary conditions are summarized in expression 4.9, 
and the corresponding exact solution of Fick’s second law is shown in equation 4.10. 
 
t = 0           -L < x < L          C=C1 
t > 0             x= ± L              C=Cs 
(4.9) 
 
= 1 − 8 1(2 + 1) − (2 + 1)  (4.10) 
 
Where Mt denotes the amount of API released at time “t” and M∞ the 
corresponding amount at infinite time.   
It is well know that expression 4.10 can be a simplified for short times (i.e. for 
Mt/M∞ ≤ 0.6) as shown in equation 4.11 (Crank 1975). 
 
= 4  (4.11) 
 
4.5.3.2 Mathematical Model Describing Relaxation Controlled API Release from a 
Thin Polymer Film.  In the case of API release from a thin film described by Case II 





Enscore et al. (Enscore et al. 1977) by combining a kinetic expression which describes 
the rate at which the penetrant is absorbed by the systems and a mass balance expression.  
The two principal assumption with a case II transport are: (1) the concentration profile of 
the penetrant is step-like, and (2) both the dissolving front and the swollen-glassy 
interphase (boundaries shown as XS and XG, respectively in Figure 4.31) move at a 
constant velocity (Comyn 1985; Narasimhan and Peppas 1997).  It should point out that 
this model was developed to describe sorption of solvents into a glassy polymer.  
However, this model is used to describe the release profile of drug delivery systems 
where API release is said to be relaxation controlled, since the swelling and dissolution 
kinetics of the polymer film control the release of the API.   
Having the aforementioned assumptions in mind, then a mass balance for one-
dimensional transport can be defined by expression 4.12, and the kinetic expression is 
given by equation 4.13.  
 = ( − )  (4.12) 
 
=  (4.13) 
 
Where the product (L – x)YZ represents the volume of the swollen layer, in more 
detail (L – x) is the thickness of the swollen layer, L the characteristic length of the film 
(i.e. half it thickness) and 0 ≤ x ≤ L.  The constants Co and ko represent the equilibrium 





Then, equation 4.14 is obtained by substituting the mass balance expression into 
the kinetic expression (equations 4.12 and 4.13, respectively).  This expression is used to 
obtain a relationship between x and time.  
 ( − ) ( ) = ( ) (4.14) 
 
Through differentiation and simplification expression 4.14 becomes: 
 
= −  (4.15) 
 
Then, the algebraic relationship for x as a function of time is given by equation 
4.16, only for 0 ≤ t ≤ L ⋅ Co/ko; in other words, from the beginning of dissolution until the 
“glassy” or dry region is completed depleted. 
 
= −  (4.16) 
 
By substituting equation 4.16 in 4.12 and by further simplification results in 
expression 4.17, this expression described the release of an API from a relaxation 
controlled systems until the “glassy” region is completely depleted.  
 





4.5.4 Determination of API Release Mechanisms from Several API / Polymer 
Excipient Binary Systems 
In the present study the experimental data for the three binary systems: S30INM, 
S15CBZ and EPO30INM are fitted using a semi-empirical mathematical model known as 
the Power Law model shown in equation 4.18.   
  
= ∙  (4.18) 
 
Where Mt and M∞ are the masses of released API at time "t" and at infinite time, 
respectively, k is a constant which accounts for structural and geometric characteristics of 
the sample, t is the release time, and n is the release exponent which depends on sample 
geometry and release mechanism.   
In the literature this model is widely known as the Power Law, the Korsmeyer-
Peppas model or simply the Peppas model (Costa and Sousa Lobo 2001; Siepmann and 
Peppas 2001), and can be used to identify the mechanism (i.e. Fickian diffusion, 
relaxation-controlled or anomalous transport) controlling API release from a polymer 
based system according to the values of the release exponent (n) in equation 4.18 as 
summarized in Table 4.12.  However, it should be mentioned that this approach was first 
used by Enscore et al. (Enscore et al. 1977) to identify the mechanism of fluid sorption 
and desorption (i.e. Fickian vs. Case II – relaxation controlled – transport) in polymer 
microspheres.  Latter this model was introduced by Ritger and Peppas. (Ritger and 
Peppas 1987a; b; Peppas and Sahlin 1989) to describe drug release from polymeric 
devices.  Since then many researchers have used this model or variations of it to identify 





et al. 2005; Huang et al. 2006; Andrews et al. 2008; Yang et al. 2010; Ha and Xanthos 
2011). 
In order to accurately use the Power Law model it is essential to understand the 
assumptions associated with it as well as its limitations.  First of all, equation 4.18 was 
adapted from the short time solutions for Fickian and non-Fickian transport through a 
thin film or slab (Ritger and Peppas 1987a).  Therefore, when applying this model two 
key conditions must be fulfilled: (1) one-dimensional transport must be assured, and (2) 
the model is only valid up to 60% of drug released (Ritger and Peppas 1987a).  While the 
latter can be easily meet, it is harder to comply with the former as in reality three-
dimensional transport takes place.  Nonetheless, certain geometrical consideration may be 
used in order to approximate three-dimensional transport process to a one-dimensional 
process.  By considering a disk with diameter 2a and thickness l and defining the aspect 
ratio of the samples as 2a/l, then three limiting conditions can be defined where the one-
dimensional transport can be assumed.  These are: a thin film when 2a >> l, a sphere 
when 2a ≅ l, and cylinder when 2a << l.  In these cases transport in the longest path 
(largest dimension) can be neglected with respect to the shortest path, thus the one-
dimensional approximation becomes valid.  
Since the release exponent “n” in equation 4.18 depends not only on the API 
release mechanism but it is also a function of the sample’s geometry (see Table 4.12), it 
is also important to know the aspect ratio of the sample in order to do a correct 
interpretation of the fitting results.  This geometry dependence can be seen clearly in 
Figure 4.32, which shows the correlation between the release exponent “n”, for a 






Figure 4.32  Release exponent (n) in the Power law model for API release controlled by 
Fickian diffusion as a function of the aspect ratio of the sample.  Figure adapted from: 
(Ritger and Peppas 1987a). 
In the present study, the release mechanism of INM and CBZ from the amorphous 
solid solutions and dispersion S30INM, EPO30INM and S15CBZ are determined using 
compression molded samples of 19∅ x 0.3 mm which resulted in an aspect ratio of 63, 







Table 4.12  Values of the Power Law Release Exponent “n” for Each API Release 
Mechanism and Sample Geometry   
Mechanism Controlling 
the API Release  
Release Exponent (n) Values 
Cylindrical Sample* 
2a/l ≤ 0.2 
Spherical Sample* 
1 ≤ 2a/l ≤ 2 
Thin Film* 
2a/l ≥ 50 
Fickian diffusion 0.45 0.43 0.50 
Relaxation controlled 0.89 0.85 1 
Anomalous transport 0.45<n<0.89 0.43<n<0.85 0.50<n<1 
*Limiting values for the aspect rations, 2a/l, were determined from Figure 4.32  
Source: (Ritger and Peppas 1987a) 
In vitro dissolution tests of the S30INM system are performed in a phosphate 
buffer solution with pH 7.4 and containing an average of 35 mg of drug loading.  The 
S15CBZ system containing an average of 16 mg of drug loading is tested in deionized 
water, which is the dissolution medium established for CBZ in its USP monograph.  
Finally the EPO30INM system is tested in two solutions: a hydrochloric acid buffer 
solution with pH 1.2 and a phosphate buffer solution with pH 7.4.  In both cases the 
samples’ drug loading is an average of 30 mg.  These two buffer solutions were selected 
because they provide two extreme scenarios.  At pH 1.2 INM solubility is extremely low 
(i.e. 1 mg/L (Yazdanian et al. 2004)) but the excipient is soluble.  On the other hand, at 
pH 7.4 the drug solubility is much higher (i.e. 1300 mg/L (Yazdanian et al. 2004)) but the 
excipient is insoluble, it only swells as the solvent is absorbed.   
Figure 4.33 shows the experimentally determined APIs release profiles under the 
four in vitro dissolution conditions evaluated together with the Power law fittings.  It 
should be pointed out that in the case of S30INM, S15CBZ and EPO30INM in pH 1.2 





model can be applied.  As can be seen in Figure 4.33 the fittings, obtained using 
OriginPro® software, are in very good agreement with the experimental data.  A 
summary of the values of the release exponent (n) and the Power law constant (k) 
determined for each system are shown in Table 4.13. 
 
Table 4.13  Determined Values of the Release Exponent (n) and the Power Law Constant 
(k) for the Binary Systems Using Samples of 19 ∅ x 0.3 mm (Thin Film Geometry).   
Parameter S30INM S15CBZ 
EPO30INM 
pH 1.2 pH 7.4 
n 1.02 ± 0.05 0.71 ± 0.01 1.0 ± 0.1 0.499 ± 0.008 
k [min-n] 0.040 ± 0.004 0.027 ± 0.001 0.06 ± 0.02 0.0030 ± 0.0001 












As can be seen in Table 4.13 and Figures 4.33 (a) and (c), the API release rate of 
two of the systems is independent of time, often referred to as zero order release 
(Narasimhan 2000; Costa and Sousa Lobo 2001).  The two systems that show this 
behavior are S30INM and EPO30INM in pH 1.2; in both cases the release exponent 
obtained is 1 (specifically 1.02 ± 0.05 and 1.0 ± 0.1, respectively), which corresponds to 
relaxation-controlled API release in a thin film or slab.  From a physical point of view the 
release rate of INM from these systems is controlled by the swelling of the solid solution, 






























































Figure 4.33  Comparison between experimentally determined API release from disks of 
19 ∅ x 0.3 mm (), and the power law fitting (dashed lines) for the binary systems: (a) 
S30INM in pH 7.4, (b) S15CBZ in deionized water, (c) EPO30INM in pH 1.2, and (d) 
EPO30INM in pH 7.4.  All dissolution tests performed using a USP apparatus 2 and in 
triplicate. 
 
In this liming case, a thin film geometry where the Power law release exponent 
takes the value n = 1 the empirical constant (k) has physical meaning, and it is defined by 
equation 4.19, as follows: 
 






Where ko is the relaxation constant [mg/cm
2min], Co is the equilibrium penetrant 
concentration, and L is the sample’s characteristic length (in the case of a thin film it 
corresponds to the half-thickness of the sample, ½ l).   
It should be noted that there are two more considerations associated with a case II 
transport: (1) the concentration profile of the penetrant (buffer solution in the present 
case) is step-type, and (2) both the dissolving front and the swollen-glassy interphase 
(boundaries shown as XS and XG, respectively in Figure 4.31) move at a constant velocity 
(Comyn 1985; Narasimhan and Peppas 1997). 
The results in Table 4.13 show that the S30INM system has a lower k value than 
the EPO30INM system in pH 1.2, these are 0.040 ± 0.004 min-1 and 0.06 ± 0.02 min-1, 
respectively.  Then it can be inferred that the ratio between relaxation constant and 
equilibrium penetrant concentration (i.e. ko/Co) for the system EPO30INM in pH 1.2 is 
slightly higher than in the system S30INM.  This ratio represents the rate at which the 
relaxation front moves toward the core of the sample (Enscore et al. 1977); thus, the 
advance rate of the dissolving face and of the glassy-swollen interface is faster in the case 
of EPO30INM in pH 1.2 than in the case of S30INM.  As the name of this mechanism 
indicates, the release rate is controlled by the relaxation rate of the solid solution 
triggered by solvent absorption and subsequent swelling.  Therefore, overall system 
mobility and more specifically the mobility of the polymeric phase will greatly affect the 
release rate, and hence polymer swelling can be can be seen as a viscous response of the 
material (Comyn 1985).  Since EPO has lower viscosity than PVCap-PVAc-PEG as well 
as lower molecular weight (47 x 103 g/mol and 118 x 103 g/mol, respectively), then 





Thus, the relaxation front can move faster in the EPO30INM system than in the S30INM 
system resulting in higher k value and faster release.   
As expected the INM release from the EPO30INM systems in pH 7.4 is diffusion 
controlled and the release exponent is 0.499 ± 0.008 (see Tables 4.12 and 4.13).  Since 
EPO is insoluble at pH 7.4 while INM is soluble, then it is logical that its release is 
described by Fickian diffusion though the swollen polymer.  As discussed above for the 
limiting case for a thin film with n = 1, when n = 0.5 then the constant “k” in equation 
4.18 also has physical meaning and is defined by equation 4.20.  
 
= 4  (4.20) 
 
Where D is the diffusion coefficient [cm2/s], and L is the sample’s characteristic 
length (i.e. half thickness of the sample, ½ l).  In this case the Power law model becomes 
the short time approximated solution for the diffusion equations through a thin film 
(Crank 1975; Comyn 1985).  Then the diffusion coefficient of INM through EPO in a 
buffer solution with pH 7.4 is 6.6 x 10-12 cm2/s, which is in the same order of magnitude 
compared to the values reported in the literature for other APIs and small molecules 
diffusing through polymers (Enscore et al. 1977; Huang et al. 2006). 
From a physical perspective, INM release in this case is driven by the solvent 
concentration gradient across the sample (Peppas and Sahlin 1989; Amidon et al. 2000).  
In addition, INM diffusion through the swollen layer with respect to the glassy region is 





section 4.2.1, INM ionization is highly favored at pH 7.4 and thus its release under these 
conditions is further favored.   
Finally, CBZ’s release mechanism from the S15CBZ system is controlled by 
anomalous transport.  As can be seen in Table 4.13 the release exponent was determined 
to be 0.71 ± 0.01.  Anomalous transport results from the combined influence of both 
diffusion and relaxation phenomena during drug release (Vrentas et al. 1975; Frisch 
1980; Ritger and Peppas 1987a).  Specifically for the S15CBZ system coupling of 
relaxation and diffusion may result from the two phases present in the system.  It was 
shown above that this system is an amorphous solid dispersion.  
4.5.5 Effect of Cellular Structure on the API Release Rate  
Figures 4.34 through 4.37 show comparisons between the API release profiles from 
foamed and un-foamed disks of S30INM, S15CBZ and EPO30INM in pHs 1.2 and 7.4.  
It is important to point out the in all cases the samples were placed in the USP apparatus 
2 as disks without modifying the geometry of the samples.  In other words, the cellular 
structures were not disrupted or destroyed.  Therefore, the changes in release/dissolution 
profiles of the foamed samples with respect to their un-foamed counterpart can be 
attributed solely to geometrical changes introduced by the cellular structure.  
The results shown in Figures 4.34 through 4.37 indicate that API release was 
accelerated upon foaming in all cases.  However, the degree in which the foamed 
structure enhances API release rate differs among the systems been evaluated. 
In the case of the S30INM system (see Figure 4.34) complete release is achieved 





the f-S30INM sample is 20 min, while the un-foamed sample required 35 min for 
completing INM release; this represents a reduction in release time of 43 %.   




















































Figure 4.34  INM’s release profiles from the S30INM solid solutions: (×) un-foamed 
disks (19∅ x 0.3 mm), and the corresponding () foamed disks in phosphate buffer 
solution with pH 7.4.  Inset plot shows a detail of the initial 5 min of the release profiles.  
Dissolution profiles obtained using a USP apparatus 2.  Tests were performed in 
triplicate. 
Since INM’s monograph states – for all its immediate release dosage forms – that 
no less than 80 % of the drug must be released in 20 min then it is relevant to compare 
the amount of INM released in 20 min and the time required to release 80 % of the API.  
Within 20 min, 78 ± 3 % of INM is released from the un-foamed samples, but 99 ± 1 % 
from the f-S30INM disks; this represents a 27 % increase in the amount of API been 
released upon foaming.  On the other hand, from the release profile it can be established 





required for the un-foamed samples.  Therefore, by using cellular structures it is possible 
to assure that the immediate release requirement is fulfilled.   
The inset plot in Figure 4.34 shows a detail of the first 5 min of the release 
profiles of the S30INM samples.  In this detail of the release profiles a “burst” in release 
can be seen for the f-S30INM sample; 13-fold more API is released from the foamed 
sample compared to the un-foamed one.  In 30 s the amount of INM released from          
f-S30INM is 14 ± 2 % while only 1.1 ± 0.1 % from its un-foamed counterpart.  This 
behavior results from faster solvent absorption in the foamed samples compared to the 
un-foamed ones due to higher surface area and shorter characteristic lengths along the 
cell walls in the latter case.  The characteristic length for the un-foamed disk is 150 μm 
(half-thickness of the disk) while in the foamed samples it is 0.4 - 1.7 μm (i.e. the cell 
wall thicknesses, reported in Table 4.11). 
In the previous section it was shown that INM release from the S30INM system is 
relaxation-controlled, in other words the swelling and dissolution kinetics of the solid 
solution drive the release of the API.  Therefore, the change in sample geometry 
introduced by the cellular structure affects the swelling kinetics of the solid solution not 
only by changing the characteristic lengths but by introducing very complex velocity 
profiles of the penetrant advancing front throughout the foamed structure.  Since there is 
a distribution of characteristic lengths there is also a distribution of swelling or 
“relaxation” rates.  This further contributes to accelerate the release rate in foamed 
samples and it will be discussed in more detail in section 4.7.2. 
The other system that has relaxation-controlled API release is EPO30INM in pH 





are shown in Figure 4.35.  As with S30INM, the most significant difference in release 
rate due to the cellular structure is observed in the initial region of the release profile.  In 
30 s the amount of API released from the foamed samples is one-order of magnitude 
higher compared to the amount released from the un-foamed samples; 10.8 ± 0.3 % from 
f-EPO30INM and only 1.3 ± 0.3 % from the un-foamed disks.  This results from faster 
solvent absorption and faster swelling of the foamed samples sample due to an increase in 
surface area and reduction in characteristic lengths from 150 μm to 0.5 - 10.6 μm (see 
Table 4.11).  However, after 2 min the profiles become parallel to each other.   





































Figure 4.35  INM release profiles from the EPO30INM solid solutions: (×) un-foamed 
disks (19∅ x 0.3 mm), and the corresponding () foamed disks in hydrochloric acid 
buffer solution with pH 1.2.  Dissolution profiles obtained using a USP apparatus 2.  
Tests were performed in triplicate. 
On the other hand, in both, foamed and un-foamed samples the apparent solubility 
of INM in pH 1.2 is increased.  A very high degree of oversaturation of INM in the 
solution is evident in Figure 4.35; by UV analysis the concentration of drug was 





hydrochloric buffer solution is only 1 mg/L (Yazdanian et al. 2004).  These results show 
that a higher degree of oversaturation is obtained with the f-EPO30INM samples than 
with the un-foamed ones.  Due to this oversaturated state, INM tents to recrystallize and 
precipitates, and as a result 100 % of release was not reached even if the solid solution 
dissolved or disintegrated completely.  Liu et al. (Liu et al. 2010) observed for this 
system that the level of oversaturation as well as the duration of the oversaturated state 
are related to the processing conditions used to produce the solid solution.  Consequently, 
it can be inferred that because the batch foaming process changes the thermal history of 
the solid solution, then the increase in apparent solubility observed for the foamed 
samples could result not only from the increase in release rate but also be due to the 
conformation changes (i.e. changes in the spatial arrangement of the molecules) 
introduced during the batch foaming process.   
Figure 4.36 shows the release profiles of CBZ from foamed and un-foamed 
amorphous solid dispersions.  These results clearly show a significant enhancement on 
the API release rate upon foaming.  As an example in 60 min 90 ± 2 % of CBZ is 
released from the f-S15CBZ disks while 49 ± 2 % from the un-foamed ones.  In other 
words, 83 % more CBZ is released from the foamed disks than from the un-foamed disks.  
The monograph for CBZ establishes that in 60 min at least 75 % of the API should be 
released, which is achieved after foaming the solid dispersion.   
Also in Figure 4.36 it is evident that the final concentration of drug released, from 
both foamed and un-foamed S15CBZ disks corresponds to 90 to 95 % of the nominal 
drug loading.  Since the in vitro dissolution tests is performed under sink conditions, and 





assumed that a portion of the released CBZ is trapped within the PVCap-PVAc-PEG 
micelles.  As mentioned before, in section 4.2.1, the drug concentration been determined 
through the UV analysis correspond to free drug.  When studying the dissolution 
behavior of PVCap-PVAc-PEG, no UV signal of the polymer was observed when the 
PVDF filters with pores size of 0.45μm were used, even though the polymer is a 
chromophore.  The dissolution profiles of pure PVCap-PVAc-PEG presented in section 
4.6.2 were obtained through UV analysis without filtration.  This observation suggests 
that the PVCap-PVAc-PEG micelles cannot pass through the filter and therefore micellar 
CBZ can not be detected. 














































Figure 4.36  CBZ’s release profiles from the S15CBZ solid dispersion: (×) un-foamed 
disks (19∅ x 0.3 mm), and the corresponding () foamed disks in deionized water.  Inset 
plot shows a detail of the initial 5min of the release profiles.  Dissolution profiles 






The inset in Figure 4.36 shows a detail of the first 5 min of the release profiles of 
CBZ from the S15CBZ system.  As observed for the complete release profiles, faster API 
release is also observed from f-S15CBZ than from the un-foamed disk at the beginning of 
the dissolution test.  In 30 s, 5.5-fold more CBZ is released from the foamed sample than 
from the un-foamed ones (6 ± 2 % and 1.1 ± 0.1 %, respectively).  However, this 
increment in the API release rate within 30 s is not as significant as it was observed for 
S30INM and EPO30INM at pH1.2.  These two systems have relaxation-controlled API 
release, while the S15BZ system has anomalous controlled API release.  Because the 
swelling kinetics of the amorphous solid is not the limiting process for the release of CBZ 
from the S15CBZ, then faster swelling contributes to enhanced release rate, but its 
influence is less dominant than in the relaxation-controlled systems.   
Finally, the effect of foaming on the release profile of INM from the solid 
solution EPO30INM in pH 7.4 is shown in Figure 4.37.  As in all other cases, faster API 
release rate is achieved upon foaming.  In 24 h the amount of INM released from the       
f-EPO30INM samples is 36 % more than from the un-foamed samples (15 ± 1 % and        
11 ± 1%, respectively).   
It is surprising that the release rate was enhanced even though INM’s release in 
controlled by Fickian diffusion through swollen EPO that does not dissolve under the test 
conditions.  Slower API rerelease upon foaming was expected for a system such as 
EPO30INM in pH 7.4.  Tortuosity generated by a honeycomb-like structure in a non-
dissolving cellular structure should extend the effective diffusional path of the API and 
thus slow its release.  However, as mentioned before some degree of open cells were 





tortuosity along the closed cells.  In addition, as can be seen in Figure 4.38, dimensional 
integrity of the foamed sample is disrupted during the in vitro dissolution test.  In these 
photographs it is evident that the porosity and number of open cells is increased 
considerably after the 24 h dissolution test.  This change in morphology also contributed 
in the enhancement in release rate. 









































Figure 4.37  INM’s release profiles from the EPO30INM solid solutions: () un-foamed 
disks (19∅ x 0.3 mm), and the corresponding () foamed disks in phosphate buffer 
solution with pH7.4.  Dissolution profiles obtained using a USP apparatus 2.  Tests were 
performed in triplicate. 
For this system the amount of solvent absorbed by the samples during the 
dissolution test is determined by weight difference of the samples immediately after 
extracting them from the dissolution apparatus and after drying under vacuum for 12 h.  
The amount of solvent absorbed by the f-EPO30INM samples is 51 ± 4 wt % while 26 ± 
4 wt% is absorbed by the un-foamed samples.  This increase in the amount of absorbed 





length.  Additionally, as the cellular structure collapses new available surfaces are created 
further enhancing solvent absorption and API release.  Furthermore, an increment in 
absorbed water results in higher degree of swelling which then favors API diffusion by 
providing increased mobility to the EPO chains, more available space for the diffusion of 
the INM molecules and weaker INM-EPO interactions. 
(a) (b) 
Figure 4.38  Photographs of foamed EPO30INM samples: (a) initial state of a foamed 
sample, and (b) final state of a foamed sample after 24 h dissolution test in a phosphate 
buffer solution with pH 7.4.  
In summary, cellular structures allow to increase the release rate of an API 
regardless of the mechanism controlling its release.  However, in cases where the API 
release is controlled by the swelling and dissolution kinetics of the amorphous solid 
solution, foamed structures have a very strong impact in the very early stages of the 






4.5.5.1 Quantitative Comparison Between the Release Profiles from Foamed and 
Un-Foamed Disks.  In order to establish a quantitative comparison between two release 
profiles, the USA Food and Drug Administration (FDA) in its Guidance for Industry 
(FDA 1997) recommends the use of two mathematical indices, the difference factor (f1) 
and similarity factor (f2).  These indices were proposed by Moor and Flanner and are 
defined according to the following expressions (FDA 1997; Shah et al. 1998): 
 
= ∑ | − |∑ 100  (4.21)
 
= 50	 1 + 1 ( − ) . 100  (4.22)
 
Where m is the number of time points, Rt percentage of API released from the 
reference sample (in the present case the un-foamed sample) at time t and Tt is the 
percentage of API released from the post change sample (in the present cases the foamed 
sample) at time t. 
The cumulative difference between two curves at each time point is given by f1.  
In other words, f1 is a measure of the error between two curves and the closer its value is 
to 0 the more alike the two release profiles are.  Conversely, f2 is a measure of the 
similarity between two curves.  The value of f2 ranges between 0 and 100; a higher value 
indicates that the two curves are more similar to each other.  According to FDA’s 
guidance, to consider two API release profiles to be similar f1 should be less than 15 and 





The difference and similarity factors are calculated for each un-foamed / foamed 
pair using the software Wolfram Mathematica®.  The results as well as the time ranges 
used for the calculations are summarized in Table 4.14.  The time ranges were selected 
according to FDA’s guidance.   
 
Table 4.14  Calculated Difference Factor (f1) and Similarity Factor (f2) for Foamed vs. 
Un-foamed Release Profiles of S30INM, S15CBZ and EPO30INM 
System f1 f2 
Time Range Used for the 
Calculations [min] 
S30INM 105.3 29.9 0.5-15 
S15CBZ 139.3 25.3 0.5-75 
EPO30INM_pH1.2 73.5 33.0 0.5-15 
EPO30INM_pH7.4 109.4 66.0 15-1440 
 
The results obtained for the EPO30INM in pH 7.4 are inconclusive.  Using FDA 
criteria the difference factor suggest that the profiles are different (f1 >> 15), but the 
difference factor indicates that the profiles are similar (f2>50). 
On the other hand, since f1 >> 15 and f2 < 50 for the following systems: S30INM, 
S15CBZ and EPO30INM in pH 1.2, then it can be stated that the API release profile from 
foamed samples is statistically different that the API release profile from the un-foamed 
sample.  Using these factors the impact foaming on API release can be ranked from 







4.6 Impact of Foaming on the Dissolution Profile of PVCap-PVAc-PEG 
4.6.1 Morphology of Foamed PVCap-PVAc-PEG  
Disks of 16∅ x 1 mm of PVCap-PVAc-PEG are foamed through the batch foaming 
process described in Chapter 3 using ScCO2 as PBA at 90 °C and 10.34 MPa.  During 
bubble growth, free expansion of the sample takes place; the resulting foamed disks have 
a closed cell structure as shown in Figure 4.39.  The obtained cell size varied from 100 to 
500 μm with cell wall thickness in the range 1-100 μm.  The average density of the 
foamed disks is 0.25 ± 0.05 g/cm3, approximately 4 times lower than the polymer’s 
density 1.090 ± 0.005 g/cm3.   
Figure 4.39 shows the SEM images of the cross-sectional surface of a foamed 
disk.  In the low magnification SEM in Figure 4.39 (a), is evident that the cells tend to be 
much smaller toward the edges or skin of the sample than toward the center line of the 
disk.  This distribution in cell sizes results from a non-uniform CO2 concentration across 
the sample at the moment of expansion.  It is reasonable to state that it is higher toward 
the surface compared to the central region of the samples.  This results in a greater 
amount of nucleation sites toward the surfaces than in the mid-section and therefore 
formation of smaller cells toward the edges of the sample.  The effect of exposure time of 
the sample to the ScCO2 prior to foaming on cell morphology is discussed in more detail 
in section 4.7.1.1.  
The high magnification SEM image in Figure 4.39 (b) shows a similar rough 
pattern as the one observed in the S30INM and S15CBZ samples.  As mentioned before, 





biaxial deformation during cellular growth.  Additionally, this pattern is expected to favor 




Figure 4.39  SEM images of the cross-sectional area of a foamed PVCap-PVAc-PEG 





4.6.2 Comparison Between Dissolution Profiles of Foamed and Un-Foamed    
PVCap-PVAc-PEG  
A comparison between the dissolution behavior of pure PVCap-PVAc-PEG in their un-
foamed and foamed states is presented in Figure 4.40.  The in vitro dissolution tests are 
carried out in deionized water in a USP apparatus 2.  The un-foamed and foamed disks of 
approximately 240 mg are tested without breaking them or disturbing their morphology.   
Complete dissolution was attained for both foamed and un-foamed samples.  
However, Figure 4.40 clearly shows that the time required to complete dissolution is 
significantly reduced upon foaming.  The un-foamed disks require between 8.5 h and 9 h 
to be completely dissolved, while foamed disks are completely dissolved within 5 h.  This 
represents a reduction in dissolution time of 70 to 80 % upon foaming.  











































Figure 4.40  PVCap-PVAc PEG’s dissolution profiles: () un-foamed disks (16∅ x 1 
mm), and the corresponding foamed disks () in deionized water.  Dissolution profiles 




















































Figure 4.41  Detail of the first 2 h of PVCap-PVAc PEG’s dissolution profiles: () un-
foamed disks (16∅ x 1 mm), and the corresponding foamed disks ().in deionized water.  
Dissolution profiles obtained using a USP apparatus 2.  Tests were performed in 
triplicate. 
 
The dissolution profile of the un-foamed PVCap-PVAc-PEG clearly has an “S” 
shape; Nogami et al. (Nogami et al. 1970) observed a similar shape for the dissolution 
profile of PVP in 4:1 acetone:water solution.  In Figure 4.41 it can be clearly seen that the 
dissolution profile of the un-foamed samples has a very slow initial dissolution rate; the 
amount of material been dissolved increases very slowly during the initial 60 min of the 
in vitro dissolution test.  During that time surface wetting, followed by water absorption 
and polymer swelling take place.  It is only after this swollen layer is formed and 
established that true polymer dissolution can occur.  Absorbed water plasticizes the 
polymer providing enough molecular mobility for chain reptation to occur, which, as 





mobility of the polymer chains as they go into solution (Narasimhan and Peppas 1997).  
The time lag prior to true polymer dissolution is considered as the induction time for 






Figure 4.42  Chain reptation and disentanglement process along the swollen layer: (a) 
swollen and highly entangled system, (b) macromolecular disentanglement through chain 
reptation, and (c) disentangled/dissolved chain (in bold). Source: (Narasimhan and 
Peppas 1997). 
 
By comparing the shape of the two curves in Figure 4.41 it is clear that, the 
induction time for the un-foamed PVCap-PVAc-PEG disks is approximately 60 min, but 
becomes extremely short for the foamed disks, less than 5 min.  Therefore, it can be 
concluded that wetting, water absorption and swelling rates are significantly enhanced 
upon foaming.   
Additionally, close comparison of the dissolution profiles suggests that the most 
significant change in dissolution rates occurs during the initial stages of the test.  For 
example, in 15 min the amount of polymer dissolved from the foamed samples is 21-fold 
higher than that dissolved from the un-foamed sample (13 ± 6 % of polymer dissolves 
from the foamed sample, while only 0.6 ± 0.1 % dissolves from the un-foamed disk).  
However, after the first 60 min the two curves seem to be parallel to each other (see 
Figures 4.40 and 4.41), suggesting that once the foamed structure has formed the swollen 





In addition to the difference in shape of the dissolution profiles, differences in the 
swelling behavior were also observed.  In the case of the un-foamed disk, first a swollen 
layer is formed which progressively moves toward the interior core of the sample and at 
the same time the size of the disks is reduced due to dissolution.  In the case of the 
foamed disks, the whole sample becomes very flexible (from being rigid and brittle) as 
soon it is immersed in deionized water, an indication that the polymer is plasticized by 
the absorbed water.  Subsequently the cellular structure seems to collapse, and holes 
throughout the samples can be seen as it dissolves.  This collapse is similar to the one 
shown for the EPO30INM system at pH 7.4 in Figure 4.38.   
The enhancement in dissolution rate observed for PVCap-PVAc-PEG is a 
consequence of faster solvent absorption, which is reflected as a large reduction in 
induction time.  Reduction in characteristic length for mass transfer and higher surface 
area in the foamed disks promotes faster solvent absorption.  In addition, the collapse of 
the cellular structure as the polymer dissolves, further contributes to enhance its 
dissolution rate.     
4.7 Impact of Foam Morphology on the Release / Dissolution Behavior of the 
S30INM Binary System  
In section 4.6 it was shown that cellular structures can accelerate the API release rates 
independently of their release mechanism.  Then, in section 4.7 it was also shown that the 
dissolution rate of pure PVCap-PVAc-PEG can be accelerated as well, through the 
formation of closed cell foamed structures.  The objective of this section is to gain 





samples on the API release rate and disintegration behavior of an amorphous solid 
solution.   
4.7.1 Characterization of the S30INM Foams Produced by Batch Foaming with 
ScCO2  
The batch foaming process using ScCO2 as PBA is used to produce foamed samples with 
different cellular morphologies.  The detailed morphological characterization of the 
cellular structures produced is presented next.  Additionally, the impact of the foaming 
process and the morphology of the foams produced on the state of INM are evaluated 
immediately after foaming and after a 6-month physical stability test. 
4.7.1.1 Morphology of the Cellular Structures of the Foamed S30INM Binary 
System.  Solid foams were produced through the batch foaming process described in 
Chapter 3 employing ScCO2 as PBA.  Disks of 16 ∅ x 1 mm were exposed to the PBA at 
a 100°C (a temperature above the Tg of the S30INM system which is 62 ± 1°C as 
reported in section 4.1) for 15, 30, and 60 min.  The corresponding foamed samples are 
referred to in the text as F15, F30 and F60, respectively.   
The differences between un-foamed and foamed disks can be clearly seen 
macroscopically in Figure 4.43 and in more detail in the SEM images of their cross-
sectional surfaces in Figure 4.44.  The photographs of the samples (Figure 4.43) show 
great levels of expansion of the disks as a result of the batch foaming process.  This is a 
consequence of the creation of closed-cells in the foamed samples.  These can be clearly 
seen in the SEM images of the cross-sectional areas of the samples in Figure 4.44, where 
all foamed samples have honeycomb-like cross-sections.  As expected, un-foamed disks 






Figure 4.43  Photographs of (a) un-foamed disk and foamed disks: (b) F15, (c) F30, and 
(d) F60. 
 
The batch foaming process used in this study has four process variables which can 
affect the foam characteristics and cellular morphology.  These variables are: chamber 
temperature, gas pressure, CO2 exposure time, and depressurization rate.  A detailed 
study of the effect of these process variables on the foam structure (i.e. cell sizes and 
density) is out of the scope of the present discussion.  However it can be found elsewhere 
(Goel and Beckman 1994a; b; Arora et al. 1998; Sun et al. 2004), and in Appendix E 
where photographs of foamed PVCap-PVAc-PEG samples produced at different 
temperatures and pressures are shown.   
The ScCO2 exposure time is varied between 15 and 60 min in order to produce 
different foam morphologies and study their influence on API release.  By varying ScCO2 
exposure time the concentration of gas dissolved varies, affecting the cellular structure.  
Furthermore under non-equilibrium conditions a gas concentration gradient across the 
sample can be expected (Goel and Beckman 1994a; b).  This is shown schematically in 
Figure 4.45 and its consequences on the morphology of the foam morphology are 
analyzed latter in this section.  The different morphologies produced can be observed in 







Figure 4.44  SEM images of a cross-sectional surfaces of the S30INM samples (250X in 
the left column and 5.00kX in the right). Un-foamed disk: (a) and (b), F15: (c) and (d), 





From the low magnification SEM images of the foamed samples [Figures 4.44 
(c), (e), and (g)] it becomes evident that as the ScCO2 exposure time increases, the 
cellular structure becomes more uniform with overall smaller cells.  The values reported 
in Table 4.15 show that the size of the largest cells is reduced from 600 to 200 μm by 
increasing the gas exposure time.  In addition, also in Table 4.15, it is evident that the 
distribution of wall thickness becomes narrower with increasing ScCO2 exposure time.  
The upper limit of the wall thickness is reduced significantly from 40.7 to 1.2 μm by 
increasing the ScCO2 exposure time from 15 to 60 min.  
Table 4.15  Summary of the Characteristics of the Foams Produced by the Batch 
Foaming Process with ScCO2 at 10.34 MPa and 100 °C of S30INM Disks of 16∅ x 1 












0 1.01±0.05 - - 
F15 15 0.095±0.006 18-600 0.2-40.7 
F30 30 0.036±0.002 18-400 0.2-9.7 
F60 60 0.033±0.002 60-200 0.5-1.2 
 
In addition to the cell sizes, close inspection of the cross sectional surfaces of the 
foamed disks showed that the F15 and F30 samples have two cell size populations, see 
Figures 4.44 (c) and (e), respectively.  Even though the difference in cell sizes is 
significantly more pronounced for the F15 samples than for the F30 ones, in both cases a 
skin / core-like morphology is obtained.  Larger cells are obtained toward the core of the 
disks and smaller ones formed toward and at the edges.  On the other hand, foamed disks 
produced by exposing the samples to ScCO2 for 60min (F60) have very uniform cell size 





The lack of uniformity observed in the F15 and F30 samples can be attributed to a 
non-uniform CO2 concentration across the sample prior to foaming.  During the 
pressurized step of the batch foaming process, the PBA diffuses and dissolves in the 
sample.  However, this is not an instantaneous process; sufficient time is needed to reach 
equilibrium and uniform CO2 concentration throughout the disk (Goel and Beckman 
1994a; Arora et al. 1998).  In the cases of F15 and F30, the gas concentration at the 
moment the pressure is release has not reached equilibrium resulting in a CO2 
concentration gradient, being higher toward the edges (that is the “skin” region) than 
toward the core of the sample, as it is schematically represented in Figure 4.45.  Based on 
the homogenous nucleation theory (Colton and Suh 1987; Kumar and Suh 1990; Goel 
and Beckman 1994a), nucleation rates tend to be faster in high CO2 concentration regions 
(i.e. disk’s “skin”).  It is generally accepted that faster nucleation rates result in more 
nuclei, leading to smaller cells  toward the edges compared to the core.   
 
Figure 4.45  Schematic representation of the CO2 concentration along the thickness of a 
S30INM disk of 16∅ x 1 mm as a function of exposure time (15, 30, and 60 min) to 





On the other hand, as mentioned before, the low magnification SEM image of the 
cross-sectional area of a F60 sample, Figure 4.44 (g), clearly shows that the cell size 
distribution across the thickness of the disk is very uniform.  These results suggest that 
after 60 min of exposure to ScCO2, the gas concentration in the S30INM disk is uniform, 
as shown schematically in Figure 4.45, and probably very close to the equilibrium gas 
concentration.  Therefore, it can be conclude that a uniform cell size distribution was 
produced for the F60 samples due to uniform gas concentration. 
The presence of the closed cells in the foamed samples resulted in a reduction in 
density with respect to compression molded disks (i.e. un-foamed samples).  From the 
data presented in Table 4.15 it can be seen that all foamed samples have a significant 
reduction in density with respect to the un-foamed HME sample (which is                    
1.01 ± 0.05 g/cm3).  The F15 samples showed a ~10-fold reduction in density, while F30 
and F60 have very similar densities, namely ~28 and ~30-fold density reduction with 
respect to the un-foamed disks.  These results indicate that the F30 and F60 samples have 
similar porosities or void fractions, but, the cellular morphology or spatial arrangement of 
the bubbles are different.  This can be easily visualized through Figure 4.46.  These 
schemas represent an idealization of two foamed structures with same void fractions, and 
therefore same densities, but with completely different cell sizes; one represents a foam 
with large cells and the other a foam with small cells.  Theoretically, the same free area, 







Figure 4.46  Schematic representation of two closed-cell geometries with same free 
space but with different configurations.  These schematic representations are idealizations 
of two foamed structures with same densities (i.e. same void fractions), but one has very 
big cells and the other has small cells.   
 
As observed for the F30 and F60 disks, where samples with similar densities have 
different cell sizes is not uncommon and it has been reported in the literature by other 
authors (Goel and Beckman 1994b; Arora et al. 1998).  As mentioned before, the 
differences in cell sizes in these two samples results from differences in the amount of 
gas dissolved in the sample at the moment of depressurization.  The amount of dissolved 
gas not only affects the nucleation rate and number of nuclei, but it also affects the 
kinetics of bubble growth and therefore the final packing of the cells.  The effect of gas 
concentration in cellular growth is rather complex because many of the material 
properties are affected by the amount of CO2 dissolved.  Furthermore, the concentration 
of dissolved CO2 is continuously changing during cellular growth, as dissolved gas 
diffuses from bulk into the growing cells and is also lost along the sample outer surfaces 
during expansion.  From a general perspective, as the concentration of dissolved CO2 





polymer interface.  As a result the gas diffusion rate from the bulk into the bubbles is 
increased.  Additionally, the bi-axial stretching deformation of the material as the gas 
bubbles grow is affected due to changes in the viscoelastic properties of the material 
(Colton and Suh 1987; Goel and Beckman 1994a; b).   
Finally, the high magnification SEM images of the cross-sectional areas of all the 
foamed samples showed regular rough patterns similar to the ones observed for the 
foamed samples f-S30INM and f-S15CBZ and PVCap-PVAc-PEG, which we discussed 
earlier.  
4.7.1.2 State of INM in the Foamed S30INM Samples.  Comprehensive 
characterization of all samples is performed combining SEM, DSC, XRD and FT-IR.  
Since each technique has a different level of detection sensitivity of crystalline content, 
several characterization techniques were employed and combined in order to have a 
higher level of confidence regarding the morphological state of INM in the different 
samples.   
It should be mentioned that the characterization of the samples is conducted 
before and after the batch foaming process using ScCO2 as the PBA in order to establish 
if this process induces morphological changes in the S30INM binary system after 
compounding.  Several factors may induce morphological changes in the API during 
batch foaming operations with ScCO2.  First, since amorphous states are metastable, by 
increasing the system’s mobility through heating or in the presence of ScCO2, API 
recrystallization may be induced.  As mentioned above batch foaming of the S30INM 
system is carried out above its Tg and the samples are subjected to this process 





plasticizer for many polymers, further contributing to increase macromolecular mobility 
during batch foaming operations.  Another factor that may contribute to introduce 
morphological changes to the S30INM system during batch foaming is the fact that 
ScCO2 accelerates the crystallization of INM from its amorphous state, as was discussed 
in detail in section 4.3.  
Through SEM inspection of the samples, there is no evidence of crystalline 
particles within the bulk of the samples, nor along the walls of the cells of foamed disks 
(see Figure 4.44).  This can be seen as a strong indicator that INM exists in the 
amorphous state in the un-foamed samples and it remains amorphous after the post-
processing batch foaming process.  SEM analysis of fracture surfaces of melt mixed 
samples has been used effectively by other authors to determine the presence of 
crystalline API within the sample (Yang et al. 2010; Ha and Xanthos 2011). 
A summary of the thermal properties of foamed and un-foamed samples is 
presented in Table 4.16 and characteristic thermograms of the samples can be seen on 
Figure 4.4.  The results in Table 4.16 show that the Tg of un-foamed and foamed samples 
are lower than that for the pure polymer (73 ± 2 °C), due to the plasticizing effect of 
dissolved INM in PVCap-PVAc-PEG, but higher than that of amorphous INM          






Table 4.16  Summary of the Thermal Transitions Determined from DSC First Heating 
(Unless Otherwise Specified) of Foamed and Un-foamed S30INM Samples.  Properties 
of PVCap-PVAc-PEG and INM are Shown as Reference (DSC Thermal Analyses Were 
Performed in Triplicate)  
Sample Tg [°C] Tm [°C] 
PVCap-PVAc-PEG 73 ± 2 - 
INM 46.33 ± 0.07* 161.0±0.3 
Un-foamed disk 62 ± 1 - 
F15 62 ± 3 - 
F30 63 ± 1 - 
F60 65 ± 1 - 
* Value determined through DSC second heating 
All the foamed and un-foamed samples showed a single glass transition 
temperature and no endothermic peaks can be seen in the high temperature region on the 
DSC thermograms of these samples (see Figure 4.4).  These results suggest that in both 
the un-foamed and foamed samples INM and the excipient exist as a single phase 
amorphous system (i.e. an amorphous solid solution).  As mentioned before, the un-
foamed sample has a Tg 11 °C lower than that of the pure polymer, additionally, all 
foamed samples show a similar shift in Tg with respect to PVCap-PVAc-PEG as the un-
foamed sample.  Although the F30 and F60 samples show slightly higher Tg values, the 
small difference with respect to the un-foamed sample can be considered negligible and 
within the experimental error (given by standard deviation).  Also, it is important to keep 
in mind that, although DSC is one of the most commonly used techniques to determine 
residual crystallinity, it may not be capable of detecting small amounts of residual 
crystallinity.  Its minimum detection limit has been estimated to be ~2 wt% by Leuner 




















































Figure 4.47  Characteristic 1st heating thermograms (unless otherwise indicated) of: (a) 
PVCap-PVAc-PEG, (b) F60, (c) F30, (d) F15, (e) un-foamed, (f) INM (2nd heating), and 
(g) INM.  
In agreement with SEM and DSC results, XRD patters show no evidence of the 
presence of crystalline INM in both the un-foamed and foamed samples (see            
Figure 4.48).  Only pure INM (γ-INM) and the physical mixture show sharp peaks which 
indicate the presence of a crystalline material.  More specifically, diffraction patters of 
these two samples show the characteristic γ-INM peaks, which are seen at 11.7°, 19.7°, 
21.9° and 26.7° (2θ), as reported by Otsuka et al. (Otsuka et al. 2001).  However, it 
should be pointed out that in the physical mixture sample the intensity and definition of 
these peak decreases compared to that of crystalline INM due to the presence of 70 wt% 





PVAc-PEG, and all the foamed and un-foamed S30INM samples only show the broad 
diffraction pattern characteristic of amorphous materials.   

























Figure 4.48  XRD patterns of crystalline INM, S30INM samples – physical mixture, un-
foamed sample, and foamed samples (F15, F30, and F60) – and PVCap-PVAc-PEG. 
Finally, FT-IR analysis of all the samples also shows strong evidence that INM 
exists in the amorphous state in both the un-foamed and foamed samples (see          
Figure 4.49).  The characteristic peak for the stretching vibration of the C=O bond of 
INM’s benzoyl group in un-foamed and all foamed samples appears at 1683 cm-1, which 
































Figure 4.49  Comparison of the FT-IR spectra of the un-foamed and foamed (F15, F30, 
and F60) S30INM samples. Spectra of pure PVCap-PVAc-PEG and INM (in its γ-form 
and amorphous state) are shown as reference.  
In summary, the comprehensive characterization of the foamed and un-foamed 
S30INM samples carried out in this work through SEM, DSC, XRD, and FT-IR, strongly 
suggests that INM is in amorphous state and forming a single phase with PVCap-PVAc-
PEG.  Furthermore, the system remains as an amorphous solid solution after the batch 
foaming process with ScCO2. 
4.7.1.3 Long Term Physical Stability of the Foamed S30INM samples.  Amorphous 
solid solutions as any other amorphous material are frozen in a high-energy metastable 
state (Hancock and Zografi 1997; Zhang et al. 2004).  This high energy state is one of the 
reasons amorphous systems exhibit higher API dissolution / release rates and higher 





lead to increased bioavailability.  However, the high energy state in which an amorphous 
material is frozen renders it thermodynamically driven toward a lower energy and a more 
stable state, by recrystallization of the API (Hancock and Zografi 1997).  This transition 
is particularly critical in amorphous drug delivery systems because a change in state in 
the active ingredient during the shelf-life of dosage forms results in a change in its 
performance, and specifically in its bioavailability.   
In addition to the higher free energy state in amorphous solid solution another 
factor that may contribute to a phase transition of the API is water absorption by the 
excipients.  The majority of the polymeric excipients used during HME process are either 
highly hydrophilic or water soluble, and, thus, prone to absorbing water from the 
environment.  Absorbed water acts as a plasticizer for the system and, as a result, the Tg 
of the amorphous system is decreased and its mobility increased.  As an example, the Tg 
of PVP has been reported to decrease by 10 °C when stored at 25 °C and 80 % RH 
(Ahlneck and Zografi 1990).  Thus, as a result of increased mobility the recrystallization 
of the API may be facilitated.  API recrystallization, under high humidity conditions, in 
HME-prepared amorphous solid solutions has been reported in the literature for several 
API / polymer excipient pairs (Prodduturi et al. 2004; Patterson et al. 2007).   
In the case of the foamed dosage forms, another factor that may further affect the 
shelf life of a drug product is the considerable increase in surface area of the samples 
upon foaming, as is evident in the SEM images shown in Figure 4.44.  Therefore, water 
uptake and exposure to environmental conditions is enhanced and thus potentially 
detrimental to the stability of the amorphous solid solution.  Specifically for the S30INM 





SEMs in Figure 4.44, signify an increase the surface area beyond the already higher 
surface area that results from the cellular structure.   
The shelf-life or long term physical stability of the S30INM system is evaluated 
by placing the foamed and un-foamed samples in open container for 6 months in an 
environmental chamber at constant 75 % RH.  The temperature in the chamber was 
continuously monitored but not controlled, with the recorded temperatures showing 
fluctuations between 15° and 32 °C with average temperature of 25 ± 3 °C in the 6-month 
period. 
The state of INM in all the foamed and un-foamed samples after been stored for 
6-month at 25 ± 3 °C and 75 % RH is examined through FT-IR spectroscopy.  Figure 
4.50 shows the spectra of the foamed and un-foamed samples before and after the long 
term stability test.  These results clearly show no change in the state of INM in any of the 
samples.  There are no detectible changes in the spectra, as it can be seen in              
Figure 4.50 (a) in the range between 2000 and 500 cm-1.  In more detail, in Figure 4.50 
(b) is evident that the peak associated with stretching vibration of the C=O bond in the 
benzoyl group in INM appears at 1683 cm-1, corresponding to amorphous INM.  These 
results clearly indicate that INM did not recrystallize in either foamed or un-foamed 
samples after the 6-month stability test.   
Another important factor associated with the shelf life stability of a dosage form 
is its dimensional stability.  Figure 4.51 shows a comparison of the physical dimensions 
of the samples before [Figure 4.51 (i)] and after the stability test [Figure 4.51 (ii)].  These 
photographs clearly show that while the un-foamed samples have very high dimensional 





batch foaming process, the solid solution is subjected to plastic deformation at a 
temperature where the material is softened but not in molten state.  Therefore, residual 
stresses are introduced to the material as well as high levels of orientation are introduced 
to the sample.  Once humidity is absorbed by the foamed samples, water is dissolved in 
the amorphous solid solution plasticizing it.  Due to the increased mobility and reduction 
in mechanical strength of the solid solution (caused by plasticization), oriented polymer 
chains can relax and as a result the foamed samples shrink.  
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Figure 4.50  Comparison of the FT-IR spectra of the S30INM un-foamed and foamed 
(F15, F30, and F60) samples: (black spectra) before and (red spectra) after 6-month 







Figure 4.51  Photographs comparing the S30INM samples (a) un-foamed, (b) F15, (c) 
F30, and (d) F60 disks: (i) before stability test, and (ii) after 6-month in the 
environmental chamber at 25 ± 3 °C and 75 % RH.   
4.7.2 Effect of the Cellular Morphology on INM’s Release Rate 
The release profiles of INM from un-foamed and foamed S30INM disks are presented in 
Figure 4.52.  However, when analyzing these results, it is important to have the following 
key information in mind regarding the samples used in this study.  First, all samples were 
analyzed without grinding or in any way breaking the cellular structure.  In other words, 
the samples were placed in the dissolution bath as the disks shown in Figure 4.43.  Since 
the weight of the samples was kept constant (~240 mg of total weight and hence ~72 mg 
of INM), the differences observed in the release profiles can be solely attributed to the 
morphological dissimilarities of the three cellular structures.  Second, it should be 
mentioned that, although the dimensions of the samples are “not patient compliant”, they 
were chosen in order to gain fundamental understanding of the influence of the 
morphology of the cellular structure on the release rate and disintegration behavior of the 




















































Figure 4.52  INM’s release profiles from the S30INM solid solutions: () un-foamed 
disks (16∅ x 1 mm), and the corresponding foamed disks F15 (), F30 (), and F60 () 
in phosphate buffer solution with pH 7.4.  Dissolution profiles obtained using a USP 
apparatus 2.  Tests were performed in triplicate. 
 



































Figure 4.53  Detail of the initial 14 min of INM’s release profiles from the S30INM solid 
solutions: () un-foamed disks (16∅ x 1 mm), and the corresponding foamed disks F15 
(), F30 (), and F60 () in phosphate buffer solution with pH 7.4.  Dissolution profiles 





From the complete dissolution profiles presented in Figure 4.52, it is evident that 
all samples reached 100 % of release, although at different rates.  Experimentally, it was 
found that the release rate of the samples decreases in the following order: F15 > F30 > 
F60 > un-foamed disks.  The time required to reach 100% release is 120 min (2 h) for the 
un-foamed disks, while for the foamed disks F15, F30, and F60 the times required for 
completing INM’s release are 30, 60 and 90 min, respectively.  In other words, the time 
to complete the release of INM from the foamed samples is 25 to 75% shorter than that of 
the un-foamed disks.   
In Figures 4.52 and 4.53, it is evident that the shape of the INM’s release profiles 
is affected by the cellular morphology of the sample.  The differences among the release 
profiles reflect differences in the disintegration/dissolution behavior of the samples, as 
will be discussed below in more detail.     
In section 4.5 was shown that INM release from the S30INM amorphous solid 
solution is relaxation controlled, in order words it is controlled by the swelling and 
dissolution kinetics of the whole solid solution.  Figure 4.54 schematically shows the 
physical aspects of “one-dimensional” swelling and dissolution of in polymer based 
systems.  Initially, a sample of thickness 2L is in a glassy state (as in the case of the un-
foamed disks evaluated in this study).   
The first steps toward dissolution are wetting of the amorphous solid solution 
surface and solvent absorption.  As the solvent (or body fluid) penetrates into the sample, 
it acts as a plasticizer locally lowering the glass transition temperature of the system and 
greatly increasing molecular mobility.  Once the concentration of the solvent in the 





temperature of the solvent and a swollen layer is formed (see Figure 4.54 (b)) (Peppas et 
al. 1994; Narasimhan and Peppas 1997).  Due to the higher polymer mobility along the 
swollen layer, the material in this region is in a rubbery state while in the dry region it 
remains in a glassy state.  As mentioned before, the length of time required to form the 
swollen layer is the induction time of the dissolution process.  Since the mobilities of the 
polymer and API through this swollen layer are very high, it is only after the induction 
time that API diffusion and true polymer dissolution can begin, see Figure 4.54 (c) 
(Peppas et al. 1994; Narasimhan and Peppas 1997; Narasimhan 2001). 
 
Figure 4.54  Schematic representation of one-dimensional polymeric swelling and 
dissolution processes.  (a) initial glassy solid solution of thickness 2L, (b) initial swelling 
step where two boundaries are seen: rubbery-solvent inter-phase and glassy-rubbery 
inter-phase, (c) true dissolution process starts when both inter-phases move inward, and 
(d) final dissolution step where the entire solid solution is in the rubbery state. 
 
In relaxation controlled systems, reports in the literature indicate that, once the 
swollen layer is formed, the rates of solvent absorption and polymer dissolution are 
synchronized, i.e., become equal (Peppas et al. 1994; Narasimhan and Peppas 1997; 
Miller-Chou and Koenig 2003).  In other word, the thickness of the swollen layer remains 
constant and the two boundaries (i.e. the swollen-solvent and the swollen-glassy inter-
phases) move at the same rate.  This is represented in the relaxation model by a constant 
advance rate of the swelling front (i.e. ko/Co in equation 4.19 in section 4.5.4).  Then, as 
polymer and API molecules are released to the solution, both glassy-rubbery and 





glassy region is completely depleted, followed by complete dissolution (Peppas et al. 
1994; Narasimhan and Peppas 1997; Colombo et al. 2000; Narasimhan 2001; Siepmann 
and Peppas 2001). 
In the case of un-foamed disks, the release/dissolution behavior is in agreement 
with the API release mechanism described above.  Un-foamed disks show an induction 
time of about one minute; in Figure 4.53 this is seen as a smooth and slow increase in the 
release rate during the initial stages of the dissolution test.  Afterwards, disintegration of 
the sample occurs from the outside toward the inside.  In other words, the sample’s size is 
reduced slowly and gradually.   
In the case of INM’s release from foamed samples, although all the mass transfer 
processes described above take place, there are some differences in the disintegration 
behavior.  These differences lead to faster release and are described below.   
First, it is interesting to note that in Figure 4.53 the induction time for the un-
foamed disk can be clearly identified, but this is not the case for the foamed disks.  In 
other words, the release profiles of the foamed samples do not show a gradual and slow 
increase in the amount of INM been released during the initial stages of the dissolution 
test.  On the contrary, all foamed samples show an initial “burst” on API release.  For 
example in the first one minute, the amount of INM released from the F15 disks is ~12-
fold more than that from the un-foamed disks (10.7 ± 0.6 % and 0.9 ± 0.2 % from the F15 
and un-foamed disks, respectively).  This suggests that in the foamed structures the 
induction time is reduced from ~1 min to less than 30 s – time at which the first sample is 
draw from the dissolution apparatus.  Therefore, it can be concluded that solvent 






Figure 4.55  SEM images of edge section of the fracture surface of foamed S30INM 






In systems where the API release is relaxation controlled, as is the case for the 
S30INM system, the API release rate and solvent absorption rates are inversely 
proportional to the sample’s characteristic length (Enscore et al. 1977).  For example, the 
induction time for the S30INM disks is reduced from ~ 1 min for a sample of 16∅ x 1 
mm to ~30 s for a sample of 19∅ x 0.3 mm (see Figure 4.34).  Therefore, the reduction in 
induction time in the foamed samples with respect to the un-foamed disk results from 
shorter characteristic length and higher surface area through the walls of the cells.  The 
characteristic length for un-foamed disk is 0.5 mm (half its thickness); while for foamed 
samples characteristic lengths are between 40.7 and 0.2 μm (i.e. wall thickness reported 
in Table 4.15).   
Among the foamed samples there are also differences during the initial stages of 
the dissolution profiles.  Within 30 s the amount of INM released from the F60 samples is 
4.8 ± 0.2 %, while from the F15 and F30 samples it is 7.6 ± 0.4 % and 9 ± 2 %, 
respectively (see Figure 4.53).  At the beginning of the test, the F15 and F30 samples 
have even faster release rates than F60 because they have higher cell density and smaller 
cells along the disk surface, see Figure 4.55.  As dissolution starts, these smaller cells 
open due to dissolution and as a result the surface area for F15 and F30 is higher 
compared to F60, thus the release rate of INM is further enhanced for F15 and F30.   
It should also be noted that during the first 5 min of the dissolution test, the 
release profiles of INM from the F15 and F30 samples are almost identical, see Figure 
4.53.  This is most likely associated with the similarities observed through the SEM 
images of the cross section of these foamed disks.  In Figures 4.55 (a) and (b) is clear that 





However, it seems that once the outer layers are depleted, the dissolution of these two 
samples continues at different rates (see Figure 4.53).   
Even though all foamed samples showed a reduction in induction time, two 
distinct disintegration behaviors are observed.  These are schematically presented in 
Figures 4.56 (a) and (b) and compared to the dissolution mechanism of the un-foamed 
disks, Figure 4.56 (c). 
 
Figure 4.56  Schematic representation of the dissolution/disintegration mechanism 
observed for different samples: (a) F60 foamed disks, (b) F15 and F30 foamed disks and 
(c) un-foamed disks. 
 
Similar to the un-foamed disks, during the dissolution test of the F60 disks, the 
samples progressively becomes smaller as disintegration/dissolution takes place.  
However, the size reduction results from breakage of small pieces of the outer layers of 
the foamed structure as shown schematically in Figure 4.56 (a).  These small pieces 
dissolve completely afterwards in the aqueous solution.  Given that the disintegration 





un-foamed samples and the F60 samples are parallel to each other, see Figure 4.52.  
Therefore, the release rate enhancement observed for the F60 disks with respect to the 
un-foamed disks is primarily due to reduction of the induction time (i.e. faster swelling).  
On the other hand, during dissolution of the F15 and F30 samples, random and 
extensive breakage of the foamed structure is observed, this is shown schematically in 
Figure 4.56 (b).  In more detail, after swelling, the cellular structure started to collapse by 
forming holes throughout the disk followed by random breakage/cleavage of the disks 
into smaller pieces.  This random and extensive breakage of the cellular structure resulted 
in a significant increase in INM’s release rate with respect to un-foamed disk.  
Based on the different disintegration mechanisms observed, it can be concluded 
that the random and extensive breakdown of the disks is favored primarily by a non-
uniform wall thickness distribution.  Unlike F60, F15 and F30 have very broad 
distribution of wall thicknesses (see Table 4.15).  Sections of the foamed sample, with 
thinner wall thickness, tend to swell faster than the ones with thicker walls, introducing 
stresses that induce disintegration by random breakage/cleavage of the foamed sample.  
As it can be seen in Table 4.15, the wall thicknesses observed in the F15 samples have a 
2 order of magnitude span (0.2 - 40.7 μm); while the wall thicknesses of the F30 samples 
are in the range 0.2 – 9.7 μm.  Therefore, F15 disks have a more pronounced non-
uniformity of the cellular structure than F30 and thus it shows faster release rate.  The 
F60 samples only have a very small difference between maximum and minimum wall 
thicknesses (0.5 -1.2 μm) and thus these samples do not experience extensive breakage 





Besides the differences in swelling rates through the foamed samples caused by 
differences in wall thickness, also residual stresses and chain orientation introduced 
during batch foaming process affect the swelling and dissolution kinetics of polymer 
based systems.  In terms of orientation, it has been reported that when the solvent 
absorption front moves parallel to the preferential orientation of the polymer chains then ⁄ ∝ ; in contrast when absorption is perpendicular to its preferential orientation ⁄ ∝ ⁄  (Frisch 1980).  In the case of un-foamed disks, due to the nature of the 
compression molding process, polymer chains are radially oriented, thus, mass transfer 
during swelling and dissolution is dominantly parallel to the polymer chains’ preferential 
orientation.  On the other hand, in the foamed samples polymer chains are bi-axially 
oriented along the walls of the cells.  These may also contribute toward a distribution of 
swelling and dissolution rates through the samples, because in some regions the 
advancing swelling front may be moving at a constant rate while in other regions at a 
variable rate.  As a result, internal stresses are buildup throughout the foamed structure, 
and, thus, fracture is promoted during dissolution.   
In terms of residual stresses, which exist in the foamed samples and became 
evident during the 6-month stability stat, these may also favor fracture of the foamed 
samples during dissolution.  Although these residual stresses tent to be relaxed as a result 
of solvent absorption, they may also promote environmental stress cracking during 
dissolution.   
4.7.2.1 Quantitative Comparison Between the Release Profiles from Foamed and 
Un-Foamed Disks.  The difference and similarity factors (f1 and f2, respectively) are 





Wolfram Mathematica®.  INM’s release profiles from each foamed sample are compared 
to that of the un-foamed samples.  In addition INM’s release profiles from foamed 
samples are also compered.  The results from these analyses are summarized in Table 
4.14, together with the time ranges used for the calculations, and the sample’s release 
profile is used as reference in the calculation.     
Table 4.17  Calculated Difference Factor (f1) and Similarity Factor (f2) for Several Pairs 
of INM’s Release Profiles from S30INM solid solutions (UF is used to indicate the Un-
foamed sample) 
Sample pair f1 f2 
Time Range Used for the 
Calculations [min] 
Reference Sample 
UF-F15 229.5 25.3 0.5 - 20 UF 
UF-F30 123.1 31.4 0.5 - 30 UF 
UF-F60 24.1 55.5 0.5 - 60 UF 
F15-F30 22.7 43.3 0.5 - 20 F15 
F15-F60 50.7 30.1 0.5 - 20 F15 
F30-F60 36.3 39.4 0.5 - 30 F30 
 
The results obtained for the pair UF-F60 (un-foamed vs. F60) are inconclusive.  
Using FDA criteria (FDA 1997) the difference factor suggest that the profiles are 
different (f1 > 15), but the difference factor indicates that the profiles are similar (f2>50).  
It is interesting to note, that this behavior was also observed when comparing INM’s 
release profiles from f-EPO30INM with un-foamed EPO30INM in pH 7.4, where the 
release profiles also appear to be parallel to each other.  
On the other hand, since f1 >> 15 and f2 < 50 for the F15 and F30 samples, when 
compared to the un-foamed sample, then it can be stated that INM’s release profile from 





Using these factors, the impact of the foam morphology on INM release can be ranked 
from higher to lower impact as follows: F15 > F30 >F60.   
Using the same approach the release profiles among foamed samples are also 
compared.  From the results presented in Table 4.17 it can be concluded that the release 
profiles of INM from all three foamed morphologies are statistically different.  
Additionally, the biggest statistical difference is observed between the pair F15 - F60, 
followed by F30 - F60, and, finally, the least different are the pair F15 - F30.   
The results from the statistical analyses are in agreement with the observed 
disintegration/dissolution behavior of the samples.  In the case of F15 and F30, which 
both showed extensive breakage of the sample during disintegration, are the ones that 
showed the highest statistical difference with respect to the release profile of the un-
foamed sample, but among the foamed samples the pair F15 - F30 showed to be must 
similar.  On the other hand, F60 which has similar disintegration behavior as the un-
foamed samples is the most statistically similar to the un-foamed disks and statistically 
different to the profiles from F15 and F30.  
4.7.2.2 Summary.  The initial stages of API release from a solid solution is a “surface” 
phenomenon, in other words is controlled by the surface characteristics of the samples 
and, in the case of foamed samples, by the outer layer of cells.  Therefore independently 
of the overall cellular morphology, by reducing the characteristic length along the 
sample’s surface (and as a consequence increasing its surface area of the sample), the 
API release rate can be increased.  And this enhancement in API release rate results 






On the other hand, in order to significantly reduce the dissolution/release rate, it is 
essential to promote extensive and random breakage of the sample.  In other words, 
promote fast disintegration of the dosage form.  The key feature of the cellular 
morphology in achieving this is to produce a non-uniform cellular structure with very 
broad distribution of wall thicknesses, which introduces internal stresses to the foamed 
structure by differences in the swelling rates throughout the sample.   
It should be noted that in the present case, the non-uniformities in the cellular 
structure are achieved by a batch process under non-equilibrium conditions.  Therefore it 
may not be possible to directly apply these findings to a commercial manufacturing 
setting.  However, the fundamental knowledge gained indicates that differences in 
swelling rates introduce internal stresses that promote disintegration by extensive fracture 
of the foamed dosage form.  Thus, it may be possible to mimic this phenomenon by 
incorporating additional excipients, such as super-disintegrants (examples of which 
include croscarmellose sodium and crospovidone) into the formulation been extruded.  
Such disintegrant particulates, whose action mechanism is rapid swelling, will introduce 
strong localized internal stresses and promote fracture and disintegration of the cellular 
structure accelerating API release.  Furthermore by doing so it may be possible to 
manufacture fast dissolving dosages by continuous or semi-continuous processes such as 






CHAPTER 5  
CONCLUDING REMARKS AND SUGGESTED FUTURE WORK 
5.1 Summary 
The batch HMM and continuous HME processes are used to produce several amorphous 
API / Polymer systems.  Foamed samples are produced by batch foaming using ScCO2 as 
the PBA, and by foamed extrusion via CO2 continuous injection between two melt seals 
in the extruder.  Comprehensive characterization of the binary systems is carried out 
combining DSC, FT-IR, XRD, and SEM analyses.  These analyses show that the 
S30INM and EPO30INM systems produced are amorphous solid solutions, while the 
S15CBZ system is an amorphous solid dispersion.  Furthermore, while subjecting pure 
amorphous INM to the batch foaming process caused it to accelerate its recrystallization, 
neither INM nor CBZ experienced any morphology changes during batch foaming of 
both the amorphous solid solutions and the amorphous solid dispersion. 
The most important contributions of this dissertation can be grouped into three 
areas: (a) an understanding of the mechanism by which foamed dosages can lead to faster 
API release as well as the key morphological aspects of the cellular structure needed to 
achieve this, (b) an understanding of the correlation between the mechanism controlling 
the release of an API from an amorphous dosage and the enhancement in its release rate 
upon foaming, and (c) an understanding of the impact of the morphology of the cellular 
structure on the milling efficiency of HME products and the dissolution performance of 
the particles produced.  
Foamed S30INM samples with three different morphologies are produced via 




foamed samples are compared to that of the un-foamed sample.  The time to complete the 
release of INM from the foamed S30INM solid solutions is 25 to 75 % shorter than that 
of the un-foamed samples.  Furthermore, a strong correlation between foam morphology 
and release rate enhancement is observed.  On one hand, the induction time for 
dissolution (i.e. the time necessary for surface wetting, solvent absorption and swelling) 
is significantly shorter for the foamed sample, as a result of higher surface area and 
shorter characteristic lengths for mass transfer along the walls of the cells.  However, the 
key aspect for significantly enhancing the API release rate is shown to be the extensive 
and random breakage / cleavage of the foamed dosage forms, leading to their 
disintegration.  This is facilitated in foamed structures with very broad distribution of 
wall thicknesses, which leads to internal stresses due to different local swelling rates in 
the sample.  In this sense, such foam morphologies act as disintegrant-less disintegrants, 
speeding up API release.  
The impact of foaming on the API release profile from binary systems with 
different release mechanisms is also investigated.  Fitting the in vitro dissolution data to 
the Power law model allowed the identification of the mechanism controlling the release 
of the API from several systems.  In the cases of the EPO30INM in pH 1.2 as well as the 
S30INM systems, the INM’s release is relaxation controlled.  On the contrary, INM’s 
release from the EPO30INM system in pH 7.4 is controlled by Fickian diffusion.  And in 
the case of CBZ from the S15CBZ amorphous solid dispersion anomalous transport 
controls its release.  In all four cases the release rate of the APIs is increased upon 
foaming.  However, in the systems where the API release is controlled by the swelling 
and dissolution kinetics of the amorphous system, the foamed structure has a stronger 




dissolution process the API release rate is mainly affected by the disintegration behavior 
(or dimensional integrity) of the foamed sample, which creates fresh and large surface 
areas for release/dissolution.  In addition, statistical indices are used to quantify the 
impact of foaming on the release profile for all the systems; these statistical analyses 
show that the strongest impact is observed for S15CBZ, followed by S30INM and then 
EPO30INM in pH 1.2.  
The foam extrusion process is used to produce the cellular S30INM amorphous 
solid solutions.  By varying the foam extrusion conditions two distinct cellular structures 
are produced: (1) a high density foam of 0.24  0.05 g/cm
3
, which showed a highly non-
uniform morphology with loosely packed cells of 0.8- 2.2 mm, and (2) a low density 
foam of 0.071  0.004 g/cm
3
, with small and closely packed cells of 27 - 320 m, these 
results in a cellular structure with thinner walls.  The milling efficiency of these two 
foamed extrudates is compared to that of the un-foamed extrudates prepared by 
conventional HME process.  It is shown that the milling efficiency of the HME 
extrudates is increased because of the presence of cellular structures.  Foamed extrudates 
compared to un-foamed ones, milled under the same conditions resulted in smaller 
particles with a narrower particle size distribution and lower bulk density.  Nonetheless, 
by simply introducing some degree of porosity in the extrudate (as in the case of the high 
density foam) without actually producing a foamed structure with closely packed cells 
and thin walls still results in a tighter particle size distribution compared to un-foamed 
extrudates; however, the particles produced by milling the high density foams have 
comparable morphology and average size as the ones produced by milling the un-foamed 
extrudates.  Furthermore, the similarities between the particles produced by milling the 




performance, these two samples show to have almost identical API release profiles.  
Conversely, milled low-density extrudates have considerably smaller particles with 
higher surface area, and, thus, their dissolution rate is significantly enhanced with respect 
to that of crystalline INM and the other two milled solid solutions.   
The substantial improvement in milling efficiency achieved through the foamed 
extrudates has a direct impact in the currently used commercial manufacture practices, 
because it signifies that in one milling pass it is possible to produce particles with narrow 
particle size distributions and the desired mean size for the production of the final dosage 
forms.  Therefore, manufacturing time and costs can be reduced. 
5.2 Suggested Future Work 
5.2.1 Fast Disintegration of Foamed Samples 
As mentioned earlier, in order to achieve a significant enhancement in API release rate 
through foamed structures, it is necessary to have non-uniform cellular structures.  In this 
study these non-uniformities are obtained by a batch process under non-equilibrium CO2 
concentration conditions.  Therefore it may not be possible to directly apply these 
findings in a commercial manufacturing setting.  However, the fundamental knowledge 
gained indicates that differences in swelling rates introduced internal stresses that 
promote disintegration of the foamed dosage form.  Thus, it may be possible to mimic 
this phenomenon by incorporating additional excipients, such as super-disintegrants 
(examples of which include croscarmellose sodium and crospovidone) into the 
formulation been extruded.  Such disintegrant particulates, whose action mechanism is 




extensive disintegration of the cellular structure accelerating API release.  Furthermore 
by doing so it may be possible to manufacture fast dissolving dosages by continuous or 
semi-continuous processes such as foam extrusion and foam injection molding.   
5.2.2 Dimensional Stability of Cellular Structures 
Since the foamed samples produced by batch foaming with ScCO2 showed poor 
dimensional stability in a high humidity environment, it would be of interest to evaluate 
the use of enteric coatings to act as a barrier against humidity during the shelf life of the 
product.  However, to achieve this a solvent-free coating method must also be 
investigated. 
5.2.3 Milling Efficiency of Foamed Structures 
Since a strong and positive correlation between foam structure and milling efficiency is 
observed, it will be technologically important to perform a more detailed study of the 
broad area of foam morphology-mechanical properties-milling efficiency, involving 
parametric studies with the extrusion and milling processes, and characterization of the 
fracture and compaction properties of the foamed structures and milled particulates. 
Finally, studying the tableting performance of the particles produced by milling of 
foamed and un-foamed extrudates is of great importance.  Compaction of the ground 
foamed extrudates during the tableting operation is expected to be facilitated, when 
compared to the compaction of particles produced by milling un-foamed extrudates.  The 
particles produced by milling the foamed extrudates retained some of their cellular 
structure, a feature which should enable particle deformation during compression of 




5.2.4 Foam Extrusion of Pharmaceutical Systems 
During the HME process of a miscible binary system comprised of an API and polymer 
excipient, it is well known that the API gradually dissolves in the molten polymer.  
However, during the foam extrusion process (or gas - assisted HME process) the system 
being processed becomes a ternary one composed by an API, the blowing agent gas and 
the polymer excipient.  Therefore, it is of great importance to understand how the 
presence of the gas affects the dissolution of the API in the polymer melt from a 
thermodynamic as well as a kinetic perspective.  Comprehensive rheology studies of 
binary and ternary blends with different compositions should be performed in order to 





APPENDIX A  
SCREW NOMENCLATURE 
 





Figure A.1  Detailed description of the nomenclature used for: conveying screw elements 
and (b) kneading blocks.  Source: (Leistritz 2012) 
 
 
Figure A.2  Schematic representation of a conveying screw element and a kneading 
block.  Source: (Leistritz 2012)
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APPENDIX B  
THERMAL STABILITY THROUGH TGA 
B.1 TGA Ramp Analyses 
Figures B.1 through B.3 show the weight loss curves for PVCap-PVAC-PEG, INM and 
CBZ obtained through TGA ramp analyses performed at heating rate of 10 C/min in dry 
air atmosphere.  
 












































Figure B.2  TGA weight loss for INM in dried air at a heating rate of 10 C/min. 
 
 



















































































B.2 TGA Isothermal Analyses  
Figures B.4 through B.5 show the TGA results for isothermal analyses for PVCap-
PVAC-PEG, INM and CBZ in dry air atmosphere. 
 
Figure B.4  TGA results for PVCap-PVAc-PEG isothermal analyses in dry air at: (a) 110 
C, (b) 120 C, (c) 130 C, (d) 140 C, and (e) 150 C.  Samples were heated to the 
prescribed temperature at 40 C and held isothermally for 60 min. 
 
Figure B.5  TGA results for PVCap-PVAc-PEG isothermal analyses in dry air at: (a) 130 
C, (b) 140 C, (c) 150 C, (d) 155 C, and (e) 160 C. Samples were heated to the 
















































































APPENDIX C  
CALCULATION OF THE THEORETICAL DENSITY OF FOAMED 
EXTRUDATES 
C.1   Theoretical Density Calculations for the LD-fHME Samples (4 w/w% CO2) 
Flow rate of solids (S30INM) base of feeding rate of 1.5kg/h and measured density of un-
foamed extrudates: 
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Flow rate of CO2 exiting the die, based on experimentally set feeding rate of 1 
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Then the volume fraction occupied by the gas can be calculated as follows: 
 
        ⁄
            
       (C.3) 
 
Theoretical foam density can be calculated used the expression for void fraction 
as follows: 
 
    
  
   





Where v is the void fraction, f density of the foamed material and uf the density 
of the un-foamed material (Kaewmesri et al. 2006). 
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C.2 Density Values of CO2 at the Foam Extrusion Processing Conditions 
The density values of CO2 used for the volume calculations in Chapter 4, section 4.4.1 
are summarized in Table C.1. 
Table C.1  Density Values of CO2 at Various Pressures and Temperatures 
Temperature [C] Pressure [MPa] Density [g/cm
3
] 
102 3.7 0.057 
102 1.8 0.026 
102 0.101 0.001 
97 3.4 0.053 
97 1.7 0.025 
97 0.101 0.001 






APPENDIX D  
RHEOLOGICAL PROPERTIES OF PVCAP-PVAC-PEG 
 
Rheological properties of PVCap-PVAc-PEG were determined combining capillary 
rheometry and Rheometrics Mechanical Spectrometer (RMS) at different temperatures.   
 
Figure D.1  Superposition of shear viscosity with shear rate at several temperatures 


















Shear rate [1/s] 
150°C RC 160°C RC 170°C RC





APPENDIX E  
BATCH FOAMING PROCESSING WINDOW  
 
Figure E.1 shows the effect of the batch foaming temperature and pressure on the 
morphology of the foamed PVCap-PVAc-PEG samples 
(a) 
(b) (c) (d) 
(e) (f) 
Figure E.1  Photographs of PVCap-PVAc-PEG (a) Un-foamed sample, and foamed 
samples with CO2 for 30 min at (b) 74 °C and 6.89 MPa, (c) 80 °C and 6.89 MPa, (d) 85 






Ahlneck, C. and G. Zografi (1990). "The Molecular Basis of Moisture Effects on the 
Physical and Chemical Stability of Drugs in the Solid State." International Journal 
of Pharmaceutics 62(2-3): 87-95. 
Ahuja, N., O. P. Katare and B. Singh (2007). "Studies on Dissolution Enhancement and 
Mathematical Modeling of Drug Release of a Poorly Water-Soluble Drug Using 
Water-Soluble Carriers." European Journal of Pharmaceutics and 
Biopharmaceutics 65(1): 26-38. 
Amidon, G. L., P. I. Lee and E. M. Topp (2000). Transport Processes in Pharmaceutical 
Systems. Marcel Dekker, Inc, New York, NY. USA. 
Amidon, G. L., H. Lennernäs, V. P. Shah and J. R. Crison (1995). "A Theoretical Basis 
for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug 
Product Dissolution and in Vivo Bioavailability." Pharmaceutical Research 12(3): 
413-420. 
Andrews, G. P., O. Abu-Diak, F. Kusmanto, P. Hornsby, Z. Hui and D. S. Jones (2010). 
"Physicochemical Characterization and Drug-Release Properties of Celecoxib 
Hot-Melt Extruded Glass Solutions." Journal of Pharmacy and Pharmacology 
62(11): 1580-1590. 
Andrews, G. P., D. S. Jones, O. A. Diak, C. P. McCoy, A. B. Watts and J. W. McGinity 
(2008). "The Manufacture and Characterisation of Hot-Melt Extruded Enteric 
Tablets." European Journal of Pharmaceutics and Biopharmaceutics 69(1): 264-
273. 
Andronis, V. and G. Zografi (2000). "Crystal Nucleation and Growth of Indomethacin 
Polymorphs from the Amorphous State." Journal of Non-Crystalline Solids 
271(3): 236-248. 
Arkenau-Maric, E. and J. Bartholomaus (2008). "Process for the Production of an Abuse-
Proofed Solid Dosage Form". United States Patent 2008/0312264. 
Arora, K. A., A. J. Lesser and T. J. McCarthy (1998). "Preparation and Characterization 
of Microcellular Polystyrene Foams Processed in Supercritical Carbon Dioxide." 




Badgujar, B. and A. Mundada (2011). "The technologies used for developing orally 
disintegrating tablets: A review." Acta Pharmaceutica 61(2): 117-139. 
Banbury, S. and K. MacGregor (2011). "Fast-Dispersing Dosage Forms for Pedriatic 
Market." Drug Development and Delivery 11(2): 32-35. 
BASF (2010). "Soluplus. Technical Information", Limburgerhof, Germany. 
Benet, L. Z., C.-Y. Wu and J. M. Custodio (2006). "Predicting drug absorption and the 
effects of food on oral bioavailability." Bulletin Technique Gattefassé 99: 9-16. 
Bhugra, C. and M. J. Pikal (2008). "Role of Thermodynamic, Molecular, and Kinetic 
Factors in Crystallization from the Amorphous State." Journal of Pharmaceutical 
Sciences 97(4): 1329-1349. 
Breitenbach, J. (2002). "Melt extrusion: from process to drug delivery technology." 
European Journal of Pharmaceutics and Biopharmaceutics 54(2): 107-117. 
Breitenbach, J. and H. Baumgartl (2000). "Solid Foamed Active Substance Preparations". 
Unated States Patent 6,158,424. 
Brittain, H. G. (2009). Polymorphism in Pharmaceutical Solids. Informa Healthcare 
USA, Inc, New York, NY. USA. 
Brown, C. D., N. Faridi, C. A. McKelvey, H. Suwardie, L. Zhu, M.-W. Young, P. Wang 
and C. G. Gogos (2011). "Evaluation of Foaming of Pharmaceutical Polymers by 
CO2 and N2 to Enable Drug Products". ANTEC 2011. Society of Plastic 
Engineers, Boston, MA. USA: 1224-1228. 
Bruce, L. D., N. H. Shah, A. Waseem Malick, M. H. Infeld and J. W. McGinity (2005). 
"Properties of Hot-Melt Extruded Tablet Formulations for the Colonic Delivery of 
5-Aminosalicylic Acid." European Journal of Pharmaceutics and 
Biopharmaceutics 59(1): 85-97. 
Burnett, E. S. (1923). "Experimental Study of the Joule-Thomson Effect in Carbon 




Campbell, D., R. A. Pethrick and J. R. White (2000). Polymer Characterization. Physical 
Techniques. Stanley Thornes Ltd., Cheltenham. UK. 
Cho, K. Y. and S. S. H. Rizvi (2010). "New Generation of Healthy Snack Fodd by 
Supercritical Fluid Extrusion " Journal of Food Processing and Preservation 
34(2): 192-218. 
Chokshi, R. J., H. K. Sandhu, R. M. Iyer, N. H. Shah, A. W. Malick and H. Zia (2005). 
"Characterization of Physico-Mechanical Properties of Indomethacin and 
Polymers to Assess their Suitability for Hot-Melt Extrusion Processs as a Means 
to Manufacture Solid Sispersion/Solution." Journal of Pharmaceutical Sciences 
94(11): 2463-2474. 
Chokshi, R. J., N. H. Shah, H. K. Sandhu, A. W. Malick and H. Zia (2008). "Stabilization 
of Low Glass Transition Temperature Indomethacin Formulations: Impact of 
Polymer-Type and its Concentration." Journal of Pharmaceutical Sciences 97(6): 
2286-2298. 
Choudhary, M., Y. Delaviz, R. Loh, M. Polasky, C. Wan, D. B. Todd, K. S. Hyun, S. 
Dey and F. Wu (2005). "Measurement of Shear Viscosity and Solubility of 
Polystyrene Melts Containing Various Blowing Agents." Journal of Cellular 
Plastics 41(6): 589-599. 
Clarke, A. J. (2005). "Novel Pharmaceutical Dosage Forms and Method for Producing 
Same". United States Patent Application 2005/0202090 A1. 
Colombo, P., R. Bettini, P. Santi and N. A. Peppas (2000). "Swellable Matrices for 
Controlled Drug Delivery: Gel-layer Behaviour, Mechanisms and Optimal 
Performance." Pharmaceutical Science & Technology Today 3(6): 198-204. 
Colton, J. S. and N. P. Suh (1987). "The Nucleation of Microcellular Thermoplastic 
Foam With Additives: Part I: Theoretical Considerations." Polymer Engineering 
& Science 27(7): 485-492. 
Comyn, J., Ed. (1985). Polymer Permeability. New York, NY. USA, Elsevier Applied 
Science. 
Costa, P. and J. M. Sousa Lobo (2001). "Modeling and Comparison of Dissolution 




Crank, J. (1975). The Mathematics of diffusion. Oxford Science Publications, New York, 
NY. USA. 
Crowley, M. M., F. Zhang, M. A. Repka, S. Thumma, S. B. Upadhye, S. Kumar Battu, J. 
W. McGinity and C. Martin (2007). "Pharmaceutical Applications of Hot-Melt 
Extrusion: Part I." Drug Development and Industrial Pharmacy 33(9): 909-926. 
Dahan, A. and J. Miller (2012). "The Solubility–Permeability Interplay and Its 
Implications in Formulation Design and Development for Poorly Soluble Drugs." 
The AAPS Journal 14(2): 244-251. 
Davies, O. R., A. L. Lewis, M. J. Whitaker, H. Tai, K. M. Shakesheff and S. M. Howdle 
(2008). "Applications of Supercritical CO2 in the Fabrication of Polymer Systems 
for Drug Delivery and Tissue Engineering." Advanced Drug Delivery Reviews 
60(3): 373-387. 
DiNunzio, J. (2011). "Amorphous Formulation Desing for Melt Exrusion". Leistritz 
Pharmaceutical Extrusion Seminar, Somerville, NJ. 
Doelker, E. (1993). "Cellulose Derivatives". Biopolymers I. R. Langer and N. Peppas. 
Springer Berlin Heidelberg, New York, NY. USA. 107: 199-265. 
Doherty, C. and P. York (1989). "Microenvironmental pH Control of Drug Dissolution." 
International Journal of Pharmaceutics 50(3): 223-232. 
Doseva, V., S. Shenkov and V. Y. Baranovsky (1997). "Complex Formation Between 
Polymethacrylic Acid and Copolymers of Adipic Acid with Poly(ethylene glycol) 
in Aqueous Solution." Polymer 38(6): 1339-1344. 
Edwards, A. D., B. Y. Shekunov, A. Kordikowski, R. T. Forbes and P. York (2001). 
"Crystallization of Pure Anhydrous Polymorphs of Carbamazepine by Solution 
Enhanced Dispersion with Supercritical Fluids (SEDS™)." Journal of 
Pharmaceutical Sciences 90(8): 1115-1124. 
Elkovitch, M. D. and D. L. Tomasko (2000). "Effect of Supercritical Carbon Dioxide on 
Morphology Development During Polymer Blending." Polymer Engineering & 




Enscore, D. J., H. B. Hopfenberg and V. T. Stannett (1977). "Effect of Particle Size on 
the Mechanism Controlling n-Hexane Sorption in Glassy Polystyrene 
Microspheres." Polymer 18(8): 793-800. 
Faridi, N. and D. B. Todd (2007). "Solubility Measurements of Blowing Agents in 
Polyethylene Terephthalate." Journal of Cellular Plastics 43(4-5): 345-356. 
FDA (1997). "FDA Guidance for Industry: Dissolution Testing of Immediate Release 
Solid Oral Dosage Forms". FDA, Rockville, MD. USA. 
FDA (2004). "Guidance for Industry. PAT - A Framework for Innovative Pharmaceutical 
Development, Manufacturing and Quality Assurance". FDA, Rockville, MD. 
USA. 
FDA (2008). "FDA Guidance for Industry: Orally Disintegrating Tablets". FDA, 
Rockville, MD. USA. 
Follonier, N., E. Doelker and E. T. Cole (1995). "Various ways of modulating the release 
of diltiazem hydrochloride from hot-melt extruded sustained release pellets 
prepared using polymeric materials." Journal of Controlled Release 36(3): 243-
250. 
Forster, A., J. Hempenstall, I. Tucker and T. Rades (2001). "Selection of Excipients for 
Melt Extrusion with Two Poorly Water-Soluble Drugs by Solubility Parameter 
Calculation and Thermal Analysis." International Journal of Pharmaceutics 226(1-
2): 147-161. 
Frisch, H. L. (1980). "Sorption and Transport in Glassy Polymers–A Review." Polymer 
Engineering & Science 20(1): 2-13. 
Fukuda, M., N. A. Peppas and J. W. McGinity (2006). "Floating Hot-Melt Extruded 
Tablets for Gastroretentive Controlled Drug Release System." Journal of 
Controlled Release 115(2): 121-129. 
Ghebre-Sellassie, I. and C. Martin (2007). Pharmaceutical Extrusion Technology. 




Goel, S. K. and E. J. Beckman (1994a). "Generation of Microcellular Polymeric Foams 
Using Supercritical Carbon Dioxide. I: Effect of Pressure and Temperature on 
Nucleation." Polymer Engineering & Science 34(14): 1137-1147. 
Goel, S. K. and E. J. Beckman (1994b). "Generation of Microcellular Polymeric Foams 
Using Supercritical Carbon Dioxide. II: Cell Growth and Skin Formation." 
Polymer Engineering & Science 34(14): 1148-1156. 
Gogos, C. G. (2012). "Fundamentals of Dispersive and Distributive Mixing with 
Dissolution and Applications to Hot Melt Extrusion". Leistritz Pharmaceutical 
Extrusion Seminar, Somerville, NJ. 
Govindarajan, R., A. Zinchuk, B. Hancock, E. Shalaev and R. Suryanarayanan (2006). 
"Ionization States in the Microenvironment of Solid Dosage Forms: Effect of 
Formulation Variables and Processing." Pharmaceutical Research 23(10): 2454-
2468. 
Greenhalgh, D. J., A. C. Williams, P. Timmins and P. York (1999). "Solubility 
Parameters as Predictors of Miscibility in Solid Dispersions." Journal of 
Pharmaceutical Sciences 88(11): 1182-1190. 
Guo, Q., P. T. Knight, J. Wu and P. T. Mather (2010). "Blends of Paclitaxel with POSS-
Based Biodegradable Polyurethanes: Morphology, Miscibility, and Specific 
Interactions." Macromolecules 43(11): 4991-4999. 
Ha, J. U. (2011). "Study of controlled release of active pharmaceutical ingredients from 
functionalized nanoclays and polymer matrices". Ph.D Dissertation, New Jersey 
Institute of Technology, Newak, NJ. USA. 
Ha, J. U. and M. Xanthos (2011). "Drug Release Characteristics from Nanoclay Hybrids 
and Their Dispersions in Organic Polymers." International Journal of 
Pharmaceutics 414(1-2): 321-331. 
Han, C. D., Y. W. Kim and K. D. Malhotra (1976). "A Study of Foam Extrusion Using a 
Chemical Blowing Agent." Journal of Applied Polymer Science 20(6): 1583-
1595. 
Han, X., K. W. Koelling, D. L. Tomasko and L. J. Lee (2002). "Continuous Microcellular 
Polystyrene Foam Extrusion with Supercritical CO2." Polymer Engineering & 




Han, X., K. W. Koelling, D. L. Tomasko and L. J. Lee (2003). "Effect of Die 
Temperature on the Morphology of Microcellular Foams." Polymer Engineering 
& Science 43(6): 1206-1220. 
Hancock, B. C. and G. Zografi (1997). "Characteristics and Significance of the 
Amorphous State in Pharmaceutical Systems." Journal of Pharmaceutical 
Sciences 86(1): 1-12. 
Hardung, H., D. Djuric and S. Ali (2010). "Combining HME & Solubilization: Soluplus 
The Solid Solution." Drug Delivery Technology 10(3): 20-27. 
Hemker, D. J. and C. W. Frank (1990). "Dynamic Light-Scattering Studies of the Fractal 
Aggregation of Poly(methacrylic acid) and Poly(ethylene glycol)." 
Macromolecules 23(20): 4404-4410. 
Higuchi, W. I., N. A. Mir and S. J. Desai (1965). "Dissolution Rates of Polyphase 
Mixtures." Journal of Pharmaceutical Sciences 54(10): 1405-1410. 
Holl, M. R., V. Kumar, J. L. Garbini and W. R. Murray (1999). "Cell Nucleation in 
Solid-State Polymeric Foams: Evidence of a Triaxial Tensile Failure 
Mechanism." Journal of Materials Science 34(3): 637-644. 
Hsu, Y.-Y., J. D. Gresser, D. J. Trantolo, C. M. Lyons, P. R. J. Gangadharam and D. L. 
Wise (1996). "Low-Density Poly(-lactide-co-glycolide) Foams for Prolonged 
Release of Isoniazid." Journal of Controlled Release 40(3): 293-302. 
Hsu, Y. Y., J. D. Gresser, D. J. Trantolo, C. M. Lyons, P. R. J. Gangadharam and D. L. 
Wise (1997). "Effect of Polymer Foam morphology and Density on Kinetics of in 
vitro Controlled Release of Isoniazid from Compressed Foam Matrices." Journal 
of Biomedical Materials Research 35(1): 107-116. 
Huang, J., R. J. Wigent, C. M. Bentzley and J. B. Schwartz (2006). "Nifedipine Solid 
Dispersion in Microparticles of Ammonio Methacrylate Copolymer and 
Ethylcellulose Binary Blend for Controlled Drug Delivery: Effect of Drug 
Loading on Release Kinetics." International Journal of Pharmaceutics 319(1-2): 
44-54. 
Kaewmesri, W., P. C. Lee, C. B. Park and J. Pumchusak (2006). "Effects of CO2 and 
Talc Contents on Foaming Behavior of Recyclable High-melt-strength PP." 




Kipouros, K., K. Kachrimanis, I. Nikolakakis, V. Tserki and S. Malamataris (2006). 
"Simultaneous Quantification of Carbamazepine Crystal Forms in Ternary 
Mixtures (I, III, and IV) by Diffuse Reflectance FTIR Spectroscopy (DRIFTS) 
and Multivariate Calibration." Journal of Pharmaceutical Sciences 95(11): 2419-
2431. 
Kolter, K., M. Karl, S. Nalawade and N. Rottmann (2010). Hot-Melt Extrusion with 
BASF Pharma Polymers. Extrusion Compendium. BASF The Chemical 
Company, Ludwigshafen, Germany. 
Korsmeyer, R. W., R. Gurny, E. Doelker, P. Buri and N. A. Peppas (1983). "Mechanisms 
of Solute Release from Porous Hydrophilic Polymers." International Journal of 
Pharmaceutics 15(1): 25-35. 
Kumar, V. and N. P. Suh (1990). "A Process for Making Microcellular Thermoplastic 
Parts." Polymer Engineering & Science 30(20): 1323-1329. 
Lee, M., C. B. Park and C. Tzoganakis (1999). "Measurements and Modeling of 
PS/Supercritical CO2 solution viscosities." Polymer Engineering & Science 39(1): 
99-109. 
Lee, S. T. (2000). Foam Extrusion. Principles and Practice. Technomic Publishing 
Company, Inc., Lancaster, PA. USA. 
Lee, S. T. and D. Scholz (2009). Polymeric Foams. Technology and Developments in 
Regulation, Process, and Products. CRC Press, Boca Raton, FL. 
Leistritz (2012). "Extruder Manual". Leistritz, Somerville, NJ. USA. 
Leitner, W. (2000). "Green chemistry: Designed to dissolve." Nature 405(6783): 129-
130. 
Lele, B. S. and A. S. Hoffman (2000). "Mucoadhesive Drug Carriers Based on 
Complexes of Poly(acrylic acid) and PEGylated Drugs Having Hydrolysable 
PEG-Anhydride-Drug Linkages." Journal of Controlled Release 69(2): 237-248. 
Leuner, C. and J. Dressman (2000). "Improving Drug Solubility for Oral Delivery Using 





Li, Y., J. Han, G. G. Z. Zhang, D. J. W. Grant and R. Suryanarayanan (2000). "In Situ 
Dehydration of Carbamazepine Dihydrate: A Novel Technique to Prepare 
Amorphous Anhydrous Carbamazepine." Pharmaceutical Development and 
Technology 5(2): 257-266. 
Liu, H. (2010). "Hot Melt Mixing/Extrusion and Dissolution of Drug (Indomethacin) in 
Acrylic Copolymer Matrices". Ph.D. Disseratation, New Jersey Intitute of 
Technology, Newark, NJ. USA. 
Liu, H., P. Wang, X. Zhang, F. Shen and C. G. Gogos (2010). "Effects of Extrusion 
Process Parameters on the Dissolution Behavior of Indomethacin in Eudragit® E 
PO Solid Dispersions." International Journal of Pharmaceutics 383(1-2): 161-169. 
Lowes, M. M. J., M. R. Caira, A. P. Lotter and J. G. D. Van Watt (1987). 
"Physicochemical properties and X-ray structural studies of the trigonal 
polymorph of carbamazepine." Journal of Pharmaceutical Sciences 76(9): 744-
752. 
Loxley, A. (2010). "Hot Melt Extrusion in the Production of Drug Elution Medical 
Devices". APV Experts' Workshop on Hot Melt Extrusion and its Use in the 
Manufacturing of Pharmaceutical Dosages Forms. A. International Association 
for Pharmaceutical Technology, Tarrytown, NY. USA. 
Lyons, J. G., M. Hallinan, J. E. Kennedy, D. M. Devine, L. M. Geever, P. Blackie and C. 
L. Higginbotham (2007). "Preparation of Monolithic Matrices for Oral Drug 
Delivery Using a Supercritical Fluid Assisted Hot Melt Extrusion Process." 
International Journal of Pharmaceutics 329(1-2): 62-71. 
Malaj, L., R. Censi, M. Mozzicafreddo, L. Pellegrino, M. Angeletti, R. Gobetto and P. Di 
Martino (2010). "Influence of Relative Humidity on the Interaction Between 
Different Aryl Propionic Acid Derivatives and Poly(vinylpyrrolydone) K30: 
Evaluation of the Effect on drug Bioavailability." International Journal of 
Pharmaceutics 398(1-2): 61-72. 
Matsuda, Y., R. Akazawa, R. Teraoka and M. Otsuka (1994). "Pharmaceutical Evaluation 
of Carbamazepine Modifications: Comparative Study for Photostability of 
Carbamazepine Polymorphs by using Fourier-transform Reflection-absorption 
Infrared Spectroscopy and Colorimetric Measurement." Journal of Pharmacy and 




McKelvey, C. A., C. D. Brown, L. Schenck, M. Lowinger and J. Moser (2010). 
"Engineering Solid Solutions Physical Properties to Enable Pharmaceutical 
Products". ANTEC 2010. Society of Plastics Engineers, Orlando, FL. USA: 1184-
1188. 
McLaughlin, R., S. Banbury and K. Crowley (2009). "Orally Disintegration Tablets. The 
effect of Recent FDA Guidance on ODT Technologies and Applications." 
Pharmaceutical Technology. 
Meeussen, F., E. Nies, H. Berghmans, S. Verbrugghe, E. Goethals and F. Du Prez (2000). 
"Phase behaviour of poly(N-vinyl caprolactam) in water." Polymer 41(24): 8597-
8602. 
Miller-Chou, B. A. and J. L. Koenig (2003). "A Review of Polymer Dissolution." 
Progress in Polymer Science 28(8): 1223-1270. 
Mills, N. (2007). Polymer Foams Handbook. Engineering and Biomechanics 
Applications and Design Guide. Elsevier, Burlington, MA. USA. 
Moneghini, M., I. Kikic, D. Voinovich, B. Perissutti and J. Filipović-Grčić (2001). 
"Processing of carbamazepine–PEG 4000 solid dispersions with supercritical 
carbon dioxide: preparation, characterisation, and in vitro dissolution." 
International Journal of Pharmaceutics 222(1): 129-138. 
Moraru, C. I. and J. L. Kokini (2003). "Nucleation and Expansion During Extrusion and 
Microwave Heating of Cereal Foods." Comprehensive Reviews in Food Science 
and Food Safety 2(4): 147-165. 
Moribe, K., Y. Tozuka and K. Yamamoto (2008). "Supercritical Carbon Dioxide 
Processing of Active Pharmaceutical Ingredients for Polymorphic Control and for 
Complex Formation." Advanced Drug Delivery Reviews 60(3): 328-338. 
Nagy, Z. K., M. Sauceau, K. Nyúl, E. Rodier, B. Vajna, G. Marosi and J. Fages (2012). 
"Use of Supercritical CO2-Aided and Conventional Melt Extrusion for Enhancing 
the Dissolution Rate of an Active Pharmaceutical Ingredient." Polymers for 





 air,  .,  .   a we a, S. G nen,  . J. Mart  ne -Miranda and S. W. Hoag (2001). 
"Influence of Various Drugs on the Glass Transition Temperature of 
Poly(vinylpyrrolidone): A Thermodynamic and Spectroscopic Investigation." 
International Journal of Pharmaceutics 225(1–2): 83-96. 
Nakamichi, K., H. Yasuura, H. Fukui, M. Oka and S. Izumi (2001). "Evaluation of a 
Floating Dosage Form of Nicardipine Hydrochloride and 
Hydroxypropylmethylcellulose Acetate Succinate Prepared Using a Twin-Screw 
Extruder." International Journal of Pharmaceutics 218(1-2): 103-112. 
Narasimhan, B. (2000). "Accurate Models in Controlled Drug Delivery Systems". 
Handbook of Pharmaceutical Controlled Release Technology. D. L. Wise. Marcel 
Dekker, New York, NY. USA: 155-181. 
Narasimhan, B. (2001). "Mathematical Models Describing Polymer dissolution: 
Consequences for Drug Delivery." Advanced Drug Delivery Reviews 48(2-3): 
195-210. 
Narasimhan, B. and N. A. Peppas (1997). "Molecular Analysis of Drug Delivery Systems 
Controlled by Dissolution of the Polymer Carrier." Journal of Pharmaceutical 
Sciences 86(3): 297-304. 
Nikitine, C., E. Rodier, M. Sauceau, J.-J. Letourneau and J. Fages (2010). "Controlling 
the Structure of a Porous Polymer by Coupling Supercritical CO2 and Single 
Screw Extrusion Process." Journal of Applied Polymer Science 115(2): 981-990. 
NIST. (2011). "NIST Chemistry WebBook."   Retrieved January 2013, from 
http://webbook.nist.gov/chemistry/. 
Nogami, H., T. Nagai and A. Kondo (1970). "Dissolution Kinetics of 
Polyvinylpyrrolidone." Chemical and Pharmaceutical Bulletin 18(6): 1185-1190. 
Oshlack, B., C. Wright and D. J. Haddox (2001). "Tamper-Resistant Oral Opioid Agonist 
Formulations". United States Patent 6,696,088 B2. 
Otsuka, M., F. Kato and Y. Matsuda (2001). "Determination of Indomethacin 
Polymorphic Contents by Chemometric Near-Infrared Spectroscopy and 




Otsuka, M., T. Ofusa and Y. Matsuda (1999). "Effect of Environmental Humidity on the 
Transformation Pathway of Carbamazepine Polymorphic Modifications During 
Grinding." Colloids and Surfaces B: Biointerfaces 13(5): 263-273. 
Ozeki, T., H. Yuasa and Y. Kanaya (1998). "Mechanism of Medicine Release from Solid 
Dispersion Composed of Poly(ethylene oxide)-Carboxyvinylpolymer 
Interpolymer Complex and pH Effect on Medicine Release." International Journal 
of Pharmaceutics 171(1): 123-132. 
Patterson, J. E., M. B. James, A. H. Forster, R. W. Lancaster, J. M. Butler and T. Rades 
(2005). "The Influence of Thermal and Mechanical Preparative Techniques on the 
Amorphous State of Four Poorly Soluble Compounds." Journal of Pharmaceutical 
Sciences 94(9): 1998-2012. 
Patterson, J. E., M. B. James, A. H. Forster, R. W. Lancaster, J. M. Butler and T. Rades 
(2007). "Preparation of Glass Solutions of Three Poorly Water Soluble Drugs by 
Spray Drying, Melt extrusion and Ball milling." International Journal of 
Pharmaceutics 336(1): 22-34. 
Peppas, N. A. and J. J. Sahlin (1989). "A simple Equation for the Description of Solute 
Release III. Coupling of Diffusion and Relaxation." International Journal of 
Pharmaceutics 57(2): 169-172. 
Peppas, N. A., J. C. Wu and E. D. von Meerwall (1994). "Mathematical Modeling and 
Experimental Characterization of Polymer Dissolution." Macromolecules 27(20): 
5626-5638. 
Prodduturi, S., R. V. Manek, W. M. Kolling, S. P. Stodghill and M. A. Repka (2004). 
"Water Vapor Sorption of Hot-Melt Extruded Hydroxypropyl Cellulose Films: 
Effect on Physico-Mechanical Properties, Release Characteristics, and Stability." 
Journal of Pharmaceutical Sciences 93(12): 3047-3056. 
Qi, S., A. Gryczke, P. Belton and D. Q. M. Craig (2008). "Characterisation of Solid 
Dispersions of Paracetamol and EUDRAGIT® E Prepared by Hot-Melt Extrusion 
Using Thermal, Microthermal and Spectroscopic Analysis." International Journal 
of Pharmaceutics 354(1-2): 158-167. 
Ramesh, N. S. (2004). "Fundamentals of Bubble Nucleation and Growth in Polymers". 
Polimeric Foames. Mechanisms and Materials. S. T. Lee and N. S. Ramesh. CRC 




Ramesh, N. S., D. H. Rasmussen and G. A. Campbell (1991). "Numerical and 
Experimental Studies of Bubble Growth During the Microcellular Foaming 
Process." Polymer Engineering & Science 31(23): 1657-1664. 
Repka, M. A., S. K. Battu, S. B. Upadhye, S. Thumma, M. M. Crowley, F. Zhang, C. 
Martin and J. W. McGinity (2007). "Pharmaceutical Applications of Hot-Melt 
Extrusion: Part II." Drug Development and Industrial Pharmacy 33(10): 1043-
1057. 
Ritger, P. L. and N. A. Peppas (1987a). "A Simple Equation for Description of Solute 
Release I. Fickian and Non-fickian Release from Non-swellable Devices in the 
Form of Slabs, Spheres, Cylinders or Discs." Journal of Controlled Release 5(1): 
23-36. 
Ritger, P. L. and N. A. Peppas (1987b). "A simple Equation for Description of Solute 
Release II. Fickian and Anomalous Release from Swellable Devices." Journal of 
Controlled Release 5(1): 37-42. 
Rowe, R. C., P. J. Sheskey and M. E. Quinn (2009). Handbook of Pharmaceutical 
Excipients. Pharmaceutical Press, Washington D.C.. USA. 
Rustichelli, C., G. Gamberini, V. Ferioli, M. C. Gamberini, R. Ficarra and S. Tommasini 
(2000). "Solid-State Study of Polymorphic Drugs: Carbamazepine." Journal of 
Pharmaceutical and Biomedical Analysis 23(1): 41-54. 
Sato, Y., T. Takikawa, S. Takishima and H. Masuoka (2001). "Solubilities and Diffusion 
Coefficients of Carbon Dioxide in Poly(vinyl acetate) and Polystyrene." Journal 
of Supercritical Fluids 19(2): 187-198. 
Sauceau, M., J. Fages, A. Common, C. Nikitine and E. Rodier (2011). "New Challenges 
in Polymer Foaming: A Review of Extrusion Processes Assisted by Supercritical 
Carbon Dioxide." Progress in Polymer Science 36(6): 749-766. 
Saunders, J. H. (1991). "Fundamentals of Foam Formation". Handbook of Polymeric 
Foams and Foam Technology. D. Klempner and K. C. Frisch. Hanser, New York, 
NY. USA: 5-15. 
Schneider, H. A., J. Rieger and E. Penzel (1997). "The Glass Transition Temperature of 
Random Copolymers: 2. Extension of the Gordon-Taylor Equation for 




Sears, J. K. and N. W. Touchette (1985). "Plasticizers". Encyclopedia of Polymer Science 
and Engineering. H. F. Mark, N. M. Bikales, C. G. Oveberger and G. Menges. 
John Wiley & Sons, New York, NY. Supplement: 568-648. 
Sethia, S. and E. Squillante (2004). "Solid Dispersion of Carbamazepine in PVP K30 by 
Conventional Solvent Evaporation and Supercritical Methods." International 
Journal of Pharmaceutics 272(1–2): 1-10. 
Shah, V. P., Y. Tsong, P. Sathe and J.-P. Liu (1998). "In Vitro Dissolution Profile 
Comparison—Statistics and Analysis of the Similarity Factor, f2." Pharmaceutical 
Research 15(6): 889-896. 
Shutov, F. A. (1991). "Cellular Strucuture and Properties of Foamed Polymers". 
Handbook of Polymeric Foams and Foam Technology. D. Klempner and K. C. 
Frisch. Hanser, New York, NY. USA: 16-46. 
Siepmann, J. and N. A. Peppas (2001). "Modeling of Drug Release from Delivery 
Systems Based on Hydroxypropyl Methylcellulose (HPMC)." Advanced Drug 
Delivery Reviews 48(2-3): 139-157. 
Smith, K. L., A. E. Winslow and D. E. Petersen (1959). "Association Reactions for 
Poly(alkylene Oxides) and Polymeric Poly(carboxylic Acids)." Industrial & 
Engineering Chemistry 51(11): 1361-1364. 
Socrates, G. (2000). Infrared and Raman Charcateristic Group Frequencies. Tables and 
Charts. John Wiley & Sons, LTD, New Yrok, NY. USA. 
Sriwongjanya, M. and R. Bodmeier (1998). "Effect of ion exchange resins on the drug 
release from matrix tablets." European Journal of Pharmaceutics and 
Biopharmaceutics 46(3): 321-327. 
Streubel, A., J. Siepmann and R. Bodmeier (2003). "Floating Matrix Tablets Based on 
Low Density Foam Powder: Effects of Formulation and Processing Parameters on 
Drug Release." European Journal of Pharmaceutical Sciences 18(1): 37-45. 
Sun, H., G. S. Sur and J. E. Mark (2002). "Microcellular Foams from Polyethersulfone 
and Polyphenylsulfone: Preparation and Mechanical Properties." European 




Sun, X., H. Liu, G. Li, X. Liao and J. He (2004). "Investigation on the Cell Nucleation 
and Cell growth in Microcellular Foaming by Means of Temperature Quenching." 
Journal of Applied Polymer Science 93(1): 163-171. 
Tadmor, Z. and C. G. Gogos (2006). Principles of Polymer Processing. Wiley-
Interscience, Hoboken, NJ. USA. 
Taylor, L. S. and G. Zografi (1997). "Spectroscopic Characterization of Interactions 
Between PVP and Indomethacin in Amorphous Molecular Dispersions." 
Pharmaceutical Research 14(12): 1691-1698. 
Throne, J. L. (2004). Thermoplastic Foam Extrusion. An Introduction. Hanser, Munich. 
Germany. 
Todd, D. B. (1998). "Introduction to Compounding". Polymer Processing Institute Books 
from Hanser Publishers. D. B. Todd. Hanser/ Gardner Publications, Inc., 
Cincinnati, OH: 1-12. 
Todd, D. B., C. G. Gogos and D. Champarampopoulos (1998). "Helical Barrel 
Rheometer". United States Patent 5,708,197. 
Tomasko, D. L., H. Li, D. Liu, X. Han, M. J. Wingert, L. J. Lee and K. W. Koelling 
(2003). "A Review of CO2 Applications in the Processing of Polymers." Industrial 
& Engineering Chemistry Research 42(25): 6431-6456. 
Ugaonkar, S., A. C. Nunes and T. E. Needham (2007). "Effect of n-scCO2 on crystalline 
to amorphous conversion of carbamazepine." International Journal of 
Pharmaceutics 333(1–2): 152-161. 
Verreck, G., A. Decorte, K. Heymans, J. Adriaensen, D. Cleeren, A. Jacobs, D. Liu, D. 
Tomasko, A. Arien, J. Peeters, P. Rombaut, G. Van den Mooter and M. E. 
Brewster (2005). "The Effect of Pressurized Carbon dioxide as a Temporary 
Plasticizer and Foaming Agent on the Hot Stage Extrusion Process and Extrudate 
Properties of Solid Dispersions of Itraconazole with PVP-VA 64." European 
Journal of Pharmaceutical Sciences 26(3-4): 349-358. 
Verreck, G., A. Decorte, K. Heymans, J. Adriaensen, D. Liu, D. Tomasko, A. Arien, J. 
Peeters, G. Van den Mooter and M. E. Brewster (2006a). "Hot Stage Extrusion of 
p-Amino Salicylic Acid with EC Using CO2 as a Temporary Plasticizer." 




Verreck, G., A. Decorte, K. Heymans, J. Adriaensen, D. Liu, D. L. Tomasko, A. Arien, J. 
Peeters, P. Rombaut, G. Van den Mooter and M. E. Brewster (2007). "The Effect 
of Supercritical CO2 as a Reversible Plasticizer and Foaming Agent on the Hot 
Stage Extrusion of Itraconazole with EC 20 cps." Journal of Supercritical Fluids 
40(1): 153-162. 
Verreck, G., A. Decorte, H. Li, D. Tomasko, A. Arien, J. Peeters, P. Rombaut, G. Van 
den Mooter and M. E. Brewster (2006b). "The Effect of Pressurized Carbon 
Dioxide as a Plasticizer and Foaming Agent on the Hot Melt Extrusion Process 
and Extrudate Properties of Pharmaceutical Polymers." Journal of Supercritical 
Fluids 38(3): 383-391. 
Vrentas, J. S., C. M. Jarzebski and J. L. Duda (1975). "A Deborah Number for Diffusion 
in Polymer-Solvent Systems." AIChE Journal 21(5): 894-901. 
Wade, L. G., Jr. (1993). Quimica Organica (In Spanish). Pearson Educacion, Mexico 
D.C.. Mexico. 
Wishart, D., C. Knox and V. Law. (2012). "DrugBank. Open Data Drug & Drug Target 
Database."   Retrieved September, 2012, from http://www.drugbank.ca/. 
Wolff, F. F., L. Zirkel, S. Betzold, M. Jakob, V. Maier, F. Nachtrab, B. C. Nicolat, T. Fey 
and H. Münstedt (2011). "Using Supercritical Carbon Dioxide for Physical 
Foaming of Advanced Polymer Materials." International Polymer Processing 
26(4): 437-443. 
Yang, M., P. Wang, C.-Y. Huang, M. S. Ku, H. Liu and C. G. Gogos (2010). "Solid 
Dispersion of Acetaminophen and Poly(ethylene oxide) Prepared by Hot-Melt 
Mixing." International Journal of Pharmaceutics 395(1-2): 53-61. 
Yang, M., P. Wang, H. Suwardie and C. G. Gogos (2011). "Determination of 
Acetaminophen's Solubility in Poly(ethylene oxide) by Rheological, Thermal and 
Microscopic Methods." International Journal of Pharmaceutics 403(1-2): 83-89. 
Yazdanian, M., K. Briggs, C. Jankovsky and A. Hawi (2004). "The “High Solubilit ” 
Definition of the Current FDA Guidance on Biopharmaceutical Classification 





Zhang, F. and J. DiNunzio (2010). "Application of Hot-Melt Extrusion for Bioavailability 
Enhancement of Poorly Soluble Drugs". ANTEC 2010. Society of Plastic 
Engineers, Orlando, FL. USA: -. 
Zhang, G. G. Z., D. Law, E. A. Schmitt and Y. Qiu (2004). "Phase Transformation 
Considerations During Process Development and Manufacture of Solid oral 
Dosage Forms." Advanced Drug Delivery Reviews 56(3): 371-390. 
Zhang, Q. and M. Xanthos (2004). "Material Properties Affecting Extrusion Foaming". 
Polymeric Foams. Mechanisms and Materials. S. T. Lee and N. S. Ramesh. CRC 
Press, Washington, D.C.. USA. 
Zhang, X., I. Burgar, M. D. Do and E. Lourbakos (2005). "Intermolecular Interactions 
and Phase Structures of Plasticized Wheat Proteins Materials." 
Biomacromolecules 6(3): 1661-1671. 
 
 
